# EDGAR Filing Document

**Accession Number:** 0000931015
**File Stem:** 0001308179-26-000087
**Filing Date:** 2026-3
**Character Count:** 432499
**Document Hash:** 619e2013610952f01179441197cfed0f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001308179-26-000087.hdr.sgml**: 20260317

**ACCESSION NUMBER**: 0001308179-26-000087

**CONFORMED SUBMISSION TYPE**: DEF 14A

**PUBLIC DOCUMENT COUNT**: 76

**CONFORMED PERIOD OF REPORT**: 20260430

**FILED AS OF DATE**: 20260317

**DATE AS OF CHANGE**: 20260317

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Polaris Inc.
- **CENTRAL INDEX KEY:** 0000931015
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS TRANSPORTATION EQUIPMENT [3790]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 411790959
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEF 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11411
- **FILM NUMBER:** 26762865

**BUSINESS ADDRESS:**
- **STREET 1:** 2100 HIGHWAY 55
- **CITY:** MEDINA
- **STATE:** MN
- **ZIP:** 55340
- **BUSINESS PHONE:** (763) 542-0500

**MAIL ADDRESS:**
- **STREET 1:** 2100 HIGHWAY 55
- **STREET 2:** NONE
- **CITY:** MEDINA
- **STATE:** MN
- **ZIP:** 55340

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** POLARIS INDUSTRIES INC/MN
- **DATE OF NAME CHANGE:** 19941004

?xml version='1.0' encoding='ASCII'? Polaris Inc. - DEF 14A

[**Table of Contents**](#toc)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934 (Amendment No.)

☑ Filed by the Registrant ☐ Filed by a party other than the Registrant &nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| CHECK THE APPROPRIATE BOX: | CHECK THE APPROPRIATE BOX: |
| ☐ | Preliminary Proxy Statement |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☑ | Definitive Proxy Statement |
| ☐ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 |

---

![](pro014545_def14ax2x2.jpg)

**Polaris Inc.**

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

---

| | |
|:---|:---|
| PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY): | PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY): |
| ☑ | No fee required |
| ☐ | Fee paid previously with preliminary materials |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |

---

------

[**Table of Contents**](#toc)

![](pro014545_def14ax1x1.jpg)

------

[**Table of Contents**](#toc)

---

| | |
|:---|:---|
| ![](pro014545_def14ax2x2.jpg) | ![](pro014545_def14ax2x1.jpg) |

---

---

| | | | |
|:---|:---|:---|:---|
| ![](pro014545_def14ax2x3.jpg) | &nbsp;&nbsp;&nbsp;**John P. Wiehoff**<br> **Chair of the Board** | ![](pro014545_def14ax2x4.jpg) | &nbsp;&nbsp;&nbsp;**Michael T. Speetzen**<br> **Chief Executive Officer** |

---

On behalf of the Board of Directors and the executive leadership team, we invite you to attend the Polaris Annual Meeting of Stockholders on April 30, 2026, at 9:00 a.m. Central Time. We are grateful for your continued support of Polaris, particularly as our industry navigates this challenging and rapidly evolving environment.

2025 was a year marked by headwinds outside our control, such as shifting tariff regulations, weakened consumer confidence, and industry-wide pressure. Throughout these challenges, the Board and leadership team remained steadfast in our commitment to the Company's long-term strategy and to managing the variables within the Company's control. Management implemented a tariff-mitigation strategy and set a goal of lowering China-based spend by 80% by year-end 2027. Consumers responded positively to our product innovation and new product launches, and our deliberate efforts to manage inventory provided support to our dealer network. As a result, the Company delivered on its commitments to gain share across all segments, enhance operations, and achieve healthy dealer inventory levels. These results are evidence of disciplined execution and a resilient strategy.

As part of our long-term strategy focused on growth and creating stockholder value, the Board and management reevaluated the continuation of the Indian Motorcycle business as part of Polaris' business model. After much consideration and a thorough analysis, the Company separated and divested the Indian Motorcycle business, a transaction which closed in the first quarter of 2026. This decision supports the Company's strategy of creating long-term profitability by focusing on the core powersports segment. The Board also approved an increase in the Company's dividend to stockholders, marking the 31st year of dividend increases and continuing the Company's status as a Dividend Aristocrat.

Despite the dynamic environment, the Board remains intentional in prioritizing strategic decisions that emphasize long-term value creation, including meaningful investments in our employees, to ensure the company remains well-positioned for sustainable growth. In January 2025, in light of the challenging environment, the Board adjusted the annual equity grant structure - shifting to a higher proportion of time-based restricted stock units and eliminating performance-based restricted stock units - to better support retention and stability in a difficult and rapidly evolving environment. The Board continues to assess the Company's compensation program to balance employee retention and business stability with incentives for performance and creating stockholder value.

The Board also continues to evolve. We want to express our gratitude to Kevin Farr, who recently retired from the Board after more than ten years of dedicated service and contributions to the Board, the Compensation Committee, and the Audit Committee, where he served as Chair for many years. Kevin's insights and expertise were invaluable to the Board, and he will be missed.

In closing, on behalf of the Board and the executive leadership team, we extend our deep gratitude to the Company's employees for their continued dedication and grit during challenging times. We also want to acknowledge our stockholders, and thank you for your loyalty and passion for Polaris. We remain committed to the Company's long-term growth strategy that we believe will position us to lead the industry, drive profitable growth, and deliver strong returns for stockholders.

Sincerely,

---

| | |
|:---|:---|
| ![](pro014545_def14ax2x5.jpg) | ![](pro014545_def14ax2x6.jpg) |

---

**1**

------

[**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Polaris Inc.**<br> 2100 Highway 55<br> Medina, Minnesota 55340 | Notice of<br> **Annual Meeting**<br> **of Stockholders** |

---

**Thursday, April 30, 2026**

**9:00 a.m. Central Time**

Polaris Inc. will hold its 2026 Annual Meeting of Stockholders on Thursday, April 30, 2026, at 9:00 a.m. Central Time in a virtual format. You may attend the meeting, submit questions, and vote your shares electronically during the meeting by visiting www.virtualshareholdermeeting.com/PII2026. You will need the 16-digit control number that is printed on your Notice of Internet Availability of Proxy Materials or proxy card to enter the Annual Meeting site. We recommend that you log in at least 15 minutes before the meeting begins.

At the meeting, our stockholders will be asked to:

---

| | |
|:---|:---|
| 1 | Elect three Class II directors for three-year terms ending in 2029. |
| 2 | Approve, on an advisory basis, the compensation of our Named Executive Officers. |
| 3 | Adopt the Amended & Restated 2024 Polaris Inc. Omnibus Incentive Plan. |
| 4 | Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2026. |
| 5 | Act on any other matters that may properly come before the meeting. |

---

Only stockholders of record at the close of business on March 9, 2026 may vote at the Annual Meeting or any adjournment thereof. The proxy materials were either made available to you over the Internet or mailed to you beginning on or about March 17, 2026.

By Order of the Board of Directors

![](pro014545_def14ax3x1.jpg)

**Matthew S. Winings**

Senior Vice President, General Counsel and Corporate Secretary

March 17, 2026

**How to Participate in the Virtual Annual Meeting**

---

| | | |
|:---|:---|:---|
| ![](pro014545_def14ax3x2.jpg) | ![](pro014545_def14ax3x3.jpg) | ![](pro014545_def14ax3x4.jpg) |
| **PARTICIPATE VIA THE INTERNET** | **VOTE DURING THE MEETING** | **SUBMIT QUESTIONS** |
| Visit<br> www.virtualshareholdermeeting.com/PII2026 | Click on<br> the vote button on the virtual meeting home page | Questions may be submitted live during the meeting by typing them in the dialog box on the bottom corner of the screen |

---

**For technical assistance on the day of the Annual Meeting, call the support line at 800-986-0822 (Toll Free) or 303-562-9302 (International Toll)**

**Other Ways to Vote Your Shares**

---

| | | |
|:---|:---|:---|
| ![](pro014545_def14ax3x5.jpg) | ![](pro014545_def14ax3x6.jpg) | ![](pro014545_def14ax3x7.jpg) |
| **INTERNET** | **TELEPHONE** | **MAIL** |
| Go to http://www.proxyvote.com and follow the instructions. You will need your proxy card or internet notice | Dial 1-800-690-6903 and follow the instructions <br> You will need your proxy card or internet notice | If you received paper copies of our proxy materials, mark your selection on the enclosed proxy card, date and sign your name, and promptly mail the proxy card in the postage-paid envelope provided |

---

**Please see page 94 for proxy voting deadlines. If you are a "street name" stockholder (meaning that your shares are registered in the name of your bank or broker), you will receive instructions from your bank, broker or other nominee explaining how to vote your shares.** 

**YOUR VOTE IS IMPORTANT!**

**IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE 2026 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON APRIL 30, 2026.**

**The Notice of Annual Meeting, our Proxy Statement for the 2026 Annual Meeting of Stockholders, the proxy card and our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 are available at https://materials.proxyvote.com/731068.**

**2**

------

[**Table of Contents**](#toc)

**Table of Contents**

---

| | |
|:---|:---|
| **[Notice of Annual Meeting of Stockholders](#pro014545_def14aa001)** | **[2](#pro014545_def14aa001)** |
| **[Proxy Statement Summary](#pro014545_def14aa002)** | **[6](#pro014545_def14aa002)** |
| [2026 Annual Meeting of Stockholders](#pro014545_def14aa003) | [6](#pro014545_def14aa003) |
| [Voting Roadmap](#pro014545_def14aa004) | [6](#pro014545_def14aa004) |
| [Business and Strategic Overview](#pro014545_def14aa005) | [7](#pro014545_def14aa005) |
| [Corporate Governance Highlights](#pro014545_def14aa006) | [8](#pro014545_def14aa006) |
| [Executive Compensation Highlights](#pro014545_def14aa007) | [9](#pro014545_def14aa007) |
| [Corporate Responsibility](#pro014545_def14aa008) | [10](#pro014545_def14aa008) |
| **[Corporate Governance](#pro014545_def14aa009)** | **[12](#pro014545_def14aa009)** |
| [Corporate Governance Guidelines](#pro014545_def14aa010) | [12](#pro014545_def14aa010) |
| [Board Structure](#pro014545_def14aa011) | [12](#pro014545_def14aa011) |
| [Board Leadership Structure](#pro014545_def14aa012) | [12](#pro014545_def14aa012) |
| [Board Independence](#pro014545_def14aa013) | [13](#pro014545_def14aa013) |
| [Committees of the Board](#pro014545_def14aa014) | [13](#pro014545_def14aa014) |
| [Risk Oversight](#pro014545_def14aa015) | [16](#pro014545_def14aa015) |
| [Board Effectiveness and Evaluations](#pro014545_def14aa016) | [17](#pro014545_def14aa016) |
| [Shareholder Engagement](#pro014545_def14aa017) | [18](#pro014545_def14aa017) |
| [Board Meetings](#pro014545_def14aa018) | [18](#pro014545_def14aa018) |
| [Director Orientation and Continuing Education](#pro014545_def14aa019) | [19](#pro014545_def14aa019) |
| [Director Retirement Policy](#pro014545_def14aa020) | [19](#pro014545_def14aa020) |
| [Outside Board Service](#pro014545_def14aa021) | [19](#pro014545_def14aa021) |
| [Certain Relationships and Related Transactions](#pro014545_def14aa022) | [19](#pro014545_def14aa022) |
| [Code of Business Conduct and Ethics](#pro014545_def14aa023) | [20](#pro014545_def14aa023) |
| [Insider Trading Policies and Procedures](#pro014545_def14aa024) | [20](#pro014545_def14aa024) |
| [Communications with the Board](#pro014545_def14aa025) | [20](#pro014545_def14aa025) |
| **[Proposal 1 — Election of Directors](#pro014545_def14aa026)** | **[21](#pro014545_def14aa026)** |
| [General Information](#pro014545_def14aa027) | [21](#pro014545_def14aa027) |
| [Board Refreshment](#pro014545_def14aa028) | [21](#pro014545_def14aa028) |
| [Stockholder Nominations or Recommendations of Directors](#pro014545_def14aa029) | [22](#pro014545_def14aa029) |
| [Director Skills and Qualifications Criteria](#pro014545_def14aa030) | [22](#pro014545_def14aa030) |
| [Information Concerning Nominees and Continuing Directors](#pro014545_def14aa031) | [25](#pro014545_def14aa031) |
| **[Director Compensation](#pro014545_def14aa032)** | **[30](#pro014545_def14aa032)** |
| **[Compensation Discussion and Analysis](#pro014545_def14aa033)** | **[34](#pro014545_def14aa033)** |
| [Executive Summary](#pro014545_def14aa034) | [34](#pro014545_def14aa034) |
| [Executive Compensation Program Components](#pro014545_def14aa035) | [39](#pro014545_def14aa035) |
| [Determining Executive Compensation](#pro014545_def14aa036) | [40](#pro014545_def14aa036) |
| [Compensation Decisions](#pro014545_def14aa037) | [42](#pro014545_def14aa037) |
| [Other Executive Compensation Arrangements, Policies and Practices](#pro014545_def14aa038) | [46](#pro014545_def14aa038) |
| **[Compensation Risk Assessment](#pro014545_def14aa039)** | **[49](#pro014545_def14aa039)** |

---

**3**

------

[**Table of Contents**](#toc)

**Table of Contents**

---

| | |
|:---|:---|
| **[Compensation Committee Report](#pro014545_def14aa040)** | **[50](#pro014545_def14aa040)** |
| **[Executive Compensation](#pro014545_def14aa041)** | **[51](#pro014545_def14aa041)** |
| [Summary Compensation Table](#pro014545_def14aa042) | [51](#pro014545_def14aa042) |
| [All Other Compensation Table](#pro014545_def14aa043) | [52](#pro014545_def14aa043) |
| [Grants of Plan-Based Awards](#pro014545_def14aa044) | [53](#pro014545_def14aa044) |
| [Outstanding Equity Awards at Fiscal Year-End](#pro014545_def14aa045) | [54](#pro014545_def14aa045) |
| [Option Exercises and Stock Vested in 2025](#pro014545_def14aa046) | [57](#pro014545_def14aa046) |
| [Policies and Practices Regarding the Timing of Grants of Certain Equity Awards](#pro014545_def14aa047) | [58](#pro014545_def14aa047) |
| [Nonqualified Deferred Compensation](#pro014545_def14aa048) | [58](#pro014545_def14aa048) |
| **[Potential Payments Upon Termination or Change In Control](#pro014545_def14aa049)** | **[61](#pro014545_def14aa049)** |
| [Severance Arrangements with Named Executive Officers](#pro014545_def14aa050) | [61](#pro014545_def14aa050) |
| [Equity Award Treatment Upon Termination](#pro014545_def14aa051) | [62](#pro014545_def14aa051) |
| [Non-Compete and Non-Solicitation Agreements](#pro014545_def14aa052) | [63](#pro014545_def14aa052) |
| [Potential Payments to Our Named Executive Officers Upon Termination](#pro014545_def14aa053) | [64](#pro014545_def14aa053) |
| [Potential Payments to Our Named Executive Officers](#pro014545_def14aa054) | [65](#pro014545_def14aa054) |
| **[Pay Ratio Disclosure](#pro014545_def14aa055)** | **[67](#pro014545_def14aa055)** |
| **[Pay Versus Performance Disclosure](#pro014545_def14aa056)** | **[68](#pro014545_def14aa056)** |
| **[Equity Compensation Plan Information](#pro014545_def14aa057)** | **[71](#pro014545_def14aa057)** |
| **[Proposal 2 — Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers](#pro014545_def14aa058)** | **[72](#pro014545_def14aa058)** |
| **[Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan](#pro014545_def14aa059)** | **[73](#pro014545_def14aa059)** |
| [Introduction](#pro014545_def14aa060) | [73](#pro014545_def14aa060) |
| [Why We Recommend That You Vote for This Proposal](#pro014545_def14aa061) | [73](#pro014545_def14aa061) |
| [Factors Considered in Setting Size of Requested Share Reserve](#pro014545_def14aa062) | [74](#pro014545_def14aa062) |
| [Key Compensation Practices Reflected in the A&R 2024 Plan](#pro014545_def14aa063) | [75](#pro014545_def14aa063) |
| [Summary of Other Material Terms of the A&R 2024 Plan](#pro014545_def14aa064) | [76](#pro014545_def14aa064) |
| [U.S. Federal Income Tax Consequences](#pro014545_def14aa065) | [83](#pro014545_def14aa065) |
| [New Plan Benefits](#pro014545_def14aa066) | [84](#pro014545_def14aa066) |
| [Historical Awards](#pro014545_def14aa067) | [85](#pro014545_def14aa067) |
| [Registration with the SEC](#pro014545_def14aa068) | [85](#pro014545_def14aa068) |
| **[Proposal 4 — Ratification of Appointment of Independent Registered Public Accounting Firm](#pro014545_def14aa069)** | **[86](#pro014545_def14aa069)** |
| **[Audit Committee Report](#pro014545_def14aa070)** | **[87](#pro014545_def14aa070)** |
| **[Fees Paid to Independent Registered Public Accounting Firm](#pro014545_def14aa071)** | **[88](#pro014545_def14aa071)** |
| **[Security Ownership of Certain Beneficial Owners and Management](#pro014545_def14aa072)** | **[89](#pro014545_def14aa072)** |
| [Delinquent Section 16(a) Reports](#pro014545_def14aa073) | [91](#pro014545_def14aa073) |

---

**4**

------

[**Table of Contents**](#toc)

**Table of Contents**

---

| | |
|:---|:---|
| **[Questions and Answers about the Annual Meeting and Voting](#pro014545_def14aa074)** | **[92](#pro014545_def14aa074)** |
| **[Submission of Shareholder Proposals and Nominations](#pro014545_def14aa075)** | **[96](#pro014545_def14aa075)** |
| **[Cautionary Note Regarding Forward-Looking Statements](#pro014545_def14aa076)** | **[96](#pro014545_def14aa076)** |
| **[Additional Information](#pro014545_def14aa077)** | **[97](#pro014545_def14aa077)** |
| [Householding](#pro014545_def14aa078) | [97](#pro014545_def14aa078) |
| [Annual Reports](#pro014545_def14aa079) | [97](#pro014545_def14aa079) |
| **[Appendix A](#pro014545_def14aa080)** | **[98](#pro014545_def14aa080)** |
| [Non-GAAP Reconciliation of Results](#pro014545_def14aa081) | [98](#pro014545_def14aa081) |
| **[Appendix B](#pro014545_def14aa082)** | **[100](#pro014545_def14aa082)** |
| [Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)](#pro014545_def14aa083) | [100](#pro014545_def14aa083) |

---

------

[**Table of Contents**](#toc)

**Proxy Statement Summary**

**2026 Annual Meeting of Stockholders**

---

| | | | |
|:---|:---|:---|:---|
| ![](pro014545_def14ax7x1.jpg) | ![](pro014545_def14ax7x2.jpg) | ![](pro014545_def14ax7x3.jpg) | ![](pro014545_def14ax7x4.jpg) |
| **Date and Time** | **Place** | **Proxy Mailing Date** | **Record Date** |
| Thursday, April 30, 2026<br> 9:00 a.m. Central Time | www.virtualshareholdermeeting.com/PII2026 | March 17, 2026 | March 9, 2026 |

---

**Voting Roadmap**

---

| | | | |
|:---|:---|:---|:---|
|  | **Proposals** | **Board Recommendation** | **Details** |
| ● | **Proposal 1** **–** Election of three Class II directors for three-year terms ending in 2029 | FOR EACH NOMINEE | Page 21 |
| ● | **Proposal 2 –** Approval, on an advisory basis, of the compensation of our Named Executive Officers | FOR | Page 72 |
| ● | **Proposal 3 –** Adoption of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan | FOR | Page 73 |
| ● | **Proposal 4 –** Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2026 | FOR | Page 86 |

---

**Information About the Director Nominees and Continuing Directors**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name** | **Age** | **Director**<br> **Since** | **Independent** | **Audit<br> Committee** | **Compensation**<br> **Committee** | **Corporate**<br> **Governance and**<br> **Nominating**<br> **Committee** | **Technology &**<br> **Innovation**<br> **Committee** |
| **Nominees for election at the 2026 Annual Meeting (Class II Term Ending 2029)** | **Nominees for election at the 2026 Annual Meeting (Class II Term Ending 2029)** | **Nominees for election at the 2026 Annual Meeting (Class II Term Ending 2029)** | **Nominees for election at the 2026 Annual Meeting (Class II Term Ending 2029)** | **Nominees for election at the 2026 Annual Meeting (Class II Term Ending 2029)** | **Nominees for election at the 2026 Annual Meeting (Class II Term Ending 2029)** | **Nominees for election at the 2026 Annual Meeting (Class II Term Ending 2029)** | |
| George W. Bilicic\* | 62 | 2017 | Yes | X |  | C |  |
| Gary E. Hendrickson | 69 | 2011 | Yes |  | C | X |  |
| Gwenne A. Henricks | 68 | 2015 | Yes | X |  |  | X |
| **Directors with terms expiring 2027 (Class III)** | **Directors with terms expiring 2027 (Class III)** | **Directors with terms expiring 2027 (Class III)** | **Directors with terms expiring 2027 (Class III)** | **Directors with terms expiring 2027 (Class III)** | **Directors with terms expiring 2027 (Class III)** | **Directors with terms expiring 2027 (Class III)** |  |
| Darryl R. Jackson\* | 65 | 2021 | Yes | C |  | X |  |
| Michael T. Speetzen | 56 | 2021 | No |  |  |  |  |
| John P. Wiehoff(1)\* | 64 | 2007 | Yes | X | X | X |  |
| **Directors with terms expiring 2028 (Class I)** | **Directors with terms expiring 2028 (Class I)** | **Directors with terms expiring 2028 (Class I)** | **Directors with terms expiring 2028 (Class I)** | **Directors with terms expiring 2028 (Class I)** | **Directors with terms expiring 2028 (Class I)** | **Directors with terms expiring 2028 (Class I)** |  |
| Bernd F. Kessler | 67 | 2010 | Yes |  |  | X | C |
| Lawrence D. Kingsley | 63 | 2016 | Yes |  | X |  | X |
| Gwynne E. Shotwell | 62 | 2019 | Yes | X |  |  | X |

---

X Member&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C Chair&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; \* Audit Committee Financial Experts&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1) Board Chair

---

| | |
|:---|:---|
| **6**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proxy Statement Summary**

**Business and Strategic Overview**

**Business and Strategic Overview**

![](pro014545_def14ax8x1.jpg)

**2025 Performance Results**

Our performance highlights from 2025 reflect our commitment to focus on what is controllable, while navigating a volatile tariff environment and consumer economic uncertainty.

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**Sales** | **<u>REPORTED</u>**<br>**$7,152M** | **<u>YoY Change</u>**<br>**Flat** | **<u>ADJUSTED\*</u>**<br>**$7,143M** | **<u>YoY Change\*</u>**<br>**Flat** |
| **Gross Profit Margin** | **19.1%** | **-130bps** | **19.4%** | **-131bps** |
| **Net Income** | **($466M)** | **($576M)** | **($0.5M)** | **($185M)** |
| **Adjusted EBITDA** | **n/a** | **n/a** | **$410M** | **-35%** |
| **Adjusted EBITDA Margin** | **n/a** | **n/a** | **5.7%** | **-311bps** |

---

*\** *Adjusted financial results: see Appendix A for a reconciliation of non-GAAP financial measures to the most directly comparable financial measures.*

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **7** |

---

------

[**Table of Contents**](#toc)

**Proxy Statement Summary**

**Corporate Governance Highlights**

**Corporate Governance Highlights**

**What We Do**

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;![](pro014545_def14ax9x1.jpg) | &nbsp;&nbsp;&nbsp;Majority independent Board with an independent Chair | ![](pro014545_def14ax9x1.jpg) | &nbsp;&nbsp;&nbsp;Board oversight of risk management and strategy |
| &nbsp;&nbsp;![](pro014545_def14ax9x2.jpg) | &nbsp;&nbsp;&nbsp;Majority voting standard for uncontested director elections | ![](pro014545_def14ax9x2.jpg) | &nbsp;&nbsp;&nbsp;Age limit of 72 for directors |
| &nbsp;&nbsp;![](pro014545_def14ax9x1.jpg) | &nbsp;&nbsp;&nbsp;Executive sessions of independent directors before and/or after each Board meeting | ![](pro014545_def14ax9x1.jpg) | &nbsp;&nbsp;&nbsp;Non-employee director and executive stock ownership requirements |
| &nbsp;&nbsp;![](pro014545_def14ax9x2.jpg) | &nbsp;&nbsp;&nbsp;Independent Board committees | ![](pro014545_def14ax9x2.jpg) | &nbsp;&nbsp;&nbsp;Code of Conduct applicable to all directors and executives |
| &nbsp;&nbsp;![](pro014545_def14ax9x1.jpg) | &nbsp;&nbsp;&nbsp;Substantive annual Board and Committee self-evaluations and periodic independent Board assessment process | ![](pro014545_def14ax9x1.jpg) | &nbsp;&nbsp;&nbsp;NYSE-compliant clawback policy |
| &nbsp;&nbsp;![](pro014545_def14ax9x2.jpg) | &nbsp;&nbsp;&nbsp;Active shareholder engagement program | ![](pro014545_def14ax9x2.jpg) | &nbsp;&nbsp;&nbsp;Robust director orientation and continuing education programs |

---

**Board Composition**

---

| | | | |
|:---|:---|:---|:---|
| **INDEPENDENCE** | **AVERAGE AGE** | **AVERAGE TENURE** | **DIVERSITY** |
| ![](pro014545_def14ax9x3.jpg) | ![](pro014545_def14ax9x3.jpg) | ![](pro014545_def14ax9x3.jpg) | ![](pro014545_def14ax9x3.jpg) |

---

------

---

| | |
|:---|:---|
| ![](pro014545_def14ax9x4.jpg) | &nbsp;&nbsp;&nbsp;Polaris directors <br> have a diverse <br> range of <br> qualifications <br> and skills |

---

---

| | |
|:---|:---|
| **8**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proxy Statement Summary**

**Executive Compensation Highlights**

**Executive Compensation Highlights**

**Compensation Philosophy**

We align executive compensation decisions with our desired business direction, strategy and performance. The key principles of our approach are outlined below:

![](pro014545-def14ax11x1.jpg)

**Compensation Program Design**

Our executive compensation program is designed to motivate our executives to develop strategies and pursue priorities that promote growth and deliver strong returns to stockholders. Below we illustrate the key tenets of our compensation program and the percentage of the 2025 target total direct compensation opportunity for Mr. Speetzen and the other named executive officers ("NEOs") as a group that each compensation component represents.

![](pro014545-def14ax11x2.jpg)

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **9** |

---

------

[**Table of Contents**](#toc)

**Proxy Statement Summary**

**Corporate Responsibility**

**Corporate Responsibility**

At Polaris, we are continually striving to be good stewards for our employees, riders, communities, industry and the outdoors. As the global leader in powersports, we set a high bar and continue to raise it, holding ourselves accountable by setting measurable, time-specific goals and by tracking our progress. We are committed to working toward the following goals and aspirations and communicating transparently about our progress as we learn and adapt along the way. For more detailed information, see our most recent Geared for Good report, which is available on our website.

![](pro014545-def14ax12x1.jpg)

---

| | |
|:---|:---|
| **10**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proxy Statement Summary**

**Corporate Responsibility**

![](pro014545-def14ax13x1.jpg)

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **11** |

---

------

[**Table of Contents**](#toc)

**Corporate Governance**

Our Board of Directors is committed to good corporate governance, which it believes will enhance the long-term stability and value of the Company to the benefit of all stakeholders. The Board believes that transparent disclosure of its governance practices helps stockholders assess the stability and value of the Company.

**Corporate Governance Guidelines**

Our Corporate Governance Guidelines, which are available on our website at *ir.polaris.com/investors/corporate-governance*, cover a range of topics, including director selection and qualification, director responsibilities and operation of the Board, director access to management and independent advisors, succession planning, and the Board's annual evaluations. The Board annually reviews the Corporate Governance Guidelines and updates them, as appropriate, to reflect oversight of best practices and to respond to stockholder feedback. In 2025, the Board amended the Corporate Governance Guidelines to reflect a more holistic approach to evaluating director time commitments so that our directors are able to devote the time and attention necessary for effective service on our Board.

**Board Structure**

The Board has nine members and is divided into three classes. The members of one class are elected at each annual meeting of stockholders to serve a three-year term. The Board regularly reviews its classified structure and considers stockholder feedback. The Board believes a classified board structure allows the Board to more effectively focus on generating long-term stockholder value by helping to insulate directors from potential outside pressure to focus more on short-term results. A classified Board provides Polaris stockholders with stability and continuity and ensures that, at any given time, the Board includes directors who have extensive knowledge of the Company and its business, competitive dynamics, and strategic goals.

**Board Leadership Structure**

John Wiehoff serves as independent Chair of the Board. The Board believes that an effective governance structure balances the powers of the Chief Executive Officer ("CEO") and the independent directors so the independent directors can be fully informed, can discuss and debate the issues that they deem important, and can provide effective oversight of management. The Board believes that the separation of the Chair and CEO roles is appropriate for us at this time because it allows our CEO to focus on executing Company priorities while the independent Chair focuses on leading the Board. The Board reassesses its leadership structure as needed and has the flexibility to choose a different leadership structure when our directors believe circumstances warrant.

The duties and responsibilities of the independent Chair include:

**CHAIR DUTIES AND RESPONSIBILITIES**

● Presides over Board executive sessions of independent
 directors &nbsp;&nbsp;&nbsp;&nbsp; ● Approves Board meeting agendas

● Serves as the liaison between the CEO and independent directors ● Has authority to call meetings of independent directors

● If requested by major stockholders, is available for consultation and direct
 communication ● Conducts and facilitates the annual Board self-evaluation and individual
 director interviews

● Communicates with the CEO about strategic business issues, governance processes
 and board relationships ● Coordinates with the Compensation Committee on the CEO evaluation

---

| | |
|:---|:---|
| **12**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Corporate Governance**

**Board Independence**

**Board Independence**

Our Corporate Governance Guidelines, which adopt the current standards for "independence" established by the New York Stock Exchange (the "NYSE"), require a majority of the members of the Board to be independent as determined by the Board. As part of its annual review of independence for each director, the Board must determine that the director has no material relationship with Polaris, either directly or indirectly as a partner, stockholder or officer of an organization that has a relationship with us. In making this independence determination, the Board broadly considers all relevant facts and circumstances, including director tenure. The Board has determined that our entire Board (including Kevin M. Farr, who retired as a member of the Board in January 2026), other than Mr. Speetzen, our CEO, is independent.

The Board based its most recent independence determinations, in part, upon a review by the Corporate Governance and Nominating Committee and the Board of certain transactions between Polaris and companies with which certain of our directors have relationships. Each of these transactions was made in the ordinary course of business, at arm's length, at prices and on terms customarily available to unrelated third-party vendors or customers generally, in amounts that are not material to our business or the business of the counterparty. In addition, no director had a direct or indirect personal interest, or received any personal benefit from any such transaction. Specifically, the Corporate Governance and Nominating Committee and the Board reviewed ordinary course purchases by Polaris from US Bancorp, where Mr. Wiehoff serves as a director, and ordinary course purchases by Polaris from the Mayo Clinic, where Mr. Bilicic serves as a trustee. All of these payments were less than the greater of $1,000,000 or 2% of the recipient's gross revenues in fiscal 2023, 2024 and 2025.

**Committees of the Board**

The Board has designated four standing committees: Audit, Compensation, Corporate Governance and Nominating, and Technology & Innovation. Each committee operates under a written charter that is available on our website at *ir.polaris.com/investors/corporate-governance*. All members of all the Board committees have been determined by the Board to be independent.

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Audit Committee**<br>**Members:**<br>Darryl R. Jackson, Chair\*<br> George W. Bilicic\*<br> Gwenne A. Henricks<br> Gwynne E. Shotwell<br> John P. Wiehoff\*<br>**Number of Meetings During 2025: 9**<br>\*Audit committee financial expert | &nbsp;&nbsp;&nbsp;The primary function of the Audit Committee is to assist the Board in fulfilling its fiduciary responsibilities by overseeing our financial reporting and public disclosure activities. The Audit Committee's primary purposes and responsibilities are to:<br><sup>●</sup> <br> assist the Board in its oversight of (a) the integrity of our financial statements, (b) the effectiveness of our internal control over financial reporting, (c) our compliance with legal and regulatory requirements, (d) the independent auditor's performance, qualifications and independence, and (e) the responsibilities, performance, budget and staffing of our internal audit function;<br> <sup>●</sup> <br> prepare required reports for our annual proxy statement, including the Audit Committee Report that appears later in this proxy statement;<br> <sup>●</sup> <br> serve as an independent and objective party to monitor our financial reporting process and internal control system; and<br> <sup>●</sup> <br> provide an open avenue of communication among the independent auditor, financial and senior management, the internal auditors and the Board.<br> The Audit Committee is directly responsible for the appointment, compensation, retention and oversight of the work of any independent auditor that Polaris engages, including resolution of disagreements between management and the independent auditor regarding financial reporting for the purpose of preparing the independent auditor's audit report or related work or performing other audit, review or attest services for the Company. Each such independent auditor reports directly to the Audit Committee.<br>All members of the Audit Committee have been determined to be "independent" and "financially literate" by the Board as defined in with our Corporate Governance Guidelines, rules of the United States Securities and Exchange Commission (the "SEC"), and applicable NYSE listing requirements. |

---

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **13** |

---

------

[**Table of Contents**](#toc)

**Corporate Governance**

**Committees of the Board**

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Compensation Committee**<br>**Members:**<br>Gary E. Hendrickson, Chair<br> Lawrence D. Kingsley<br> John P. Wiehoff<br>**Number of Meetings During 2025: 5**<br>| &nbsp;&nbsp;&nbsp;The primary purpose of the Compensation Committee is to assist the Board in fulfilling its responsibilities relating to the:<br><sup>●</sup> <br> compensation of our directors;<br> <sup>●</sup> <br> compensation of our CEO;<br> <sup>●</sup> <br> compensation of our other executive officers;<br> <sup>●</sup> <br> oversight of Company-wide compensation philosophy, programs, and policies;<br> <sup>●</sup> <br> executive management retention, development and succession planning; and<br> <sup>●</sup> <br> monitoring our compliance with applicable rules and regulations related to executive compensation matters.<br> The Compensation Committee also oversees the Company's human capital strategy (to the extent not covered by the full Board), administers our equity-based and cash incentive plans, reviews the Company's compensation practices to assess the level of risk, reviews and approves goals and objectives related to the compensation of executive officers, and reviews and recommends the compensation of the directors to the Board. The Compensation Committee generally may delegate its duties and responsibilities to a subcommittee and subject to certain limitations, also may delegate grant authority under the Polaris Inc. 2024 Omnibus Incentive Plan (or its successor) (the "2024 Omnibus Incentive Plan") to our officers. The Compensation Committee has the authority to retain independent counsel and other independent experts or consultants.<br>All members of the Compensation Committee meet the heightened independence requirements prescribed by NYSE listing requirements for compensation committee members. |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Corporate Governance and Nominating Committee**<br>**Members:**<br>George W. Bilicic, Chair<br> Gary E. Hendrickson<br> Darryl R. Jackson<br> Bernd F. Kessler<br> John P. Wiehoff<br>**Number of Meetings During 2025: 4**<br>| &nbsp;&nbsp;&nbsp;The Corporate Governance and Nominating Committee provides oversight and guidance to the Board regarding the membership, structure, policies and processes of the Board and its committees and facilitates the effective exercise of the Board's role in the governance of the Company. The purposes of the Corporate Governance and Nominating Committee are to:<br><sup>●</sup> <br> identify individuals qualified to become Board members, consistent with criteria approved by the Board;<br> <sup>●</sup> <br> evaluate the qualifications of potential candidates and recommend director nominees to the Board for election by the stockholders at each annual meeting of stockholders and nominees for election to fill interim vacancies on the Board;<br> <sup>●</sup> <br> develop and recommend to the Board a set of Corporate Governance Guidelines applicable to the Company; <br> <sup>●</sup> <br> review and recommend to the Board for approval corporate policies and practices with respect to the size, composition and functioning of the Board and its committees;<br> <sup>●</sup> <br> oversee the annual evaluation of the performance of the Board and each of its standing committees; and<br> <sup>●</sup> <br> address any related governance matters, including any related matters required by any applicable state and federal law, including the securities laws and the rules and regulations promulgated by the SEC and NYSE.<br> The Corporate Governance and Nominating Committee also is responsible for recommending to the Board any revisions to our governance documents, as well as developing board education, overseeing the board evaluation process, reviewing and overseeing compliance with the Company's policies and procedures regarding related person transactions and conflicts of interest, reviewing sustainability and corporate social responsibility goals and objectives and recommending appropriate measures related to these matters. |

---

---

| | |
|:---|:---|
| **14**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Corporate Governance**

**Committees of the Board**

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Technology & Innovation Committee**<br>**Members:**<br>Bernd F. Kessler, Chair<br> Gwenne A. Henricks<br> Lawrence D. Kingsley<br> Gwynne E. Shotwell<br>**Number of Meetings During 2025: 2** | The purpose of the Technology & Innovation Committee is to assist the Board by providing governance for the Company's innovation and technology development as it relates to emerging capabilities and technology strategies for our products. Among other things, the Technology & Innovation Committee reviews competitive technologies, trend analyses, competitive advantages and competitive technology analyses to drive innovation priorities. The Technology & Innovation Committee also reviews critical product innovation initiatives and conducts comprehensive assessments of selected technologies. The Technology & Innovation Committee analyzes the costs, benefits and risks associated with major innovation and technology investments, including make-versus-buy evaluations, if applicable. |

---

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; 15 |

---

------

[**Table of Contents**](#toc)

**Corporate Governance**

**Risk Oversight**

**Risk Oversight**

Our full Board is responsible for overseeing the Company's overall approach to risk management and is actively engaged in addressing the most significant risks that Polaris faces. While the Board and its committees oversee key risk areas, the Company's management is responsible for day-to-day risk management identification and mitigation, and for advising the Board on emerging and top enterprise risks.

The Board's oversight of the Company's most common risks is structured as follows:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Board of Directors** | &nbsp;&nbsp;**Board of Directors** | &nbsp;&nbsp;**Board of Directors** |
| &nbsp;&nbsp;&nbsp;<sup>●</sup> <br> **Strategic and Competitive**<br> <sup>●</sup> <br> **Operational**<br> <sup>●</sup> <br> **Financial** | &nbsp;&nbsp;&nbsp;<sup>●</sup> <br> **Cybersecurity & Artificial Intelligence**<br> <sup>●</sup> <br> **Product Quality and Safety**<br> <sup>●</sup> <br> **Economic Climate**<br> <sup>●</sup> <br> **Crisis Response** | &nbsp;&nbsp;&nbsp;<sup>●</sup> <br> **ESG**<br> <sup>●</sup> <br> **Global Trade**<br> <sup>●</sup> <br> **Legal and Regulatory**<br> <sup>●</sup> <br> **Succession Planning** |

---

![](pro014545-def14ax18x1.jpg)

---

| | | | |
|:---|:---|:---|:---|
| &nbsp;&nbsp;**Board Committees** | &nbsp;&nbsp;**Board Committees** | &nbsp;&nbsp;**Board Committees** | &nbsp;&nbsp;**Board Committees** |
| **AUDIT<br> COMMITTEE** | **COMPENSATION<br> COMMITTEE** | **CORPORATE<br> GOVERNANCE AND<br> NOMINATING COMMITTEE** | **TECHNOLOGY &<br> INNOVATION<br> COMMITTEE** |
| **Primary Risk Oversight:** | **Primary Risk Oversight:** | **Primary Risk Oversight:** | **Primary Risk Oversight:** |
| &nbsp;&nbsp;&nbsp;<sup>●</sup> <br> Financial statement integrity and reporting<br> <sup>●</sup> <br> Financial and regulatory compliance<br> <sup>●</sup> <br> Internal controls<br> <sup>●</sup> <br> Whistleblower complaints | &nbsp;&nbsp;&nbsp;<sup>●</sup> <br> Executive compensation<br> <sup>●</sup> <br> Human capital<br> <sup>●</sup> <br> Non-executive director compensation | &nbsp;&nbsp;&nbsp;<sup>●</sup> <br> Governance structure and processes<br> <sup>●</sup> <br> *Geared For Good* (our corporate responsibility framework)<br> <sup>●</sup> <br> Board education | &nbsp;&nbsp;&nbsp;<sup>●</sup> <br> Competition<br> <sup>●</sup> <br> Innovation <br> <sup>●</sup> <br> Product regulatory complexity and uncertainty |

---

![](pro014545-def14ax18x1.jpg)

---

| |
|:---|
| &nbsp;&nbsp;**Management** |
| &nbsp;&nbsp;Management identifies enterprise risks by engaging in an Enterprise Risk Management ("ERM") process. The ERM process consists of periodic risk assessments performed by Finance in partnership with the business units and other functional experts. Internal Audit presents the ERM conclusions to the Audit Committee. As appropriate, key risks are then discussed with the Board. The Company maintains regular internal risk management meetings, assigns operating risk owners with accountability for specific risk management activities, promulgates its Code of Conduct, maintains strong Legal and Finance departments and an ethics and compliance office, and conducts a comprehensive internal and external audit process. |
| &nbsp;&nbsp;**The Board believes that these processes and the division of responsibilities is an effective approach for addressing the risks facing our Company.** |

---

---

| | |
|:---|:---|
| **16**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Corporate Governance** 

**Board Effectiveness and Evaluations**

**Oversight of Sustainability and Corporate Responsibility**

The Corporate Governance and Nominating Committee has oversight responsibility over sustainability matters, and the Compensation Committee has oversight responsibility over human capital strategy (to the extent not covered by the full Board). The Board receives and discusses regular reports on sustainability and corporate responsibility matters, including those related to employee and product safety, human capital management, innovation and technology, and *Geared for Good* initiatives across the Company.

The Company's Corporate Responsibility Committee advises the Company on matters of significance to Polaris and its stakeholders concerning corporate social responsibility and sustainability and assists the Board and senior management team in addressing the impact of these matters on the Company's business, strategies, operations, performance and reputation. Members of the committee include the CEO, Chief Financial Officer ("CFO"), Chief Human Resources Officer ("CHRO"), and General Counsel, reflecting the cross-functional nature of corporate responsibility matters. This committee leverages expertise across our executive team in areas such as Supply Chain, Investor Relations, Human Resources, Manufacturing, Legal, Finance, and Environment, Health and Safety.

Under the oversight of the Corporate Responsibility Committee and with input from the Board, in 2025 we published our annual *Geared For Good* Report, which sets forth our ESG priorities, our performance in these priority areas, and targets for future improvement, including our 2035 environmental goals.

**Board Effectiveness and Evaluations**

The Corporate Governance and Nominating Committee is responsible for leading and overseeing the Board and committee evaluation process. In addition, the Board retains a third-party independent consultant on a periodic basis, most recently in 2023, to conduct the Board evaluation. The Board anticipates conducting its next independent review in late 2027. Below is a summary of our annual Board and committee evaluation processes, which the Corporate Governance and Nominating Committee reviews every year.

---

| |
|:---|
| &nbsp;&nbsp;**Annual Board and Committee Evaluation Process** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>●</sup> <br> Each director completes a written questionnaire for the Board and each committee on which the director serves. The questionnaires, which are updated annually, include open-ended questions and space for candid commentary. Topics covered include:<br> › Board/committee information and materials and meeting mechanics;<br> › Board/committee composition and structure;<br> › Board/committee interaction with management and with each other;<br> › Board/committee responsibilities and accountability; and<br> › Board meeting conduct and culture.<br> <sup>●</sup> <br> The Chair of the Board and the Chair of each committee also conduct interviews with Board members to solicit additional feedback on Board and committee performance and effectiveness.<br> <sup>●</sup> <br> The Chair of the Board also solicits feedback from individual directors on individual director performance and effectiveness.<br> <sup>●</sup> <br> Periodically, most recently in 2023, an independent consultant also interviews individual directors and members of senior management who interact with the Board.<br> › Reports are produced summarizing the questionnaire feedback. All comments are unattributed, including those shared in the independent consultant and Chair interviews. |

---

![](pro014545-def14ax19x1.jpg)

---

| |
|:---|
| &nbsp;&nbsp;**Board and Committee Review and Response** |
| &nbsp;&nbsp;&nbsp;<sup>●</sup> <br> To promote Board effectiveness, the results of the annual Board evaluation are first reviewed by the Corporate Governance and Nominating Committee and then are reviewed and addressed by the full Board in an executive session led by the Chair.<br> <sup>●</sup> <br> The results of each committee's evaluation are discussed at an executive session and further discussed by the full Board and senior management as appropriate. The Board and each Committee determine what actions are taken in response to the evaluation feedback.  |

---

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **17** |

---

------

[**Table of Contents**](#toc)

**Corporate Governance**

**Shareholder Engagement**

**Shareholder Engagement**

Our shareholder engagement efforts take place throughout the year and involve a member of our Board, when requested, key management leaders, and stockholder representatives. In 2025, Polaris reached out to stockholders representing almost 65% of our outstanding shares, and the management team met with stockholders owning almost 35% of our outstanding shares. The discussions covered various topics, including the Company's strategy, compensation program design, human capital management, sustainability goals and efforts, and governance practices. Following these engagements, management reviews feedback with the executive team, the Corporate Governance and Nominating Committee and, when relevant, the Compensation Committee. As appropriate, the Chairs of the Corporate Governance and Nominating Committee and the Compensation Committee review stockholder concerns and recommendations with the full Board.

The feedback from these meetings helps inform the Board and management about stockholder priorities and concerns. When appropriate, we make changes to address concerns raised, as noted below.

**OUR SHAREHOLDER ENGAGEMENT PROCESS**

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Assess and Prepare** | &nbsp;&nbsp;**Outreach and Engagement** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>●</sup> <br> We assess and monitor:<br> <sup>›</sup> <br> Investor policies and stewardship priorities<br> <sup>›</sup> <br> Stockholder voting results<br> <sup>›</sup> <br> Trends in governance; executive compensation; environmental, social, and regulatory policies and practices; and other matters<br> <sup>●</sup> <br> We identify and prepare for potential topics that are priorities for our stockholders | &nbsp;&nbsp;&nbsp;<sup>●</sup> <br> We reach out to our stockholders to request engagement<br> <sup>●</sup> <br> Leaders of relevant management teams and a member of our Board, when requested, meet with stockholders to actively solicit input on issues relevant to them and to provide insight to the Company's policies and strategy |
| &nbsp;&nbsp;**Evaluate** | &nbsp;&nbsp;**Respond** |
| &nbsp;&nbsp;&nbsp;<sup>●</sup> <br> Our Board and management team review stockholder input and assess any issues or concerns identified<br> <sup>●</sup> <br> Stockholder input and policies are continuously reviewed and considered when implementing best governance practices by our Board and committees | &nbsp;&nbsp;&nbsp;<sup>●</sup> <br> Our Board responds and, when appropriate, takes action to align with stockholder feedback<br> <sup>●</sup> <br> We enhance our disclosure to provide greater transparency on topics significant to our stockholders<br> <sup>●</sup> <br> Based on stockholder feedback in 2025, the Board amended the Corporate Governance Guidelines to reflect a more holistic approach to evaluating director time commitments so that our directors are able to devote the time and attention necessary for effective service on our Board, and to reduce the number of outside boards on which a non-executive director may serve from five to four. |

---

**Board Meetings**

During 2025, the full Board met seven times. Meetings are typically preceded and/or followed by an executive session of the Board, chaired by Mr. Wiehoff, without management in attendance. Each of our directors attended at least 75 percent of the aggregate number of meetings of the Board and any committee on which that director served in 2025. Board members are expected to regularly attend all Board meetings and meetings of the committees on which they serve as well as annual stockholder meetings. All members of the Board attended our 2025 Annual Meeting.

---

| | |
|:---|:---|
| **18**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Corporate Governance** 

**Director Orientation and Continuing Education**

**Director Orientation and Continuing Education**

New directors participate in a comprehensive orientation that includes meetings with senior management to discuss the Company's strategic plans, financial statements, legal and risk management, corporate responsibility, and key policies and governance practices. In addition, the Corporate Governance and Nominating Committee regularly reviews and recommends topics for director training. We encourage directors to participate in certain recommended external continuing director education programs and reimburse expenses associated with these events. Continuing director education is also provided during Board meetings by outside experts who present on issues relevant to the Board's oversight duties. In 2025, outside experts presented to the Board on topics such as innovation, activism and crisis management, the litigation landscape, and corporate governance and fiduciary duties. Finally, we provide directors with a quarterly memorandum summarizing relevant SEC, corporate responsibility and other corporate governance developments.

**Director Retirement Policy**

Our Corporate Governance Guidelines provide that once a director reaches the age of 72, the director must resign from the Board effective as of the next annual meeting. Any member of management (including the CEO) who serves as a director must retire from the Board at the same time he or she discontinues active management responsibilities with the Company or ceases to hold the position held at the time of the last annual meeting, unless requested by the Board to continue to serve. The Board does not believe that arbitrary term limits are appropriate, nor does it believe that directors should expect to be regularly re-nominated until they reach the mandatory retirement age. The Board believes that diversity of tenure among directors helps to facilitate effective Board oversight because long-tenured directors provide the Board with a deep knowledge of the Company and our industry and newer directors provide fresh perspectives. The Board regularly assesses the independence, engagement and contributions of all members in order to maximize the Board's effectiveness.

**Outside Board Service**

Directors are expected to devote sufficient time to carrying out their Board duties and responsibilities effectively. The Board believes a director who is not serving as an executive officer of a public company should serve on no more than four public company boards (including our Board), and a director who serves as an executive officer of a public company should serve on no more than two public company boards (including our Board). A director who intends to join a new outside for-profit board of directors must pre-clear this service with our Board Chair in advance. The Chair will make a determination on whether to permit or deny the outside board role, taking into consideration the time commitments related to that role, the needs of our Board, potential conflicts of interest and any other relevant factors.

**Certain Relationships and Related Transactions**

During 2025, we did not engage in any transactions with related persons that are required to be described in this Proxy Statement pursuant to Item 404(a) of Regulation S-K.

Our written Related-Person Transactions Policy, which is applicable to all of our directors, nominees for directors, executive officers and 5% stockholders and their respective immediate family members, prohibits "related-person transactions" unless approved by the Corporate Governance and Nominating Committee.

Matters considered to be a related-person transaction subject to the policy include any transaction in which we are directly or indirectly a participant and the amount involved exceeds or reasonably can be expected to exceed $120,000, and in which a director, nominee for director, executive officer or 5% stockholder, or any of their respective immediate family members, has or will have a direct or indirect material interest.

Any potential related-person transaction will be analyzed by the General Counsel, in consultation with management, as appropriate, to determine whether the transaction or relationship constitutes a related-person transaction requiring compliance with the policy. The General Counsel's conclusion and analysis are reported to the Chair of the Corporate Governance and Nominating Committee.

The Corporate Governance and Nominating Committee reviews the material facts of all related-person transactions that require the Committee's approval and either approves or disapproves each one. Any related-person transaction that is not approved or ratified, is voided, terminated or amended, or such other actions may be taken, in each case as determined by the Committee, to avoid or otherwise address any resulting conflict of interest.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **19** |

---

------

[**Table of Contents**](#toc)

**Corporate Governance**

**Code of Business Conduct and Ethics**

**Code of Business Conduct and Ethics**

We have adopted a Code of Business Conduct and Ethics applicable to all employees, including our CEO, our CFO and all other executive officers, and the Board, which is available on our website at *ir.polaris.com/investors/corporate-governance*. The full Board received Code of Conduct training in 2025. If we waive any of the provisions of the Code of Business Conduct and Ethics with respect to the CEO, CFO, any executive officer or any member of the Board, we intend to disclose such actions on our website at the same location.

**Insider Trading Policies and Procedures**

We have adopted an insider trading policy and procedures applicable to directors, officers, employees, and other covered individuals, and have implemented processes applicable to us, that we believe are reasonably designed to promote compliance with insider trading laws, rules and regulations, and listing standards of the NYSE.

**Communications with the Board**

Any stockholder or other interested party who would like to communicate with the directors, individually or as a group, may do so by writing to the intended member or members of the Board, c/o Corporate Secretary, Polaris Inc., 2100 Highway 55, Medina, Minnesota 55340, or by sending an email to PolarisCorporate.Secretary@polaris.com.

All such communications received will be reviewed initially by the office of our Corporate Secretary and will be relayed as addressed unless the Corporate Secretary determines that the communication is an advertisement, promotional material, or otherwise inappropriate to disseminate.

---

| | |
|:---|:---|
| **20**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proposal 1 — Election of Directors**

**General Information**

The Board currently has nine members and is divided into three classes. The Board set the number of directors at nine members, following the retirement of Kevin M. Farr in January 2026, in accordance with the Company's Bylaws. The members of one class are elected at each annual meeting of stockholders to serve a three-year term. Our Board selected the three nominees based upon their diverse mix of skills, backgrounds, and perspectives, including their functional areas of experience, educational background, employment experience, and leadership performance. All of the Class II nominees are presently Polaris directors who were elected by stockholders at the 2023 Annual Meeting for terms expiring at the 2026 Annual Meeting.

Proxies will be voted "for" the election of each of the nominees unless you indicate that you wish to "abstain" or vote "against" any or all of the nominees. Our Certificate of Incorporation provides that nominees will be elected only if they receive a majority of the votes cast with respect to an uncontested election meaning the number of shares voted "for" a nominee must exceed the number of shares voted "against" that nominee. Each nominee elected as a director will continue to serve through the expiration of the three-year term or until his or her earlier death, resignation or retirement.

Any director who does not receive a majority of the votes cast "for" his or her election in an uncontested election must promptly tender a resignation. In that event, the Corporate Governance and Nominating Committee will make a recommendation to the Board on whether to accept or reject the resignation. The Board, after taking into account the recommendation, will publicly disclose its decision and rationale within 90 days after the election. The director who failed to receive a majority vote will not participate in the decision.

We expect each nominee standing for election as a director to be able to serve if elected. If any nominee is not able to serve, proxies will be voted in favor of the remainder of those nominated and may be voted for any substitute nominees designated by the Board, unless an instruction to the contrary is indicated on the proxy. There are no family relationships between or among any of our executive officers, directors or director nominees.

**Board Refreshment**

The Company's comprehensive Board and committee refreshment and succession planning process is designed to enable the Board and each committee to be made up of highly qualified directors, with the independence and diversity of skills and perspectives to provide strong and effective oversight. As a result of this process, in the last five years, the Company has added two new directors resulting in a Board with a balanced mix of tenures and a comprehensive skill set relevant to our industry and future.

In the past, the Corporate Governance and Nominating Committee has retained a national executive and director search firm to assist the Board in conducting searches to identify potential qualified candidates to be considered for possible appointment to the Board. The independent search firm provided the Corporate Governance and Nominating Committee with background information on candidates as well as an assessment of their respective qualifications. The Corporate Governance and Nominating Committee then evaluated and screened the candidates, conducted interviews and reviewed the candidates against our criteria for selecting director nominees, including the specific skills discussed below, functional areas of experience, educational background, employment experience, diversity of perspective, and leadership performance. When the Corporate Governance and Nominating Committee deems it in the best interest of the Company to add a new director to the Board, the Committee expects to again retain a national executive director search firm to assist the Board in conducting a search. The Corporate Governance and Nominating Committee will also consider director candidates submitted by stockholders and other stakeholders, subject to the terms of the Company's Bylaws.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **21** |

---

------

[**Table of Contents**](#toc)

**Proposal 1 — Election of Directors**

**Stockholder Nominations or Recommendations of Directors**

**Stockholder Nominations or Recommendations of Directors**

If a stockholder wishes to have the Corporate Governance and Nominating Committee consider a candidate for nomination as a director, the stockholder's notice must include the information specified in our Bylaws, including the stockholder's name and address, the information required to be disclosed by the SEC's proxy rules, a written consent of the candidate to be named in the proxy statement and to serve as a director if elected, specified information regarding the stockholder's interests in our capital stock, and the representations specified in our Bylaws. The Corporate Governance and Nominating Committee will evaluate recommended nominees based on the same factors it uses to assess candidates from other sources. Alternatively, stockholders may directly nominate a person for election to our Board by complying with the procedures set forth in our Bylaws, any applicable rules and regulations of the SEC and any other applicable laws.

**Director Skills and Qualifications Criteria**

The Corporate Governance and Nominating Committee seeks to achieve a balance of knowledge, experience and perspective on the Board and also evaluates intangible factors it deems appropriate to develop a heterogeneous and cohesive Board. These intangible factors, which are described in the Committee's charter, include characteristics such as integrity, judgment, and diversity of thought, as well as the willingness and ability to devote adequate time to Board duties for a sustained period.

In response to stockholder feedback, the Corporate Governance and Nominating Committee enhanced its skills matrix to identify skills attributable to each individual director and developed a second matrix to convey how each skill is aligned with each of Polaris' six strategic pillars. The Committee regularly reviews, and if necessary refreshes, these matrices.

---

| | |
|:---|:---|
| **22**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proposal 1 — Election of Directors**

**Director Skills and Qualifications Criteria**

The matrix below shows how our preferred Board skills are aligned with the Company's six strategic pillars.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Strategic Pillars** | **Strategic Pillars** | **Strategic Pillars** | **Strategic Pillars** | **Strategic Pillars** | **Strategic Pillars** |
|  | **Best**<br> **Customer**<br> **Experience** | **Inspirational**<br> **Brands** | **Rider**-**Driven**<br> **Innovation** | **Agile &**<br> **Efficient**<br> **Operations** | **Best Team,**<br> **Best**<br> **Culture** | **Geared For**<br> **Good** |
| **Board Skills** | ![](pro014545-def14ax23x1.jpg) | ![](pro014545-def14ax23x2.jpg) | ![](pro014545-def14ax23x3.jpg) | ![](pro014545-def14ax23x4.jpg) | ![](pro014545-def14ax23x5.jpg) | ![](pro014545-def14ax23x6.jpg) |
| **Accounting and Financial Expertise**<br> *Specialized financial reporting expertise, e.g. experience as a CFO/CPA at Big-4 firm* |  |  |  | ![](pro014545-def14ax23x7.jpg) |  | ![](pro014545-def14ax23x7.jpg) |
| **Consumer Insights/Marketing Expertise**<br> *Exec-level role overseeing consumer insights or marketing at a large company* | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) |  |  | ![](pro014545-def14ax23x8.jpg) |
| **Consumer/Manufacturing Industry Expertise**<br> *Exec-level role in the consumer and manufacturing industry* | ![](pro014545-def14ax23x7.jpg) |  |  | ![](pro014545-def14ax23x7.jpg) |  | ![](pro014545-def14ax23x7.jpg) |
| **Corporate Governance Experience**<br> *Experience serving on and leading boards/committees of other large public companies* |  |  |  | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) |
| **Digital/E-Commerce Expertise**<br> *Specialized expertise in digital marketing, digital technology, data analytics, and/or AI* | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) |  |  |
| **Executive Leadership Experience**<br> *Current or former executive or CEO at a large company* | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) |
| **Global Experience**<br> *Current or former executive or CEO role at a global company or a company with international operations* | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) |
| **Innovation/Technology**<br> *Exec-level role overseeing significant innovation* | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) |  |  |
| **Legal Expertise**<br> *Specialized legal qualifications, such as experience as a lawyer at a large firm or company* |  |  |  | ![](pro014545-def14ax23x7.jpg) |  | ![](pro014545-def14ax23x7.jpg) |
| **Product Quality and Safety Expertise**<br> *Exec-level role overseeing product quality and safety* | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) |
| **Regulatory/Compliance Expertise**<br> *Exec-level role in a highly regulated industry or overseeing regulatory/compliance programs* | ![](pro014545-def14ax23x7.jpg) |  | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) |  | ![](pro014545-def14ax23x7.jpg) |
| **Risk Management/Oversight**<br> *Exec-level role with significant enterprise risk-management responsibility* | ![](pro014545-def14ax23x8.jpg) |  |  | ![](pro014545-def14ax23x8.jpg) |  | ![](pro014545-def14ax23x8.jpg) |
| **Strategy and M&A**<br> *Significant experience leading strategy and M&A matters* | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) |  |  |

---

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **23** |

---

------

[**Table of Contents**](#toc)

**Proposal 1 — Election of Directors**

**Director Skills and Qualifications Criteria**

Our Board is made up of individuals with a diverse mix of experience, backgrounds and skill sets that complement the Company's long-term strategy. Our directors also have the professional and personal qualifications and attributes necessary to effectively oversee and guide our business and future direction. Set forth below is a matrix identifying the skills possessed by each individual director.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Director Skills** | **Director Skills** | **Director Skills** | **Director Skills** | **Director Skills** | **Director Skills** | **Director Skills** | **Director Skills** | **Director Skills** |
| | **George**<br> **Bilicic** | **Gary**<br> **Hendrickson** | **Gwenne**<br> **Henricks** | **Darryl**<br> **Jackson** | **Bernd**<br> **Kessler** | **Lawrence**<br> **Kingsley** | **Gwynne**<br> **Shotwell** | **Michael**<br> **Speetzen** | **John**<br> **Wiehoff** |
| **Accounting** **and Financial** **Expertise** | ![](pro014545-def14ax23x7.jpg) |  |  | ![](pro014545-def14ax23x7.jpg) |  |  |  | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) |
| **Consumer/Manufacturing Industry Expertise** |  | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) |  |
| **Consumer Insights/Marketing Expertise** |  | ![](pro014545-def14ax23x7.jpg) |  | ![](pro014545-def14ax23x7.jpg) |  |  | ![](pro014545-def14ax23x7.jpg) |  |  |
| **Corporate** **Governance** **Experience** | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) |  |  |  | ![](pro014545-def14ax23x8.jpg) |  | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) |
| **Digital/** **E-Commerce** **Expertise** |  |  |  | ![](pro014545-def14ax23x7.jpg) |  |  |  |  |  |
| **Executive** **Leadership** **Experience** | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) |
| **Global** **Experience** | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) |
| **Innovation/Technology** | ![](pro014545-def14ax23x8.jpg) |  | ![](pro014545-def14ax23x8.jpg) |  | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) |  |
| **Legal Expertise** | ![](pro014545-def14ax23x7.jpg) |  |  |  |  |  |  |  |  |
| **Product Quality** **and Safety** **Expertise** |  |  | ![](pro014545-def14ax23x8.jpg) |  | ![](pro014545-def14ax23x8.jpg) |  | ![](pro014545-def14ax23x8.jpg) |  |  |
| **Regulatory/Compliance Expertise** | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) |  |  |
| **Risk Management/Oversight** | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) | ![](pro014545-def14ax23x8.jpg) |
| **Strategy** **and M&A** | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) | ![](pro014545-def14ax23x7.jpg) |

---

---

| | |
|:---|:---|
| **24**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proposal 1 — Election of Directors**

**Information Concerning Nominees and Continuing Directors**

**Information Concerning Nominees and Continuing Directors**

Our directors, introduced below, bring a broad range of leadership and experience to the boardroom and regularly contribute to the process of effectively overseeing and guiding our business and affairs. Other than our CEO, all of the members of the Board are independent. Preparation, engagement and participation are expected from our directors, as well as high personal and professional ethics, integrity and values. All of our current directors satisfy these requirements. With its diverse mix of experience, backgrounds and skill sets that complement the Company's long-term strategy, the Board believes it is well positioned to represent the best interests of the Company's stockholders.

**The Board, upon recommendation of the Corporate Governance and Nominating Committee, unanimously recommends a vote FOR the election of the Class II nominees as directors.**

---

| | |
|:---|:---|
| **Director Nominees — Class II (Term Ending 2029)** | **Director Nominees — Class II (Term Ending 2029)** |
| &nbsp;&nbsp;&nbsp;<br> **Age 62**<br> **Director**<br> **since: 2017**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit<br> ●  Corporate Governance and Nominating, Chair | **GEORGE W. BILICIC** |
| &nbsp;&nbsp;&nbsp;<br> **Age 62**<br> **Director**<br> **since: 2017**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit<br> ●  Corporate Governance and Nominating, Chair | **Skills and Qualifications:**<br> Mr. Bilicic has extensive **leadership and risk management and oversight experience** acquired while addressing complex situations in the legal field and the financial, energy and infrastructure sectors. He brings to the Board significant **accounting and financial expertise, as well as innovation and technology** and **global experience,** obtained over 20 years in leadership roles at Lazard, a leading financial advisory and asset management firm. He also possesses deep insights into **strategy and M&A** gained over his career, including in his roles in the practice of law, investment banking and business more generally. The Board also benefits from his **corporate governance experience** and his **regulatory/compliance** and **legal expertise** developed while at Cravath, a large law firm, earlier in his career and during his time at Lazard. Such skills were further advanced when he served as President, Chief Legal Officer and Chief Compliance Officer at Sempra Energy, one of the largest utility holding companies in the United States, where he had broad responsibilities across various businesses, legal, compliance, strategy and business development. |
| &nbsp;&nbsp;&nbsp;<br> **Age 62**<br> **Director**<br> **since: 2017**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit<br> ●  Corporate Governance and Nominating, Chair | &nbsp;&nbsp;&nbsp;**Other Current Public Company Directorships:**<br> ●  None<br> **Former Public Company Directorships Held during the Past 5 Years:**<br> ●  None |
| &nbsp;&nbsp;&nbsp;<br> **Age 62**<br> **Director**<br> **since: 2017**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit<br> ●  Corporate Governance and Nominating, Chair | &nbsp;&nbsp;&nbsp;&nbsp;**Experience:**<br> ●  **Lazard Ltd.,** a leading financial advisory and asset management firm<br> –<br> Vice Chairman, Investment Banking and Global Head of Power, Energy & Infrastructure (since April 2020)<br> –<br> Served in various roles including as Vice Chairman of Investment Banking, Head of U.S. Midwest Investment Banking and Global Head of Power, Energy & Infrastructure (March 2002 to May 2008 and November 2008 to May 2019)<br> ●  Served in various executive roles, including President, Chief Legal Officer, and Chief Compliance Officer, **Sempra Energy,** an energy infrastructure company (June 2019 – March 2020)<br> ●  Managing Director and Head of Infrastructure, **Kohlberg Kravis Roberts & Co.** (May 2008 - October 2008)<br> ●  Managing Director, **Merrill Lynch & Co., Inc.** (2001 - 2002)<br> ●  Partner, **Cravath, Swaine & Moore LLP** (1995 – 2000)<br> ●  Serves on the Board of Trustees of the Mayo Clinic and on various committees, including as Chair of the Audit and Compliance Committee. |

---

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **25** |

---

------

[**Table of Contents**](#toc)

**Proposal 1 — Election of Directors**

**Information Concerning Nominees and Continuing Directors**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;<br> **Age 69**<br> **Director**<br> **since: 2011**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Compensation, Chair<br> ●  Corporate Governance and Nominating | **GARY E. HENDRICKSON** |
| &nbsp;&nbsp;&nbsp;<br> **Age 69**<br> **Director**<br> **since: 2011**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Compensation, Chair<br> ●  Corporate Governance and Nominating | **Skills and Qualifications:**<br> Mr. Hendrickson brings to the Board significant **consumer and manufacturing industry expertise,** knowledge of the competitive landscape, **marketing** and **consumer insights** that he developed during his 23-year tenure at Valspar, a global paint and coating manufacturing company, and his service as the Chairman of the Board of The AZEK Company Inc., a manufacturer of residential and commercial outdoor living products. He also brings to the Board extensive **global and executive leadership experience** and expertise overseeing **strategy, M&A, risk management,** and **regulatory and compliance** matters that he obtained while holding leadership positions with responsibility for Asia Pacific operations and later serving as COO and then CEO of Valspar up through and including the $11.3 billion acquisition of Valspar by Sherwin Williams in 2017. The Board also benefits from his **corporate governance experience** gained serving on other public company boards. |
| &nbsp;&nbsp;&nbsp;<br> **Age 69**<br> **Director**<br> **since: 2011**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Compensation, Chair<br> ●  Corporate Governance and Nominating | &nbsp;&nbsp;&nbsp;**Other Current Public Company Directorships:**<br> ●  **James Hardie Industries PLC,** a fiber-cement building materials manufacturer (since 2025)<br> **Former Public Company Directorships Held during the Past 5 Years:**<br> ●  **The AZEK Company Inc.,** an outdoor living products manufacturer (2017 - 2025)<br> ●  **Waters Corporation,** a laboratory instrument and software company (2018 – 2022) |
| &nbsp;&nbsp;&nbsp;<br> **Age 69**<br> **Director**<br> **since: 2011**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Compensation, Chair<br> ●  Corporate Governance and Nominating | &nbsp;&nbsp;&nbsp;&nbsp;**Experience:**<br> ●  **The Valspar Corporation**, a global paint and coatings manufacturer (1997 – 2017)<br> –<br> Chairman and Chief Executive Officer (2011 – 2017)<br> –<br> President and Chief Operating Officer (2008 – 2011)<br> –<br> Held various other executive leadership roles including positions with responsibility for the Asia Pacific operations |
| &nbsp;&nbsp;&nbsp;<br> **Age 68**<br> **Director**<br> **since: 2015**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit<br> ●  Technology & Innovation | **GWENNE A. HENRICKS** |
| &nbsp;&nbsp;&nbsp;<br> **Age 68**<br> **Director**<br> **since: 2015**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit<br> ●  Technology & Innovation | **Skills and Qualifications:**<br> Ms. Henricks has substantial **manufacturing industry expertise, and strategy and M&A** and **global experience,** developed over her 35-year career at Caterpillar, Inc., the world's largest manufacturer of construction equipment. In her role as Vice President of Caterpillar's Industrial Powers Systems Division, she oversaw the global business unit's supply chain, manufacturing, product management and development, external sales and distribution functions. Her engineering and **executive leadership** roles throughout her career, including service as Vice President, Product Development & Global Technology, and Chief Technology Officer contributed to her expertise in **innovation and technology, product quality and safety, regulatory and compliance and risk management.** |
| &nbsp;&nbsp;&nbsp;<br> **Age 68**<br> **Director**<br> **since: 2015**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit<br> ●  Technology & Innovation | &nbsp;&nbsp;&nbsp;**Other Current Public Company Directorships:**<br> ●  None<br> **Former Public Company Directorships Held during the Past 5 Years:**<br> ●  None |
| &nbsp;&nbsp;&nbsp;<br> **Age 68**<br> **Director**<br> **since: 2015**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit<br> ●  Technology & Innovation | &nbsp;&nbsp;&nbsp;&nbsp;**Experience:**<br> ●  **Caterpillar Inc.**, a world leading manufacturer of construction and mining equipment, diesel and natural gas engines, industrial gas turbines and diesel-electric locomotives (1981 – 2016)<br> –<br> Chief Technology Officer and Vice President, Product Development & Global Technology (2013 – 2016)<br> –<br> Vice President, Industrial Power Systems Division (2009 - 2012)<br> –<br> Held numerous engineering and executive roles progressing in scope and complexity<br> ●  Serves on the board of Decision Sciences International Corporation |

---

---

| | |
|:---|:---|
| **26**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proposal 1 — Election of Directors**

**Information Concerning Nominees and Continuing Directors**

**Continuing Directors — Class III (Term Ending 2027)**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;<br> **Age 65**<br> **Director**<br> **since: 2021**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit, Chair<br> ●  Corporate Governance & Nominating | **DARRYL R. JACKSON** |
| &nbsp;&nbsp;&nbsp;<br> **Age 65**<br> **Director**<br> **since: 2021**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit, Chair<br> ●  Corporate Governance & Nominating | **Skills and Qualifications:**<br> Mr. Jackson possesses deep **accounting and financial, consumer insights and marketing** expertise, as well as **executive leadership** and strategy experience, gained during his more than 30-year career in financial services. He also provides **manufacturing industry** and **digital and E-commerce expertise** developed through various roles at Hendrick Automotive Group and Chrysler Financial. He contributes to the Board his **global experience, regulatory and compliance** and **risk management** expertise developed over his career, including time as a Director of the advisory business of PricewaterhouseCoopers and as an auditor for Deloitte and Touche. |
| &nbsp;&nbsp;&nbsp;<br> **Age 65**<br> **Director**<br> **since: 2021**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit, Chair<br> ●  Corporate Governance & Nominating | &nbsp;&nbsp;&nbsp;**Other Current Public Company Directorships:**<br> ●  None<br> **Former Public Company Directorships Held during the Past 5 Years:**<br> ●  None |
| &nbsp;&nbsp;&nbsp;<br> **Age 65**<br> **Director**<br> **since: 2021**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit, Chair<br> ●  Corporate Governance & Nominating | &nbsp;&nbsp;&nbsp;&nbsp;**Experience:**<br> ●  **Hendrick Automotive Group**, the largest privately held automotive retail organization in the United States <br> –<br> Vice President, Financial Services and Fixed Operations (since 2020)<br> –<br> Vice President, Financial Services (2018 – 2020)<br> –<br> Director, Business Development and Strategic Initiatives (2015 – 2018)<br> ●  Director – Advisory, **PricewaterhouseCoopers** (2012 – 2015)<br> ●  **Chrysler Financial** (1992 – 2011)<br> –<br> Chief Operating Officer (2008 – 2011)<br> –<br> Held leadership positions in operations, sales, marketing, and financial analysis<br> ●  Serves on the boards of the North Carolina Automobile Dealers Association and Securian Financial |
| &nbsp;&nbsp;&nbsp;<br> **Age 56**<br> **Director**<br> **since: 2021**<br> **CEO**<br> **Committees:**<br> ●  None | **MICHAEL T. SPEETZEN** |
| &nbsp;&nbsp;&nbsp;<br> **Age 56**<br> **Director**<br> **since: 2021**<br> **CEO**<br> **Committees:**<br> ●  None | **Skills and Qualifications:**<br> Mr. Speetzen has **executive leadership experience** in the **consumer and manufacturing industries and** expertise in **innovation and technology,** gained while serving as CFO and then CEO at Polaris and in prior senior roles at StandardAero, ITT and Xylem. He also possesses comprehensive expertise in **accounting and finance, strategy and M&A**, and **risk management oversight,** as well as **global experience,** acquired through his career in various leadership roles with corporate finance groups of multinational manufacturing companies such as Honeywell, General Electric and Xylem. He also brings to the Board **corporate governance experience** gained from serving on other public boards. |
| &nbsp;&nbsp;&nbsp;<br> **Age 56**<br> **Director**<br> **since: 2021**<br> **CEO**<br> **Committees:**<br> ●  None | &nbsp;&nbsp;&nbsp;**Other Current Public Company Directorships:**<br> ●  **Pentair plc,** an American water treatment company (since 2018)<br> **Former Public Company Directorships Held during the Past 5 Years:**<br> ●  None |
| &nbsp;&nbsp;&nbsp;<br> **Age 56**<br> **Director**<br> **since: 2021**<br> **CEO**<br> **Committees:**<br> ●  None | &nbsp;&nbsp;&nbsp;&nbsp;**Experience:**<br> ●  **Polaris Inc.**<br> –<br> Chief Executive Officer (April 2021 - present)<br> –<br> Interim Chief Executive Officer (January 2021 – April 2021)<br> –<br> Executive Vice President and Chief Financial Officer (2015 - 2020)<br> ●  Senior Vice President and Chief Financial Officer, **Xylem, Inc.**, a leading water technology company spun off from ITT Corporation (2011 – 2015)<br> ●  Joined **ITT Corporation**, a worldwide manufacturing company, in 2009<br> ●  Executive Vice President and Chief Financial Officer, **StandardAero Company**, a maintenance, repair and overhaul service provider<br> ●  Held positions of increasing responsibility in the finance functions of **Honeywell** and **General Electric**<br> ●  Serves on the board of Christiansen Group Insurance (since 2025) |

---

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **27** |

---

------

[**Table of Contents**](#toc)

**Proposal 1 — Election of Directors**

**Information Concerning Nominees and Continuing Directors**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;<br> **Age 64**<br> **Director**<br> **since: 2007**<br> **INDEPENDENT BOARD CHAIR**<br> since 2021<br> **Committees:**<br> ●  Audit<br> ●  Compensation<br> ●  Corporate Governance and Nominating | **JOHN P. WIEHOFF** |
| &nbsp;&nbsp;&nbsp;<br> **Age 64**<br> **Director**<br> **since: 2007**<br> **INDEPENDENT BOARD CHAIR**<br> since 2021<br> **Committees:**<br> ●  Audit<br> ●  Compensation<br> ●  Corporate Governance and Nominating | **Skills and Qualifications:**<br> Mr. Wiehoff brings to the Board expertise in **strategy** around technological transformation as well as **global** and **executive leadership** experience gained as a senior executive of C.H. Robinson Worldwide, a global transportation and supply chain company with over $24 billion in revenue. He acquired **accounting**, **financial reporting**, and **risk management** expertise through his service as a public company CFO and additional experience working at a large accounting firm. He also contributes to the Board his **corporate governance** experience acquired through his service on the boards of public companies. |
| &nbsp;&nbsp;&nbsp;<br> **Age 64**<br> **Director**<br> **since: 2007**<br> **INDEPENDENT BOARD CHAIR**<br> since 2021<br> **Committees:**<br> ●  Audit<br> ●  Compensation<br> ●  Corporate Governance and Nominating | &nbsp;&nbsp;&nbsp;**Other Current Public Company Directorships:**<br> ●  **Union Pacific Corporation,** operator of North America's premier railroad franchise (since 2023)<br> ●  **US Bancorp,** the fifth largest banking institution in the United States (since 2020)<br> **Former Public Company Directorships Held during the Past 5 Years:**<br> ●  **Donaldson Company, Inc.** (2003 – 2022)<br>|
| &nbsp;&nbsp;&nbsp;<br> **Age 64**<br> **Director**<br> **since: 2007**<br> **INDEPENDENT BOARD CHAIR**<br> since 2021<br> **Committees:**<br> ●  Audit<br> ●  Compensation<br> ●  Corporate Governance and Nominating | &nbsp;&nbsp;&nbsp;&nbsp;**Experience:**<br> ●  **C.H. Robinson Worldwide, Inc.**, a transportation, logistics and sourcing company (1992 – 2020)<br> –<br> Chairman of the Board (2007 - 2020)<br> –<br> Chief Executive Officer (2002 – 2019)<br> –<br> Held multiple leadership roles including President and Chief Financial Officer<br> ●  Held positions at **Arthur Andersen LLP** |

---

**Continuing Directors — Class I (Term Ending 2028)**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;<br> **Age 67**<br> **Director**<br> **since: 2010**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Technology & Innovation, Chair<br> ●  Corporate Governance & Nominating | **BERND F. KESSLER** |
| &nbsp;&nbsp;&nbsp;<br> **Age 67**<br> **Director**<br> **since: 2010**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Technology & Innovation, Chair<br> ●  Corporate Governance & Nominating | **Skills and Qualifications:**<br> Mr. Kessler contributes to the Board **manufacturing industry expertise, executive leadership and innovation, and regulatory/compliance** experience acquired through his leadership roles with a number of **global aerospace**, automotive and engineering companies. He obtained global experience while service as the CEO of SRTechnics AG which has facilities throughout Europe, the Middle East and China and while serving as President and CEO of MTU where he was an integral part of the company's successful initial public offering on the Frankfurt Stock Exchange. Mr. Kessler also brings to the board **product quality and safety expertise, risk management** and **strategy and M&A** experience developed through his numerous executive leadership roles, including at AlliedSignal Corp and its successor, Honeywell International Inc. |
| &nbsp;&nbsp;&nbsp;<br> **Age 67**<br> **Director**<br> **since: 2010**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Technology & Innovation, Chair<br> ●  Corporate Governance & Nominating | &nbsp;&nbsp;&nbsp;**Other Current Public Company Directorships:**<br> ●  **Latecoere S.A.**, a leader in aerostructures and interconnection systems (since 2023)<br> **Former Public Company Directorships Held during the Past 5 Years:**<br> ●  None |
| &nbsp;&nbsp;&nbsp;<br> **Age 67**<br> **Director**<br> **since: 2010**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Technology & Innovation, Chair<br> ●  Corporate Governance & Nominating | &nbsp;&nbsp;&nbsp;**Experience:**<br> ●  Chief Executive Officer, **SRTechnics AG**, a privately-held aircraft component and engine service provider (2008 - 2010)<br> ●  President and Chief Executive Officer, **MTU Maintenance**, a subsidiary of Aero Engines AG, an aircraft engine manufacturer (2004 – 2007)<br> ●  Held management and executive positions for 20 years at **Honeywell International Inc.** and its predecessor company **AlliedSignal Corp**.<br> ●  Serves as the Chairman of ProXES GmbH and on the boards of Incora and Fischer TireTech GmbH |

---

---

| | |
|:---|:---|
| **28**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proposal 1 — Election of Directors**

**Information Concerning Nominees and Continuing Directors**

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;<br> **Age 63**<br> **Director**<br> **since: 2016**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Compensation<br> ●  Technology & Innovation | **LAWRENCE D. KINGSLEY** |
| &nbsp;&nbsp;&nbsp;<br> **Age 63**<br> **Director**<br> **since: 2016**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Compensation<br> ●  Technology & Innovation | **Skills and Qualifications:**<br> Mr. Kingsley has **innovation and technology** expertise and **global, strategy and M&A**, and **executive leadership experience** in the **consumer/manufacturing industry** gained through his senior leadership roles with Pall Corporation and IDEX Corporation, both high-technology, high-growth multinational public companies. He also brings to the Board expertise in **risk management and oversight, corporate governance experience** and **regulatory/compliance expertise** acquired while serving on other public company boards, including in board leadership roles. |
| &nbsp;&nbsp;&nbsp;<br> **Age 63**<br> **Director**<br> **since: 2016**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Compensation<br> ●  Technology & Innovation | &nbsp;&nbsp;&nbsp;**Other Current Public Company Directorships:**<br> ●  Chair, **IDEXX Laboratories, Inc.,** a multinational pet healthcare innovation company (since 2019)<br> ●  **Mirion Technologies Inc.**, a medical and technological products company (since 2021)<br> **Former Public Company Directorships Held during the Past 5 Years:**<br> ●  **Rockwell Automation Corporation** (2013 - 2021) |
| &nbsp;&nbsp;&nbsp;<br> **Age 63**<br> **Director**<br> **since: 2016**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Compensation<br> ●  Technology & Innovation | &nbsp;&nbsp;&nbsp;&nbsp;**Experience:**<br> ●  **Pall Corporation**, a global supplier of filtration, separations and purification products<br> –<br> Chairman and Chief Executive Officer (2013 – 2015)<br> –<br> Chief Executive Officer and President (2011 – 2013)<br> ●  Chairman, President and CEO, **IDEX Corporation**, a developer, designer and manufacturer of fluid and metering technologies and health and science technologies (2005 – 2011)<br> ●  Held management positions of increasing responsibility with **Danaher Corporation**, **Kollmorgen Corporation** and **Weidmuller Incorporated**<br> ●  Advisory Director to Berkshire Partners, private equity investment firm (since May 2016)<br> –<br> Serves on the boards of Consolidated Precision Products and Harvey Performance, both Berkshire Partners portfolio companies.<br> ●  Serves on the board and is President of the Thousand Islands Land Trust |
| &nbsp;&nbsp;&nbsp;<br> **Age 62**<br> **Director**<br> **since: 2019**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit<br> ●  Technology & Innovation | **GWYNNE E. SHOTWELL** |
| &nbsp;&nbsp;&nbsp;<br> **Age 62**<br> **Director**<br> **since: 2019**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit<br> ●  Technology & Innovation | **Skills and Qualifications:**<br> Ms. Shotwell has **technology and innovation, global, executive leadership,** and **manufacturing industry experience** and expertise in **product quality and safety** acquired through her senior leadership roles in the aerospace sector. Through her current role as President and COO at SpaceX, she developed experience in **regulatory** and **risk management** functions. Ms. Shotwell also brings to the Board her expertise in **consumer insights** and **strategy** developed during her career focused on supporting current and future space capabilities, including during her time at Microcosm, a company recognized for innovations in space mission engineering. |
| &nbsp;&nbsp;&nbsp;<br> **Age 62**<br> **Director**<br> **since: 2019**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit<br> ●  Technology & Innovation | &nbsp;&nbsp;&nbsp;**Other Current Public Company Directorships:**<br> ●  None<br> **Former Public Company Directorships Held during the Past 5 Years:**<br> ●  None |
| &nbsp;&nbsp;&nbsp;<br> **Age 62**<br> **Director**<br> **since: 2019**<br> **INDEPENDENT**<br> **Committees:**<br> ●  Audit<br> ●  Technology & Innovation | &nbsp;&nbsp;&nbsp;&nbsp;**Experience:**<br> ●  **Space Exploration Technologies Corp.** (SpaceX), a private American aerospace manufacturer and space transportation services company<br> –<br> President and Chief Operating Officer (since 2008)<br> –<br> Vice President, Business Development (2002 – 2008)<br> ●  Director, Space Systems Division, **Microcosm, Inc.**<br> ●  Senior Project Engineer, **The Aerospace Corporation**<br> ●  Serves as a director of the Minerva Project and SpaceX, and a Trustee of Northwestern University. |

---

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **29** |

---

------

[**Table of Contents**](#toc)

**Director Compensation**

Compensation for independent directors is divided into cash and stock components. The Compensation Committee conducts an annual review of our independent director compensation and makes a recommendation for changes, as appropriate, to the Board. For 2025, the Compensation Committee's prior outside consultant, Willis Towers Watson, assessed the compensation paid to our independent directors against director compensation trends and data from our 2024, 20-company peer group (described in this proxy statement). After completing its review, in consultation with Willis Towers Watson, the Compensation Committee recommended no changes to our Board member fees and deferred stock unit grants effective May 1, 2025. The principal features of the compensation received by our independent directors are described below. Mr. Speetzen, our CEO, receives no compensation for his service as a director.

**Director Fees**

We currently pay each independent director an annual cash retainer; our independent Chair, committee Chairs and each committee member each receive an additional annual fee. Any independent director may elect to defer the receipt of all or a specified portion of the retainer and fee payments under the Polaris Inc. Deferred Compensation Plan for Directors (the "Director Deferred Compensation Plan") (as described below). The fees for 2025 for each role are set forth below:

---

| | |
|:---|:---|
| **Annual Director Fees** | **1/1/25 - 12/31/25** |
| Board Member | $110000 |
| Independent Board Chair | $170000 |
| Audit Committee Chair | $20000 |
| Compensation Committee Chair | $20000 |
| Corporate Governance and Nominating Committee Chair | $15000 |
| Technology & Innovation Committee Chair | $15000 |
| Audit Committee Member | $10000 |
| Compensation Committee Member | $7500 |
| Corporate Governance and Nominating Committee Member | $5000 |
| Technology & Innovation Committee Member | $2500 |

---

**Deferred Stock Units**

In addition to the director cash fees, we grant our independent directors an annual award of deferred stock units in an amount determined by the Board. For 2025, the directors were each granted deferred stock units with a target grant date fair value of approximately $150,000. The deferred stock units were issued under our 2024 Omnibus Incentive Plan and are fully vested upon issuance. Upon termination of service as a director or upon an earlier change in control of our Company, each independent director will receive one share of common stock for every deferred stock unit credited to his or her account. Dividend equivalents are credited to independent directors as if the deferred stock units are outstanding shares of common stock. Such dividend equivalents are deferred in the same manner as the underlying deferred stock unit and are deemed invested in additional deferred stock units.

---

| | |
|:---|:---|
| **30**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Director Compensation**

**Director Stock Ownership Guidelines**

The Board has adopted stock ownership guidelines, which provide that each independent director is expected to own, directly or indirectly, shares of our common stock, common stock equivalents and/or deferred stock units (as described herein) having a value of at least five times the amount of the annual Board member retainer (a total of $550,000). All independent directors are expected to satisfy the stock ownership guidelines within four years following the date they are first elected to the Board. All directors are in compliance with the stock ownership guidelines.

**Deferred Compensation Plan**

Under the Director Deferred Compensation Plan, independent directors can defer all or a portion of the cash director fees they would otherwise receive. Directors may elect to defer their compensation into either common stock equivalents ("CSEs") based on the then fair market value of Polaris common stock or into various investment options at Fidelity Investments Inc. Each CSE represents the economic equivalent of one share of our common stock and dividend equivalents (which are deemed invested in additional CSEs) are credited to independent directors as if the CSEs are outstanding shares of common stock.

As soon as practicable after an independent director's service on the Board terminates, or such other later distribution date as the director elects, the director will receive a distribution of the deferred compensation then credited to him or her under the Director Deferred Compensation Plan. If an independent director dies while serving on the Board, the shares and cash credited to that director under the Director Deferred Compensation Plan will be issued to his or her beneficiary. Upon a change in control of our Company (as defined in the Director Deferred Compensation Plan), each independent director will receive a cash payment equal to the value of his or her accumulated deferred compensation.

**Use of Polaris Products**

We encourage each of our independent directors to use up to ten Polaris products or services of their choosing, at no charge, to gain a first-hand understanding of the riding experience of our customers and to provide the independent directors an opportunity to evaluate product design and quality. The products used by the directors can be returned to the Company or purchased at a price greater than cost at the end of a defined usage period based upon months, miles or hours, depending upon the product line. Historically, we have sold the returned products to dealers or through auction at an amount greater than the cost of such products to the Company. As part of this program, all directors also receive the Company's parts, garments, accessories, and services at no cost.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **31** |

---

------

[**Table of Contents**](#toc)

**Director Compensation**

**2025 Director Compensation Table**

The following table sets forth the compensation earned by each of our independent directors for the year ended December 31, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name** | **Fees Earned or<br>Paid in Cash<br>($)<sup>(1)</sup>** | **Stock<br>Awards<br>($)<sup>(2)</sup>** | **All Other<br>Compensation<br>($)<sup>(3)</sup>** | **Total <br> ($)** |
| **George W. Bilicic** | 140000 | 149990 | 3110 | 293100 |
| **Kevin M. Farr<sup>(4)</sup>** | 147500 | 149990 | 7603 | 305093 |
| **Gary E. Hendrickson** | 142500 | 149990 | 36612 | 329102 |
| **Gwenne A. Henricks** | 122500 | 149990 | 4375 | 276865 |
| **Darryl R. Jackson** | 125000 | 149990 | 4476 | 279466 |
| **Bernd F. Kessler** | 132500 | 149990 | – | 282490 |
| **Lawrence D. Kingsley** | 120000 | 149990 | 24991 | 294981 |
| **Gwynne E. Shotwell** | 122500 | 149990 | 31105 | 303595 |
| **John P. Wiehoff** | 292500 | 149990 | 3651 | 446141 |

---

*(1)* *Directors may defer all or a portion of the fees otherwise payable to them in accordance with our Director Deferred Compensation Plan. With the exception of Messrs. Jackson, Kingsley, and Wiehoff, each of the current directors deferred all fees otherwise payable to him or her in 2025. The deferred amounts were converted into CSEs at the then current market price per share of our common stock, with the exception of Mr. Farr who deferred his fees into a Fidelity investment account. The aggregate number of CSEs held by each independent director as of December 31, 2025 is reflected in the "Stock Awards" column of the "Independent Directors — Outstanding Equity Awards at Fiscal Year-End" table appearing below.* 

*(2)* *On May 1, 2025, the continuing independent directors were each awarded under the 2024 Omnibus Incentive Plan 4,320 deferred stock units, each with a value equal to one share of our common stock. The grant date fair value for these deferred stock units was $34.72 per unit and was calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718 (FASB ASC Topic 718) based on the closing market price of our common stock on the award date. The aggregate number of deferred stock units and CSEs held by each independent director as of December 31, 2025 is reflected in the "Stock Awards" column of the "Independent Directors — Outstanding Equity Awards at Fiscal Year-End" table appearing below.* 

*(3)* *The following table provides more information on the type and amount of benefits included in the All Other Compensation column.* 

*(4)* *Mr. Farr retired from the Board effective January 14, 2026.* 

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **Perquisites <br> ($)<sup>(a)</sup>** | **Gross Up on<br>Perquisites<br>($)<sup>(b)</sup>** | **Total <br> ($)** |
| **George W. Bilicic** | 1765 | 1345 | 3110 |
| **Kevin M. Farr** | 4315 | 3288 | 7603 |
| **Gary E. Hendrickson** | 20777 | 15835 | 36612 |
| **Gwenne A. Henricks** | 2483 | 1892 | 4375 |
| **Darryl R. Jackson** | 2540 | 1936 | 4476 |
| **Bernd F. Kessler** | – | – | – |
| **Lawrence D. Kingsley** | 14660 | 10331 | 24991 |
| **Gwynne E. Shotwell** | 17652 | 13453 | 31105 |
| **John P. Wiehoff** | 2072 | 1579 | 3651 |

---

*(a)* *The value shown includes the cost to the Company for Polaris parts, garments, accessories, and services and the cost of the use of Polaris products. Directors are also eligible to use one boat and reimbursement of up to $35,000 for the related costs of using, storing, and maintaining the boat. The products used by our directors are either returned to the Company or purchased at a price greater than cost at the end of the defined usage period. We sell the returned products to dealers or through auction at an amount greater than cost of such products to the Company. The amount included is the imputed value based on the estimated fair market value of the use of the unit (or units) for the period of time that the unit was in the director's possession.*

*(b)* *This amount represents tax gross-ups on the use of Polaris products and related parts, garments, and accessories.*

---

| | |
|:---|:---|
| **32**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Director Compensation**

**Independent Directors — Outstanding Equity Awards at Fiscal Year-End**

The following table sets forth the number of shares of common stock underlying outstanding stock awards for each of the independent directors as of December 31, 2025.

---

| | |
|:---|:---|
| **Name** | **Stock<br> Awards<sup>(1)</sup>** |
| **George W. Bilicic** | 28973 |
| **Kevin M. Farr** | 22912 |
| **Gary E. Hendrickson** | 49718 |
| **Gwenne A. Henricks** | 34602 |
| **Darryl R. Jackson** | 9656 |
| **Bernd F. Kessler** | 57228 |
| **Lawrence D. Kingsley** | 25223 |
| **Gwynne E. Shotwell** | 24724 |
| **John P. Wiehoff** | 86553 |

---

*(1)* *Includes CSEs awarded to directors under the Director Deferred Compensation Plan, deferred stock units awarded under the 2024 Omnibus Incentive Plan, and the Polaris Inc. 2017 Omnibus Incentive Plan, as Amended (the "2017 Omnibus Incentive Plan") and the accompanying dividend equivalent units credited on each form of award.* 

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **33** |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

This Compensation Discussion and Analysis ("CD&A") describes our compensation objectives and policies and the compensation awarded to our NEOs for 2025. Our NEOs for 2025 were:

---

| | |
|:---|:---|
| **Name** | **Title** |
| Michael T. Speetzen | Chief Executive Officer |
| Robert P. Mack | Chief Financial Officer and Executive Vice President – Finance and Corporate Development |
| James P. Williams | Senior Vice President – Chief Human Resources Officer |
| Benjamin D. Duke | President – Marine |
| Michael D. Dougherty<sup>(1)</sup> | Former President – On Road and International |

---

*(1)* *Mr. Dougherty retired upon the completion of the separation of the Indian Motorcycle business, which occurred on February 2, 2026.* 

**Executive Summary**

**Compensation Philosophy**

Our executive compensation is based on a pay-for-performance philosophy to align executive compensation decisions with our corporate strategy. The goal is to provide executives with competitive compensation opportunities and actual pay outcomes that reward superior Company and individual performance. In addition, our program is typically designed to attract, motivate, and retain highly qualified executives to achieve annual and long-term goals that create stockholder value and align with stockholder interests through a combination of base salary, annual incentives and long-term incentives tied to our stock price or explicit financial metrics. We generally target our pay percentile to market median for base salary and above-market median for annual and long-term incentives. Our program, by design, emphasizes equity-based variable compensation as the largest percentage of total direct compensation for our executives. The primary objectives and priorities of the compensation program for our NEOs are the following:

![](pro014545-def14ax36x1.jpg)

We believe that our compensation policies and practices are designed to mitigate compensation-related risks to the Company's long-term performance, ethical standards and reputation. The following table summarizes some of those policies and practices.

---

| | |
|:---|:---|
| **34**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Executive Summary**

---

| | | | |
|:---|:---|:---|:---|
| **What We Do** | **What We Do** | **What We Don't Do** | **What We Don't Do** |
| ![](pro014545-def14ax37x1.jpg) | Majority of executive pay is performance-based or equity-based and not guaranteed | ![](pro014545-def14ax37x2.jpg) | No hedging of Company stock by directors or executives; limited ability to pledge |
| ![](pro014545-def14ax37x3.jpg) | Appropriate balance between short-term and long-term compensation to discourage short-term risk taking | ![](pro014545-def14ax37x4.jpg) | No excise tax gross-ups upon a change in control |
| ![](pro014545-def14ax37x1.jpg) | "Double trigger" change in control and termination of employment provisions | ![](pro014545-def14ax37x2.jpg) | No payment of dividends or dividend equivalents on unearned or unvested RSUs |
| ![](pro014545-def14ax37x3.jpg) | Rigorous stock ownership guidelines: CEO must own 5x base salary; CFO and EVPs must own 3x base salary, and all other officers must own 2x base salary | ![](pro014545-def14ax37x4.jpg) | No repricing of underwater stock options without stockholder approval |
| ![](pro014545-def14ax37x1.jpg) | NYSE-compliant clawback policy allows recovery of cash- or equity-based incentive compensation payments upon occurrence of certain financial restatements |  |  |
| ![](pro014545-def14ax37x3.jpg) | Varied quantitative performance measures |  |  |
| ![](pro014545-def14ax37x1.jpg) | Executive sessions following each Compensation Committee meeting |  |  |

---

**Compensation Program Design**

We have designed an executive compensation program that emphasizes performance-based and equity-based compensation and is significantly weighted towards long-term equity incentives. This approach helps us retain executive officers and aligns the interests of our executive officers with those of our stockholders. Below we illustrate the key tenets of our compensation program and the mix of components that made up the 2025 target total direct compensation opportunity for Mr. Speetzen and the other NEOs as a group. Please refer to the disclosure under the caption entitled "*Key Compensation Decisions*" in this CD&A for additional information about the rationale for the compensation decisions made for 2025.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **35** |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Executive Summary**

![](pro014545-def14ax38x1.jpg)

**2025 Performance Results**

The Company and the Board believe it is important to consider the broader Powersports industry context when evaluating 2025 performance. Entering the year, the industry was navigating a prolonged period of elevated interest rates that continued to suppress consumer demand for recreational vehicles and create meaningful pressure on overall market activity. Despite these macroeconomic headwinds, the Company executed well on the areas within management's control. Throughout 2025, the Company successfully right-sized dealer inventory and advanced new product innovation, finishing the year with share gains across all three operating segments. The Board views these results as evidence of disciplined execution and a resilient strategy.

At the same time, the Company faced additional financial pressure from significant tariff policy changes. While management made strident efforts to mitigate tariff impacts, the volatile and rapidly shifting tariff actions introduced substantial short-term cost impacts to the Company's supply chain and negatively affected 2025 financial performance in ways largely outside management's control.

---

| | |
|:---|:---|
| **36**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Executive Summary**

Our performance highlights from 2025 reflect our commitment to focus on what is controllable, while navigating a volatile tariff environment and consumer economic uncertainty.

---

| | | | | |
|:---|:---|:---|:---|:---|
| <br>**Sales** | **<u>REPORTED</u>**<br>**$7,152M** | **<u>YoY Change</u>**<br>**Flat** | **<u>ADJUSTED\*</u>**<br>**$7,143M** | **<u>YoY Change\*</u>**<br>**Flat** |
| **Gross Profit Margin** | **19.1%** | **-130bps** | **19.4%** | **-131bps** |
| **Net Income** | **($466M)** | **($576M)** | **($0.5M)** | **($185M)** |
| **Adjusted EBITDA** | **n/a** | **n/a** | **$410M** | **-35%** |
| **Adjusted EBITDA Margin** | **n/a** | **n/a** | **5.7%** | **-311bps** |

---

*\** *Adjusted financial results: see Appendix A for a reconciliation of non-GAAP financial measures to the most directly comparable financial measures.*

**Key Compensation Decisions**

As described above, 2025 was a year of economic uncertainty and an ever-changing and volatile tariff environment. The Company also experienced increased turnover among key leaders, increasing the need for stability and retention of executives.

The Compensation Committee made difficult compensation decisions in 2025 that recognized the continued challenging economic environment, prioritized employee retention, and responded to stockholder feedback. Unlike last year, when the Committee adopted a supplemental bonus plan as a strategic retention tool, in January 2025 the Committee returned to its usual practice of implementing only an annual incentive plan based on full-year Adjusted EBITDA (versus Adjusted EPS in prior years) performance results. The Committee's rationale for choosing Adjusted EBITDA is described below in the *Annual Incentive Compensation Plan* section of the CD&A. The Committee also approved a long-term equity compensation component mix for the CEO and the NEOs consisting of stock options and time-based restricted stock units, which the Committee believes was the best way to incentivize key executives during 2025. The Committee did not grant performance-based restricted stock unit awards in 2025 for the first time in several years due to the ongoing economic uncertainty, tariffs and their impact on consumer confidence, and the challenge of setting long-term performance goals in the current environment.

In January 2026, the Board concluded that while tariff-driven volatility continued to distort near-term results, the Company remained on track strategically and continued to perform strongly at the dealership level, with customers, and through innovation. As a result of this and to best incentivize key executives, the Compensation Committee determined it was appropriate to maintain a similar equity grant structure adopted in January 2025, but adding in the performance-based premium options along with RSUs. The premium stock options have an exercise price 10% higher than the grant date price. The Compensation Committee is closely monitoring whether our compensation program is effective in balancing our priorities of tying pay to performance, maintaining stability and retaining key employees during a volatile economic period.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **37** |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Executive Summary**

The following are the key compensation actions taken during 2025:

---

| | |
|:---|:---|
| Base Salary | Base salaries were increased by 3.5% for the CEO and the other NEOs based on individual performance and applicable market data. |
| Annual Incentive Plan | Actual incentive payouts for 2025, as a percentage of base salary, ranged from 133% to 224%. The Company was determined to have achieved Adjusted EBITDA of $538M, which was above the target level performance of $505M in the AIP performance matrix for 2025. |
| Stock Options | The NEOs were awarded stock options, which generally will vest in three equal annual installments. The options have an exercise price of $48.78, which was the closing price of our common stock on the January 29, 2025, grant date. |
| Performance Restricted<br>Stock Units ("PRSUs") | The NEOs did not receive PRSUs in 2025 due to the difficulty of setting long-term performance goals in the current challenging economic environment. |
|  | 2023-2025 PRSU Awards: The Company's PRSU awards for the 2023-2025 performance period paid out at 0% of target. The Company achieved slightly above the threshold level for one of the four performance metrics (adjusted revenue) and below the threshold for the other three performance metrics (EBITDA Margin, EBITDA and relative TSR). These PRSU awards were also subject to achievement of an adjusted return on invested capital ("ROIC") goal of 12% before any payout could be received under the EBITDA Margin or revenue metrics. ROIC is defined as net operating profit after tax ("NOPAT) for the last twelve months divided by average invested capital. ROIC may be adjusted under pre-established guidelines to account for certain other non-recurring items (or events). The Company achieved an adjusted ROIC for 2025 of 10.4%, thus there was no payout of the awards. |
| Restricted Stock Units ("RSUs") | To provide stability to the total compensation package and a service-based benefit that maintains a focus on stock growth, the NEOs were granted RSUs that generally will vest in three equal annual installments. |

---

**Our Say on Pay Results**

In making compensation decisions, the Compensation Committee generally considers the results of the Company's annual stockholder advisory votes approving the Company's named executive officer compensation. Stockholders most recently approved the Company's Say on Pay proposal at our 2025 Annual Meeting with 72% of the votes cast in favor of the compensation paid to our NEOs. In 2025, Polaris reached out to stockholders representing almost 65% of our outstanding shares, and the management team met with stockholders owning almost 35% of our outstanding shares. During these post-Meeting shareholder engagements, attended by the Chair of the Compensation Committee, CEO and CFO, when appropriate, and representatives from Investor Relations, Legal and Human Resources, the Company received feedback regarding our compensation plans. Some of our stockholders indicated that they did not support the adoption of the 2H Bonus Plan. To respond to this stockholder feedback while also addressing the need for retention and stability in a challenging economic environment, for 2025, the Compensation Committee returned to a single short-term incentive plan structure and made changes to the equity mix within the long-term incentive portion of the Company's compensation programs.

---

| | |
|:---|:---|
| **38**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Executive Compensation Program Components**

**Executive Compensation Program Components**

---

| | | | |
|:---|:---|:---|:---|
| | **Component** | **Purpose** | **Terms** |
| **Fixed** | **Base Salary** | &nbsp;&nbsp;&nbsp; **●** Provide a fixed level of consistent compensation | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **●** Salary levels are reviewed and adjusted annually as appropriate by the Compensation Committee based on a general assessment of many factors, including:<br> – Level of responsibility<br> – Experience and time in position<br> – Individual performance<br> – Market data<br> – Future potential<br> – Internal pay equity consideration |
| **Variable** | **Annual Cash Incentive Plan (AIP)** | &nbsp;&nbsp;&nbsp; **●** Reward achievement of annual Company, and for certain executives, business unit objectives<br> **●** Link pay to performance<br> **●** Align performance objectives with interests of our stockholders | &nbsp;&nbsp;&nbsp; **●** Target incentive opportunity based on responsibilities of position, expected level of contribution and consideration of market data<br> **●** Actual payouts vary based on the degree to which financial performance objectives are achieved and on consideration of other Company, business unit and individual performance factors, as determined by the Compensation Committee |
| **Variable** | **Long** **-Term Incentives (Stock Options and RSUs in 2025; Stock Options, PRSUs and RSUs in prior years)** | &nbsp;&nbsp;&nbsp; **●** Provide executive officers with incentives to achieve multi-year financial and operational objectives<br> **●** Link pay to financial, operational and stock price performance <br> **●** Align executive officers' interests with the interests of our stockholders<br> **●** Assist in retention of key executives | &nbsp;&nbsp;&nbsp; **●** Target incentive opportunity based on responsibilities of position, expected level of contribution and consideration of market data<br> **●** Stock options provide value only if our stock price increases over the option term, generally ten years<br> **●** RSUs will vest ratably over a three-year period subject to the recipient's continued employment<br> **●** PRSUs will be earned, or not, based on the degree to which specified financial objectives are attained over a three-year performance period, with results certified by the Compensation Committee. PRSUs were not granted in 2025 |
| **Other** | **Benefits and Perquisites** | &nbsp;&nbsp;&nbsp; **●** Provide an overall compensation package that is competitive with those offered by companies with which we compete for executive talent<br> **●** Provide retirement income and promote retirement savings in a tax-efficient manner | &nbsp;&nbsp;&nbsp; **●** 401(k) plan<br> **●** Health and welfare plans generally made available to our employees<br> **●** Supplemental medical, dental and vision coverage through BeniComp<br> **●** &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-qualified supplemental retirement savings plan ("SERP") with an employer match<br> **●** Only perquisites that are highly prevalent in the market are made available, and perquisites are not key drivers to the overall competitiveness of total compensation |

---

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **39** |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Determining Executive Compensation**

**Determining Executive Compensation**

**Role of the Compensation Committee**

The Compensation Committee is responsible for reviewing and approving all aspects of our executive compensation program. The Compensation Committee meets in January or February of each year to: (i) establish the annual base salary and annual incentive compensation opportunity for each of the executive officers for the current year; (ii) determine the actual annual incentive compensation to be paid to each executive officer for performance during the prior year; (iii) establish plan targets and performance measures for the one-year performance period for the annual incentive and if applicable, performance metrics and goals for any long-term incentive awards; (iv) determine the number of PRSUs earned, if any, under the long-term incentive program for the three-year performance period ended on the immediately preceding December 31; and (v) determine stock option awards, RSU awards and any other equity-based awards to be granted to executive officers.

When making individual compensation decisions for the executive officers, the Compensation Committee takes many factors into account. These factors generally include subjective and objective considerations of each individual's skills, performance and level of contribution towards desired business objectives and global business unit targets (when applicable), the Company's overall performance, retention concerns, the individual's tenure and experience with our Company and in his or her current position, the recommendations of management, the individual's current and historical compensation, the Compensation Committee's compensation philosophy, and comparisons to other comparably situated executive officers (both within the Company and within our peer group). The Compensation Committee's process uses input and analysis from a number of sources, including our management, other independent directors of the Board, the Compensation Committee's independent compensation consultant (Aon), and market studies and other comparative compensation information as discussed below.

The Compensation Committee uses this information in conjunction with its own review of the various components of our executive compensation program to determine the base salary and annual and long-term incentive targets and opportunities of the executive officers as a group and individually.

**Role of Management**

The Compensation Committee meets with our CEO and CHRO annually to review the performance of our other executive officers. The meeting includes an in-depth discussion regarding each executive officer, including, assessments of whether they achieved individual performance objectives established at the beginning of the year and their individual contributions towards achievement of our business goals.

The Compensation Committee considers input from our CEO, CFO, and CHRO when developing and selecting metrics and performance objectives for our AIP and long-term incentive program and evaluating performance against such pre-established metrics and objectives. The Compensation Committee also receives recommendations from our CEO, with the assistance of our CHRO, regarding base salary amounts, annual incentive award amounts and equity-based performance incentive awards for our other executive officers. In determining the CEO's compensation, the Compensation Committee considers performance, comparative compensation information, and input from its independent compensation consultant. Our CEO is not present during any deliberations or decision-making regarding his compensation.

**Role of the Independent Compensation Consultant**

In 2025, the Compensation Committee made a change from its prior compensation consultant, Willis Towers Watson, to engage Aon to act as its independent compensation consultant to serve in an advisory role for various technical, analytical, and plan design issues related to our compensation and benefit programs. Among other things, Aon collects market information on a variety of executive pay and design issues and assists in the design and review of programs such as our long-term incentive program and annual cash incentive plan. In addition, one or more representatives from Aon attend substantially all Compensation Committee meetings and provides the Compensation Committee with updates on regulatory changes in compensation-related issues and other developments and trends in executive compensation. The Compensation Committee has assessed the independence of Aon (and had previously assessed the independence of its prior compensation consultant) pursuant to the rules of the SEC and concluded no conflict of interest exists that would prevent the independent representation of the Compensation Committee.

---

| | |
|:---|:---|
| **40**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Determining Executive Compensation**

**Market Competitiveness Review**

The compensation peer group is established each July and is used generally as a reference for setting compensation for the following year. Our compensation consultant and the Compensation Committee periodically review the composition of the peer group of companies to assess whether it continues to be an appropriate group for comparison. The peer group begins with companies within one of several relevant Global Industry Classification Standard sectors and is further limited by considering company size (revenue and number of employees), market capitalization, industry, and business model. The Compensation Committee made no changes to the peer group for 2025.

The companies that make up the peer group used to establish the 2025 compensation of the executive officers (the Peer Group) are listed below:

---

| | | |
|:---|:---|:---|
| **2025 PEER GROUP** | | |
| AGCO Corporation | Fortive Corporation | Pentair plc |
| BorgWarner Inc. | Harley-Davidson, Inc. | Snap-On Incorporated |
| Brunswick Corporation | Hasbro, Inc. | Stanley Black & Decker, Inc. |
| Dana Incorporated | LKQ Corporation | The Timken Company |
| Donaldson Company, Inc. | Mattel, Inc. | The Toro Company |
| Dover Corporation | Oshkosh Corporation | Thor Industries, Inc. |
| Flowserve Corporation | Parker-Hannifin Corporation |  |

---

The following table summarizes our scale relative to the Peer Group.

**2025 PEER GROUP COMPARISON**

---

| | | | |
|:---|:---|:---|:---|
|  | **Revenue** **<br> ($)<sup>(1)</sup>** | **Market Capitalization** **<br> ($)<sup>(2)</sup>** | **Employee<br> (#)** |
| 25th Percentile | 4564 | 6090 | 12250 |
| Median | 5355 | 8383 | 18700 |
| 75th Percentile | 10167 | 12891 | 27925 |
| Polaris | 7152 | 3558 | 14500 |
| **Polaris Percentile** | **57th** | **7th** | **35th** |

---

*(1)* *Revenue reflected the most recent fiscal year-end.* 

*(2)* *As of December 31, 2025.* 

Both management and the Compensation Committee believe that the Peer Group provided a robust statistical set of comparison data to serve as an initial factor for comparative purposes for 2025 compensation decisions. In addition, the Compensation Committee considered data from its prior consultants' 2024 General Industry Executive Compensation Database.

The reports furnished by the compensation consultant provide the Compensation Committee with market information at the 25th, median, and 75th percentiles for each executive officer position and pay component, and for target total direct compensation, and compare the actual and target compensation amounts for each executive officer to the market amounts. The Compensation Committee generally intends to target base salaries for our executive officers at the market median for comparable positions as set forth in these reports.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **41** |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Compensation Decisions**

**Compensation Decisions**

**Base Salaries**

The following table reflects the annual base salary rates as established by the Compensation Committee for our NEOs in January 2025. Base salary rates typically go into effect April 1 of each year. Base salary rate increases in 2025 were based on individual performance and were generally implemented to maintain market competitiveness.

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **2024 Annualized<br> Base Salary<br> ($)** | **2025 Annualized<br> Base Salary<br> ($)** | **Percentage<br> Increase<br> (%)** |
| Michael T. Speetzen | 1185600 | 1227096 | 3.5% |
| Robert P. Mack | 728000 | 753500 | 3.5% |
| James P. Williams | 570000 | 590000 | 3.5% |
| Benjamin D. Duke | 582000 | 602400 | 3.5% |
| Michael D. Dougherty | 598000 | 619000 | 3.5% |

---

**Annual Incentive Compensation**

**Overview**

Our NEOs and other members of senior management selected by the Compensation Committee are eligible to earn annual cash incentive compensation under our Annual Incentive Plan ("AIP"). Cash incentives to participants in the AIP are generally payable only if and to the extent we achieve annual financial performance objectives based on one or more business criteria, as determined by the Compensation Committee.

**2025 Performance Metrics and Target Bonus Amounts**

After consideration of several factors and industry practices, the Compensation Committee selected Adjusted EBITDA as the primary performance metric for determining payouts of the 2025 annual cash incentive awards. Adjusted EBITDA is defined as net (loss) income, excluding interest expense, income tax expense, depreciation and amortization, and certain other non-cash, non-recurring, or non-operating items impacting net (loss) income from time to time. Adjusted EBITDA was chosen because it is a well-understood financial measure communicated in the public disclosures of our financial results and it closely aligns to the Company's true cash flow performance. In addition, the Compensation Committee believes that using Adjusted EBITDA drives accountability deeper in the organization and aligns with industry benchmarks.

In early 2025, the Compensation Committee also determined that for strategic business unit ("SBU") leaders, including Messrs. Dougherty and Duke, a portion (30% for Dougherty and Duke) of their incentive awards under the AIP would be based on a business unit performance component. For 2025, the Compensation Committee decided that the SBU component would be evaluated based on two metrics - revenue and gross profit dollars - weighted equally, but to earn an above target payout for revenue, the applicable SBU must meet or exceed an established gross profit margin target.

---

| | |
|:---|:---|
| **42**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Compensation Decisions**

The target payouts and relevant performance metrics for the NEOs are set forth below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Performance Metrics** | **Performance Metrics** | **Performance Metrics** |
| <br>**Name** | <br>**Target Bonus (% of<br> base salary)** | **EBITDA<br> (%)** | **SBU Revenue<br> (%)** | **SBU Gross Profit<br> Dollars<br> (%)** |
| Michael T. Speetzen | 135% | 100% | N/A | N/A |
| Robert P. Mack | 100% | 100% | N/A | N/A |
| James P. Williams | 80% | 100% | N/A | N/A |
| Benjamin D. Duke | 100% | 70% | 15% | 15% |
| Michael D. Dougherty | 100% | 70% | 15% | 15% |

---

All of the NEOs' 2025 target bonus percentages were consistent with their 2024 target awards except for Mr. Duke's, which was increased from 80% to 100%. The Compensation Committee set these target percentages based on each NEO's level of responsibility and expected contributions and the Committee's general intention to target annual incentive compensation between the market median and the 75th percentile levels for comparable positions when key financial targets are achieved.

**Annual Incentive Plan Goals, Results and Payouts**

The threshold, target and maximum EBITDA performance goals and payouts as a percent of target under the AIP for 2025 are reflected below.

---

| | | | |
|:---|:---|:---|:---|
|  | **Threshold EBITDA** | **Target EBITDA** | **Maximum EBITDA** |
| EBITDA Goals *(in millions)* | $227 | $505 | $556 |
| Payout | 40% | 100% | 200% |

---

The final performance level for 2025 Adjusted EBITDA was $538M, which was 106.6% of the target performance level of $505M, resulting in a payout percentage of 165.6% of target. The following table shows the payouts as a percentage of earned salary under the AIP based on the performance results described above:

---

| | | |
|:---|:---|:---|
| **Name** | **Incentive<br> Payout as a % of<br> Base Salary** | **Incentive<br> Amount Paid<br> ($)** |
| Michael T. Speetzen | 223.6% | 2719747 |
| Robert P. Mack | 165.6% | 1237077 |
| James P. Williams | 132.5% | 774907 |
| Benjamin D. Duke | 137.1% | 818791 |
| Michael D. Dougherty | 163.8% | 1005190 |

---

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **43** |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Compensation Decisions**

**Long-Term Incentive Compensation**

**Overview**

The Company's long-term incentive compensation typically emphasizes performance-based equity vehicles. In prior years, equity awards have been divided among stock options, RSUs, and PRSUs. In 2025, the Company withdrew guidance amid tariff and consumer uncertainty. Due to the economic uncertainty and the challenge of setting long-term performance goals, the Compensation Committee chose to provide a mix of stock options and RSUs but no PRSUs. The 2025 long-term incentive awards granted to the CEO were divided equally between stock options and RSUs. Awards for the other NEOs were allocated 40% to stock options and 60% to RSUs. The number of shares and target values of the NEOs equity awards are show below:

---

| | | | |
|:---|:---|:---|:---|
| **Named Executive Officer** | **Number of Shares<br> Subject to Stock Option** | **RSUs<br> Granted** | **Target Value<br> ($)** |
| Michael T. Speetzen | 269192 | 75052 | 7322000 |
| Robert P. Mack | 102942 | 43051 | 3500000 |
| James P. Williams | 67648 | 28291 | 2300000 |
| Benjamin D. Duke | 64706 | 27061 | 2200000 |
| Michael D. Dougherty | 47059 | 19681 | 1600000 |

---

From time to time, supplemental equity awards are granted on a selective and limited basis, generally in connection with promotions, individual outstanding performance and ability to effect desired performance results, hiring of new executives and retention situations. There were no supplemental equity awards granted in 2025. All equity-based awards were granted under the 2024 Omnibus Incentive Plan.

**Stock Option Awards**

Stock option awards granted during 2025 to our NEOs generally vest in three equal installments on February 10, 2026, February 9, 2027, and February 8, 2028, and have an exercise price of $48.78, which was the fair market value (closing price) of a share of our common stock on the January 29, 2025, grant date. Each option has a 10-year term.

Our stock option grant practices for executive officers are designed so that the stock option awards approved by the Compensation Committee at its January or February meeting will have an effective date occurring after the release of the prior year's financial results. We do not backdate or reprice stock options and have not engaged in such practices in the past.

**Restricted Stock Unit Awards**

RSUs awarded to our NEOs during 2025 will generally vest in three equal installments on February 10, 2026, February 9, 2027, and February 8, 2028. No dividend equivalents are paid on the RSUs.

**Performance Restricted Stock Unit Awards (PRSUs)**

PRSU awards may be made to each of our NEOs pursuant to the 2024 Omnibus Incentive Plan. If granted, the PRSU awards will generally be earned to the degree that we achieve performance objectives specified by the Compensation Committee at the beginning of a three-year performance period. The performance objectives are based on one or more business criteria or other metrics approved by the Compensation Committee. In establishing our performance goals, the Compensation Committee may provide that adjustments will be made for specified unusual events such as acquisitions, dispositions, restructurings and certain legal settlements.

Each PRSU will be paid out in the form of one share for each PRSU determined by the Compensation Committee to have been earned and vested over the applicable performance period.

The NEOs did not receive PRSUs in 2025.

---

| | |
|:---|:---|
| **44**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Compensation Decisions**

**2023-2025 PRSUs**

The Company's PRSU awards for the 2023-2025 performance period paid out at 0% of target. The 2023–2025 PRSUs were based on target performance objectives, set in 2023 prior to the current economic and tariff headwinds, for adjusted revenue of $9,385 million, Adjusted EBITDA Margin percentage at 14.0%, Adjusted EBITDA at $1,314 million, and relative TSR rank of the 50th percentile. The Company achieved slightly above the threshold level for adjusted revenue and below the threshold for Adjusted EBITDA Margin, Adjusted EBITDA, and relative TSR. The Company's PRSU awards for the 2023–2025 performance period were also subject to achievement of an adjusted ROIC goal of 12% before any payout could be received under the Adjusted EBITDA Margin or revenue metrics. The Company achieved an adjusted ROIC for 2025 of 10.4%, thus there was no payout of the awards.

**2023-2025 PRSU PERFORMANCE METRICS**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Weight of Metric** | **Threshold** | **Target** | **Maximum** | **Actual<br> Results** | **Percent<br> of Total<br> Payout<br> Earned<br> (%)** |
| Adjusted EBITDA Margin\* (in %) | 25% | 12.5% | 14.0% | 15.2% | 7.5% | – |
| Adjusted EBITDA (in millions) | 25% | $859 | $1314 | $1511 | $538 | – |
| Revenue\* (in millions) | 25% | $6871 | $9385 | $9943 | $7143 | 10.4% |
| Relative TSR (percentile) | 25% | 25th | 50th | ≥90th | 10.5th | – |

---

*\** *The Company is required to achieve an adjusted ROIC of 12% before any payout under the EBITDA Margin or Revenue metrics is permitted under the PRSUs. The Company achieved an adjusted ROIC of 10.4%, and therefore no amounts were paid out for the 2023-2025 PRSU awards.*

**2024-2026 PRSUs**

PRSUs granted in 2024 may be earned during the course of the 2024-2026 performance period based on the level of achievement against the performance objectives and adjustments specified at the beginning of the performance period. In 2024, the Compensation Committee selected total shareholder return relative to the Company's peer group (Relative TSR), Adjusted EBITDA Margin, Adjusted EBITDA, and Revenue Growth as the metrics for the PRSU awards, with achievement of an adjusted ROIC percentile required before any payout under the Adjusted EBITDA Margin and revenue metrics are permitted. Relative TSR for the Company or any member of the peer group during the performance period means the cumulative total shareholder return during the performance period on the applicable company's common stock as measured by the change in the company's stock price from the beginning of the performance period to the end of the performance period and takes into account the assumed reinvestment of all dividends paid during the performance period. The beginning stock price for a company will be the weighted average closing sales price as reported on the national securities exchange on which it trades during the period of November 1, 2023, through December 31, 2023. The ending stock price for a company will be the weighted average closing sales price as reported on the national securities exchange on which it trades during the period of November 1, 2026 through December 31, 2026.

For the 2024 PRSU awards, the following tables summarize the PRSU threshold, target, and maximum performance metric levels. Payouts for each NEO would be 200% of target for maximum (or greater) performance, and performance below threshold would result in no PRSUs vesting and consequently, no equity would be issued under this award.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **45** |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Other Executive Compensation Arrangements, Policies and Practices**

**2024-2026 PRSU PERFORMANCE METRICS**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Weight of Metric** | **Threshold** | **Target** | **Maximum** |
| Adjusted EBITDA Margin\* (in %) | 25% | 11% | 15% | 16% |
| Adjusted EBITDA (in millions) | 25% | $771 | $1312 | $1472 |
| Revenue\* (in millions) | 25% | $6765 | $9051 | $9494 |
| Relative TSR (percentile) | 25% | 25th | 50th | ≥90th |

---

*\** *The Company is required to achieve an adjusted ROIC of 12% before any payout under the EBITDA Margin or Revenue metrics is permitted under the PRSUs.*

**Other Executive Compensation Arrangements, Policies and Practices**

**Retirement Benefits**

We sponsor a qualified 401(k) Plan in which our NEOs may participate on the same general basis as our employees. The 401(k) Plan allows participants to make plan contributions on a pre-tax basis and to which we make Company-matching contributions dollar-for-dollar with employee contributions up to 5% of covered compensation.

We have also adopted a SERP that is intended to increase contributions limited by the application of the IRS 401(k) annual compensation limit. Additionally, the NEOs' participation in the SERP offsets employee stock option plan ("ESOP") contributions generally provided to our non-executive employee population. The SERP enables executives who participate in the 401(k) Plan, including the NEOs, to defer up to 100% of their base salary, up to 100% of amounts payable under the AIP, and PRSU and RSU awards by making contributions to the SERP. Typically, base salary and AIP deferral contributions are matched by the Company as if they had been made under the 401(k) Plan on a dollar-for-dollar basis up to 5% of covered compensation. The SERP helps executives accumulate funds for retirement on a tax-advantaged basis and is consistent with observed competitive practices of similarly situated companies.

We do not maintain a defined benefit pension plan or a defined benefit supplemental pension plan for our executive officers or non-executive employee population.

We do, however, provide certain benefits and perquisites to NEOs upon a qualifying retirement, including:

**●** Medical insurance coverage or cash equivalent for retirees and their spouses from age 55 to 64 with
 coverage coinciding with Medicare Part B on and after age 65;

**●** Dental and vision insurance coverage for retirees and their spouses at the same coverage level with the same provider
 as an active employee;

**●** Continued annual physical exams for retirees and their spouses in accordance with the active officer benefit;

**●** For the CEO only, continued supplemental medical, dental, and vision coverage through BeniComp;

**●** Continued use of Polaris products in accordance with the active NEO benefits, including related parts, garments and accessories;

**●** For AIP participants, a possible prorated payout under the plan based on the time worked during the incentive compensation
 award period payable in accordance with the normal payment schedule; and

**●** Accelerated vesting of unvested stock option and RSU awards and continued vesting of unvested PRSU awards on the terms
 described under "2025 Long-Term Incentive Compensation," provided the grant occurred at least 12 months prior
 to the retirement date and notice of intent to retire was given to the Company at least one year in advance of such retirement
 and the NEO continues to remain employed with the Company throughout the notice period.

To be eligible for full retirement-age benefits, an NEO must be at least 55 years old and have a minimum of 10 years of service to Polaris.

Messrs. Speetzen and Williams have met a portion of the retirement eligibility criteria. Mr. Dougherty, who was retirement-eligible, retired from the Company effective upon the completion of the separation of the Indian Motorcycle business, which occurred on February 2, 2026.

---

| | |
|:---|:---|
| **46**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Other Executive Compensation Arrangements, Policies and Practices**

**Perquisites**

We provide perquisites and personal benefits to our executive officers in an effort to attract and retain the best talent, but perquisites are not a material component of our executive compensation program. The perquisites and personal benefits typically provided to our NEOs are described below:

**●** Reimbursement of tax preparation, estate planning, and financial planning fees;

**●** Supplemental family medical, dental and vision coverage up to $100,000 a year through BeniComp, which covers annual expenses
 not covered under the basic medical, dental and vision benefit plans that are generally available to Company employees, and
 reimbursement of the cost of annual physicals for each executive officer and their spouse;

**●** Temporary use of Polaris products. The Company expects its executive officers to use Polaris products, so they have a
 first-hand understanding of our customers' riding experience and can evaluate product design and efficiency through
 an established, annual feedback process. This perquisite is offered to eligible salaried, exempt employees throughout the
 Company and the only variable is the type and number of products made available. The value of the temporary use of the products
 to each employee participating in the program is included as part of the employee's total compensation, and the Company
 grosses up the amount so there is no tax impact;

**●** Executive officers have access to parts, garments, accessories, and services at no cost because they are required to use
 appropriate safety equipment. The value of these items is included as part of the executive officer's compensation and
 the Company grosses up the amount so there is no tax impact to the executive officer in an effort to encourage them to experience
 our products; and

**●** Reimbursement of club entrance/initiation fees and monthly club dues.

We generally prohibit personal use of corporate aircraft by any executive officer. Occasionally, however, a guest may accompany an executive officer on business travel on a corporate jet if there is an empty seat, but there is no incremental cost to the Company. Unused tickets from business-related sponsorship agreements, which result in no incremental cost to the Company, are occasionally made available for personal use.

**Severance Arrangements**

In April 2025, we entered into new severance arrangements, replacing the prior severance agreements, with our NEOs to provide for certain benefits if an executive officer voluntarily terminates employment, retires, is involuntarily terminated without cause, is terminated without cause in connection with a change in control, or if the executive terminates his or her employment for good reason following a change in control. The new agreements were put into place to align severance terms consistently and make updates to reflect market practice. The severance arrangements with our NEOs are intended to:

**●** Allow executive officers weighing potential transactions to remain focused on stockholder interests
 and not personal interests;

**●** Provide executive officers with a measure of security in the event of an actual or potential change in corporate ownership
 or control; and

**●** Provide executive officers with a bridge to their next professional opportunity.

The severance arrangements are described in more detail beginning on page 61 under the caption entitled *"Potential Payments Upon Termination or Change-in-Control."*

**Clawback Policy**

Effective October 2, 2023, we adopted the NYSE Compensation Clawback Policy to replace our prior policy. The NYSE Compensation Clawback Policy provides for the reasonably prompt recovery (or clawback) of certain excess incentive-based compensation received during an applicable three-year recovery period by current or former executive officers in the event we are required to prepare an accounting restatement due to our material noncompliance with any financial reporting requirement under the securities laws. Triggering events include accounting restatements to correct an error in previously issued financial statements if the error is material to such previously issued financial statements, or there would be a material misstatement if the error were corrected only in the current period or left uncorrected in the current period. Excess incentive-based compensation for these purposes generally means the amount of incentive-based compensation received (on or after October 2, 2023) by an executive officer that exceeds the amount of incentive-based compensation the officer would have received had the compensation been determined based on the restated amounts, without regard to any taxes paid. Incentive-based compensation potentially subject to recovery under the mandatory accounting restatement provisions of the NYSE Compensation Clawback Policy is generally limited to any compensation granted, earned or vested based wholly or in part on the attainment of one or more financial reporting measures.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **47** |

---

------

[**Table of Contents**](#toc)

**Compensation Discussion and Analysis**

**Other Executive Compensation Arrangements, Policies and Practices**

In general, we may use a broad range of recoupment methods under the NYSE Compensation Clawback Policy for mandatory accounting restatement clawbacks. The clawback is not conditioned on the fault of the executive officer, but we are not required to clawback amounts in limited circumstances where the Compensation Committee has made a determination that recovery would be impracticable and (1) we have already attempted to recover such amounts but the direct expense paid to a third party in an effort to enforce the clawback policy would exceed the amount to be recovered, (2) the recovery of amounts would violate applicable home country law, or (3) the recovery would likely cause the non-compliance of a tax-qualified retirement plan under the Internal Revenue Code of 1986, as amended, and applicable regulations. We may not indemnify any executive officer against the loss of recovered compensation in the event of a mandatory accounting restatement.

**Hedging and Pledging Policy**

We adopted a policy that prohibits directors and executive officers from engaging in speculative trading of the Company's securities. Specifically, no officer or member of the Board of Directors may purchase any financial instruments (including prepaid variable forward contracts, equity swaps, collars, and exchange funds) that are designed to hedge or offset any decrease in the market value of Polaris securities held directly, or indirectly, by the officer or director. We also adopted a policy that prohibits directors and executive officers from pledging our common stock as collateral for a loan except where the transaction is pre-approved by the Company's General Counsel and CFO. Such pre-approval will only occur if the director or executive officer can clearly demonstrate the financial capacity to repay the loan without resorting to the pledged securities. No directors or executive officers pledged shares of Polaris common stock during 2025.

**Stock Ownership Guidelines**

The Compensation Committee believes that an important means of aligning the interests of our executive officers, including our NEOs, with the interests of our stockholders is to ensure that they own significant amounts of our common stock. To that end, the Compensation Committee adopted stock ownership guidelines that require executive officers to hold Polaris shares with a value equal to or exceeding a multiple of annual base salary as set forth in the table below. Each executive officer is expected to satisfy the stock ownership guidelines within four years following the date he or she becomes an executive officer. Failure to satisfy the stock ownership guidelines limits an executive officer's ability to sell shares of Polaris stock. In 2025, the Compensation Committee reviewed the stock ownership guidelines and made adjustments to align with market practice.

Shares included to determine whether an executive has met the applicable ownership requirement are those directly or indirectly owned, shares held in the SERP, the target number of outstanding PRSU awards and unvested RSU awards. All NEOs are in compliance with the stock ownership guidelines. The following table sets forth the stock ownership requirements as a multiple of base salary for each NEO:

---

| |
|:---|
| **Name** |
| Michael T. Speetzen 5x |
| Robert P. Mack 3x |
| James P. Williams 2x |
| Benjamin D. Duke 2x |
| Michael D. Dougherty 2x |

---

---

| | |
|:---|:---|
| **48**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Compensation Risk Assessment**

Management conducts an annual risk assessment of our employee compensation policies and practices, including those that apply to our executive officers. Management reviewed our compensation plans, program design and existing practices as well as global and local compensation policies, programs and practices applicable to all employees. Management then analyzed the likelihood and magnitude of potential risks, focusing on whether any of our compensation policies and practices varied significantly from our overall risk and reward structure, whether any such policies and practices incentivized individuals to take risks that were inconsistent with our goals, and whether any such policies and practices have resulted in establishing an inappropriate balance between short-term and long-term incentive arrangements.

Management discussed the findings of the risk assessment with the Compensation Committee. Based on the assessment, we have concluded that our compensation policies and practices are aligned with the interests of stockholders, appropriately reward pay for performance, and do not create risks that are reasonably likely to have a material adverse effect on the Company.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **49** |

---

------

[**Table of Contents**](#toc)

**Compensation Committee Report**

The Compensation Committee assists the Board in establishing a philosophy and policies regarding executive and director compensation, provides oversight of the administration of our director and executive compensation programs; and administers our equity-based compensation plans, reviews the compensation of directors, Named Executive Officers and senior management, and prepares any report on executive compensation required by the rules and regulations of the SEC or other regulatory body, including this Compensation Committee Report.

In performing its oversight responsibilities, the Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis with management. Based on the review and discussions, we have recommended to the Board that the Compensation Discussion and Analysis be included in this Proxy Statement for the 2026 Annual Meeting of Stockholders and in our Annual Report on Form 10-K for the year ended December 31, 2025.

---

| |
|:---|
| **COMPENSATION COMMITTEE** |
| Gary E. Hendrickson, Chair<br> Lawrence D. Kingsley<br> John P. Wiehoff |

---

---

| | |
|:---|:---|
| **50**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Executive Compensation**

**Summary Compensation Table**

The following table shows, for the fiscal years ended December 31, 2023, 2024, and 2025, as applicable, the annual compensation paid to or earned by our NEOs.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name and Principal<br> Position** | **Year** | **Salary<br> ($)** | **Bonus<br> ($)** | **Stock** **<br> Awards<br> ($)<sup>(1)</sup>** | **Option** **<br> Awards<br> ($)<sup>(2)</sup>** | **Non-Equity** **<br> Incentive Plan<br> Compensation<br> ($)<sup>(3)</sup>** | **All Other** **<br> Compensation<br> ($)<sup>(4)</sup>** | **Total<br> ($)** |
| &nbsp;&nbsp;&nbsp;**Michael T. Speetzen**<br> Chief Executive Officer | 2025 | 1216562 |  | 3292784 | 3661011 | 2719747 | 254533 | 11144637 |
| &nbsp;&nbsp;&nbsp;**Michael T. Speetzen**<br> Chief Executive Officer | 2024 | 1174200 |  | 3318386 | 3554217 | 792585 | 186736 | 9026124 |
| &nbsp;&nbsp;&nbsp;**Michael T. Speetzen**<br> Chief Executive Officer | 2023 | 1123750 |  | 3300279 | 3417543 | 811348 | 220557 | 8873477 |
| &nbsp;&nbsp;&nbsp;**Robert P. Mack**<br> Chief Financial Officer and Executive Vice President – Finance and Corporate Development | 2025 | 747027 |  | 1888793 | 1400011 | 1237077 | 126530 | 5399438 |
| &nbsp;&nbsp;&nbsp;**Robert P. Mack**<br> Chief Financial Officer and Executive Vice President – Finance and Corporate Development | 2024 | 721000 |  | 1027008 | 1100029 | 360500 | 2043709 | 5252246 |
| &nbsp;&nbsp;&nbsp;**Robert P. Mack**<br> Chief Financial Officer and Executive Vice President – Finance and Corporate Development | 2023 | 687500 |  | 893293 | 925040 | 445500 | 145164 | 3096497 |
| &nbsp;&nbsp;&nbsp;**James P. Williams**<br> Senior Vice President – Chief Human Resources Officer | 2025 | 584923 |  | 1241223 | 920013 | 774907 | 145400 | 3666466 |
| &nbsp;&nbsp;&nbsp;**James P. Williams**<br> Senior Vice President – Chief Human Resources Officer | 2024 | 562500 |  | 604542 | 647531 | 225000 | 121269 | 2160842 |
| &nbsp;&nbsp;&nbsp;**James P. Williams**<br> Senior Vice President – Chief Human Resources Officer | 2023 | 534625 |  | 603718 | 625042 | 286559 | 111030 | 2160974 |
| &nbsp;&nbsp;&nbsp;**Benjamin D. Duke**<br> President – Marine | 2025 | 597222 |  | 1187259 | 880002 | 818791 | 128004 | 3611278 |
| &nbsp;&nbsp;&nbsp;**Michael D. Dougherty**<br> Former President – On Road and International | 2025 | 613669 |  | 863473 | 640002 | 1005190 | 109077 | 3231411 |
| &nbsp;&nbsp;&nbsp;**Michael D. Dougherty**<br> Former President – On Road and International | 2024 | 592250 |  | 746987 | 800027 | 296125 | 97016 | 2532405 |

---

*(1)* *Amounts shown in this column represent the aggregate grant date fair value of PRSUs granted to each of our NEOs, and the grant date fair value of RSU awards granted to each of our NEOs, in the fiscal years indicated. The actual value ultimately realized by our NEOs with respect to PRSU awards will depend on our actual performance against the specified financial goals and the market value of our common stock on the vesting date, and may differ substantially from the grant date fair values shown. The grant date fair value of the time-based RSU awards was computed in accordance with FASB ASC Topic 718, based on the closing market price of our common stock on the grant date. Additional information regarding the 2025 equity awards is set forth below in the Grants of Plan-Based Awards table on page 53.* 

*(2)* *Amounts shown in this column represent the grant date fair value of stock option awards granted to each of our NEOs in the fiscal years indicated. Grant date fair value is calculated in accordance with the requirements of FASB ASC Topic 718 using the Black-Scholes method. The assumptions used in determining the grant date fair value of the 2025 awards are set forth in Note 5 to the financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.* 

*(3)* *Amounts shown in this column represent payments under the AIP, and are reported for the year in which the related services were performed and the incentive amounts earned. Additional information about these payments is set forth under the caption "Annual Incentive Compensation" on page* 

*(4)* *Amounts shown in this column include Company matching contributions to the 401(k) Plan and SERP, life insurance premiums and the aggregate incremental cost to us of the following perquisites: club dues, financial planning and tax preparation services, BeniComp supplemental medical, dental, and vision coverage, annual physicals, the use of Company products, the receipt of related parts, garments, accessories, services, and related tax gross-ups. These perquisites are described in further detail under the caption "Perquisites" on page 47. Additional detail (including quantification) regarding the components of the amounts shown for 2025 for each of our NEOs is provided in the All Other Compensation Table below.* 

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **51** |

---

------

[**Table of Contents**](#toc)

**Executive Compensation**

**All Other Compensation Table**

**All Other Compensation Table**

The following table provides additional information on the amounts reported in the All Other Compensation column of the Summary Compensation Table for 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **M. Speetzen** | **R. Mack** | **J. Williams** | **B. Duke** | **M. Dougherty** |
| 401(k) Plan Matching Contributions by Company | 17500 | 17500 | 17500 | 17500 | 17500 |
| SERP Matching Contributions by Company | 82957 | 37876 | 22996 | 23901 | 27990 |
| Life Insurance Policy Premiums | 546 | 546 | 546 | 828 | 546 |
| BeniComp Health Premiums | 21395 | 6675 | 405 | 26920 | 23176 |
| Financial Planning (Reimbursement) | 15000 | 15000 | 10000 | 1050 | 7144 |
| Club Initiation Fees and Monthly Dues (Reimbursement) | – | 13992 | – | 7896 | 23491 |
| Use of Polaris Products and Related Services<sup>(1)</sup> | 57150 | 17280 | 47356 | 12737 | 1180 |
| Polaris Parts, Garments and Accessories<sup>(2)</sup> | 5937 | 1518 | 4079 | 14114 | 3786 |
| Gross-Up on Perquisites<sup>(3)</sup> | 54048 | 16143 | 42518 | 23058 | 4264 |
| **TOTAL** | **254533** | **126530** | **145400** | **128004** | **109077** |

---

*(1)* *The Company expects its executive officers to use the Company's products so they have a first-hand understanding of our customers' riding experience and can evaluate product design and efficiency through an established, annual feedback process. Each year, the NEOs are provided the use of up to 10-16 Polaris products. In addition, all NEOs are permitted the use of one boat and are eligible for reimbursement of up to $35,000 for the related costs of using, storing, and maintaining the boat. The products used by our executives are either returned to the Company or purchased from the Company by a third party at a price greater than cost at the end of the defined usage period. We sell any returned products to dealers or through auction at an amount greater than cost of such products to the Company. The amount shown is the imputed value based on the estimated fair market value of the use of the unit (or units) for the period of time that the unit was in the executive's possession.* 

*(2)* *The value shown is the cost to the Company for Polaris parts, garments, accessories, and services provided to each of the NEOs.* 

*(3)* *This amount represents tax gross-ups on the use of Polaris products and related parts, garments, and accessories.* 

---

| | |
|:---|:---|
| **52**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Executive Compensation**

**Grants of Plan-Based Awards**

**Grants of Plan-Based Awards**

The following table summarizes each grant of an equity or non-equity incentive award during 2025 to each of our NEOs. All equity awards were granted under the 2024 Omnibus Incentive Plan. No PRSU awards were granted in 2025.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Estimated Potential Payouts** **<br> Under Non-Equity Incentive<br> Plan Awards<sup>(1)</sup>** | **Estimated Potential Payouts** **<br> Under Non-Equity Incentive<br> Plan Awards<sup>(1)</sup>** | **Estimated Potential Payouts** **<br> Under Non-Equity Incentive<br> Plan Awards<sup>(1)</sup>** | | | | |
| <br>**Name** | **Approval**<br>**and Grant** **<br> Date** | **Threshold** **<br> ($)** | **Target** **<br> ($)** | **Max** **<br> ($)** | **All Other<br> Stock<br> Awards: <br> Number of<br> Shares of<br> Stock or**<br>**Units** **<br> (#)(2)** | **All Other<br> Option Awards:<br> Number of <br> Securities <br> Underlying**<br>**Options** **<br> (#)** | **Exercise or<br> Base Price<br> of Option**<br>**Awards ($/** **<br> Sh)** | **Grant Date<br> Fair Value of<br> Stock and<br> Option**<br>**Awards** **<br> ($)(3)** |
| **Michael T. Speetzen** | 01/29/25 | - | 1642359 | 3284718 |  |  |  |  |
| **Michael T. Speetzen** | 01/29/25 |  |  |  | 75052 |  |  | 3292784 |
| **Michael T. Speetzen** | 01/29/25 |  |  |  |  | 269192 | 48.78 | 3661011 |
| **Robert P. Mack** | 01/29/25 | - | 747027 | 1494054 |  |  |  |  |
| **Robert P. Mack** | 01/29/25 |  |  |  | 43051 |  |  | 1888793 |
| **Robert P. Mack** | 01/29/25 |  |  |  |  | 102942 | 48.78 | 1400011 |
| **James P. Williams** | 01/29/25 | - | 467939 | 935877 |  |  |  |  |
| **James P. Williams** | 01/29/25 |  |  |  | 28291 |  |  | 1241223 |
| **James P. Williams** | 01/29/25 |  |  |  |  | 67648 | 48.78 | 920013 |
| **Benjamin D. Duke** | 01/29/25 | - | 597222 | 1194443 |  |  |  |  |
| **Benjamin D. Duke** | 01/29/25 |  |  |  | 27061 |  |  | 1187259 |
| **Benjamin D. Duke** | 01/29/25 |  |  |  |  | 64706 | 48.78 | 880002 |
| **Michael D. Dougherty** | 01/29/25 | - | 613669 | 1227339 |  |  |  |  |
| **Michael D. Dougherty** | 01/29/25 |  |  |  | 19681 |  |  | 863473 |
| **Michael D. Dougherty** | 01/29/25 |  |  |  |  | 47059 | 48.78 | 640002 |

---

*(1)* *Amounts in these columns represent potential payouts under the AIP. The threshold payouts under the AIP are 32% to 54% of salary and the target payouts range from 80% to 135% of salary among our NEOs. The maximum payouts represent the maximum payout amounts, which for Mr. Speetzen is 270% of salary, for Messrs. Mack, Duke, and Dougherty is 200%, and for Mr. Williams is 160%. Under the AIP, the Compensation Committee retains negative discretion to reduce the awards in their absolute discretion and therefore this table does not include a threshold payment amount. These estimated payout amounts are based on each NEO's salary for the year in which performance occurs.* 

*(2)* *Amounts in this column represent RSUs awarded to the NEOs, which will generally vest 1/3 each on February 10, 2026, February 9, 2027, and February 8, 2028, so long as the NEO remains employed on such date.* 

*(3)* *Each amount reported in this column represents the grant date fair value of the applicable award which was determined pursuant to FASB ASC Topic 718. For additional information on the valuation assumptions and more discussion with respect to the valuation of equity awards, refer to Note 5 to the audited consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.* 

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **53** |

---

------

[**Table of Contents**](#toc)

**Executive Compensation**

**Outstanding Equity Awards at Fiscal Year-End**

**Outstanding Equity Awards at Fiscal Year-End**

The following table sets forth information concerning unexercised stock option awards, unvested RSU awards, and unvested PRSU awards for each of the NEOs as of December 31, 2025, not including awards earned but not vested with a performance period ending December 31, 2025.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Option Awards** | **Option Awards** | **Option Awards** | **Option Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** |
| <br>**Name** | **Number of<br> Securities<br> Underlying<br> Unexercised<br> Options (#)<br> Exercisable** | **Number of<br> Securities<br> Underlying<br> Unexercised<br> Options (#)<br> Unexercisable** | **Option<br> Exercise<br> Price <br> ($)** | **Option<br> Expiration<br> Date** | **Number of<br> Shares or<br> Units of<br> Stock That<br> Have Not<br> Vested<br> (#)** | **Market** **<br> Value of<br> Shares or <br> Units of<br> Stock That<br> Have Not<br> Vested<br> ($)<sup>(9)</sup>** | **Equity <br> Incentive Plan<br> Awards:<br> Number of<br> Unearned<br> Shares, Units<br> or Other<br> Rights That<br> Have Not<br> Vested<br> (#)** | **Equity** **<br> Incentive Plan<br> Awards:<br> Market or<br> Payout Value<br> of Unearned<br> Shares, Units<br> or Other<br> Rights That<br> Have Not<br> Vested<br> ($)<sup>(9)</sup>** |
| **Michael T. Speetzen** | 78756 | – | 89.39 | 01/25/27 |  |  |  |  |
| **Michael T. Speetzen** | 28855 | – | 113.01 | 01/31/28 |  |  |  |  |
| **Michael T. Speetzen** | 42123 | – | 94.54 | 01/29/30 |  |  |  |  |
|  | 26604 | – | 117.37 | 01/27/31 |  |  |  |  |
|  | 25263 | – | 140.03 | 04/30/31 |  |  |  |  |
|  | 81078 | – | 111.32 | 01/26/32 |  |  |  |  |
|  | 52304<sup>(1)</sup> | 26152<sup>(1)</sup> | 117.78 | 02/01/33 |  |  |  |  |
|  | 37268<sup>(2)</sup> | 74535<sup>(2)</sup> | 89.96 | 01/31/34 |  |  |  |  |
|  | – | 269192<sup>(3)</sup> | 48.78 | 01/29/35 |  |  |  |  |
|  |  |  |  |  |  |  | 19755<sup>(4)</sup> | 1249504 |
|  |  |  |  |  | 13866<sup>(5)</sup> | 877025 |  |  |
|  |  |  |  |  | 18881<sup>(6)</sup> | 1194223 |  |  |
|  |  |  |  |  | 71733<sup>(7)</sup> | 4537112 |  |  |
| **Robert P. Mack** | 16109 | – | 89.39 | 01/25/27 |  |  |  |  |
| **Robert P. Mack** | 17313 | – | 113.01 | 01/31/28 |  |  |  |  |
| **Robert P. Mack** | 8312 | – | 84.58 | 01/30/29 |  |  |  |  |
|  | 22769 | – | 94.54 | 01/29/30 |  |  |  |  |
|  | 14002 | – | 117.37 | 01/27/31 |  |  |  |  |
|  | 3570 | – | 140.03 | 04/30/31 |  |  |  |  |
|  | 23971 | – | 111.32 | 01/26/32 |  |  |  |  |
|  | 14158<sup>(1)</sup> | 7078<sup>(1)</sup> | 117.78 | 02/01/33 |  |  |  |  |
|  | 11535<sup>(2)</sup> | 23068<sup>(2)</sup> | 89.96 | 01/31/34 |  |  |  |  |
|  |  | 102942<sup>(3)</sup> | 48.78 | 01/29/35 |  |  |  |  |
|  |  |  |  |  |  |  | 6114<sup>(4)</sup> | 386711 |
|  |  |  |  |  | 3927<sup>(5)</sup> | 248383 |  |  |
|  |  |  |  |  | 6114<sup>(6)</sup> | 386711 |  |  |
|  |  |  |  |  | 43051<sup>(7)</sup> | 2722976 |  |  |

---

---

| | |
|:---|:---|
| **54**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Executive Compensation**

**Outstanding Equity Awards at Fiscal Year-End**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Option Awards** | **Option Awards** | **Option Awards** | **Option Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** |
| <br>**Name** | **Number of<br> Securities<br> Underlying<br> Unexercised<br> Options (#)<br> Exercisable** | **Number of<br> Securities<br> Underlying<br> Unexercised<br> Options (#)<br> Unexercisable** | **Option<br> Exercise<br> Price <br> ($)** | **Option<br> Expiration<br> Date** | **Number of<br> Shares or<br> Units of<br> Stock That<br> Have Not<br> Vested<br> (#)** | **Market** **<br> Value of<br> Shares or <br> Units of<br> Stock That<br> Have Not<br> Vested<br> ($)<sup>(9)</sup>** | **Equity <br> Incentive Plan<br> Awards:<br> Number of<br> Unearned<br> Shares, Units<br> or Other<br> Rights That<br> Have Not<br> Vested<br> (#)** | **Equity** **<br> Incentive Plan<br> Awards:<br> Market or<br> Payout Value<br> of Unearned<br> Shares, Units<br> or Other<br> Rights That<br> Have Not<br> Vested<br> ($)<sup>(9)</sup>** |
| **James P. Williams** | 44748 | – | 89.39 | 01/25/27 |  |  |  |  |
| **James P. Williams** | 24046 | – | 113.01 | 01/31/28 |  |  |  |  |
| **James P. Williams** | 32809 | – | 84.58 | 01/30/29 |  |  |  |  |
|  | 28461 | – | 94.54 | 01/29/30 |  |  |  |  |
|  | 17503 | – | 117.37 | 01/27/31 |  |  |  |  |
|  | 17626 | – | 111.32 | 01/26/32 |  |  |  |  |
|  | 9566<sup>(1)</sup> | 4783<sup>(1)</sup> | 117.78 | 02/01/33 |  |  |  |  |
|  | 6790<sup>(2)</sup> | 13579<sup>(2)</sup> | 89.96 | 01/31/34 |  |  |  |  |
|  | – | 67648<sup>(3)</sup> | 48.78 | 01/29/35 |  |  |  |  |
|  |  |  |  |  |  |  | 3599<sup>(4)</sup> | 227637 |
|  |  |  |  |  | 2654<sup>(5)</sup> | 167866 |  |  |
|  |  |  |  |  | 3599<sup>(6)</sup> | 227637 |  |  |
|  |  |  |  |  | 28291<sup>(7)</sup> | 1789406 |  |  |
| **Benjamin D. Duke** | 227 | – | 121.86 | 02/19/31 |  |  |  |  |
| **Benjamin D. Duke** | 412 | – | 124.58 | 02/18/32 |  |  |  |  |
| **Benjamin D. Duke** | 7653<sup>(1)</sup> | 3826<sup>(1)</sup> | 117.78 | 02/01/33 |  |  |  |  |
|  | 6292<sup>(2)</sup> | 12582<sup>(2)</sup> | 89.96 | 01/31/34 |  |  |  |  |
|  | – | 64706<sup>(3)</sup> | 48.78 | 01/29/35 |  |  |  |  |
|  |  |  |  |  |  |  | 3335<sup>(4)</sup> | 210939 |
|  |  |  |  |  | 2123<sup>(5)</sup> | 134280 |  |  |
|  |  |  |  |  | 3335<sup>(6)</sup> | 210939 |  |  |
|  |  |  |  |  | 27061<sup>(7)</sup> | 1711608 |  |  |

---

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **55** |

---

------

[**Table of Contents**](#toc)

**Executive Compensation**

**Outstanding Equity Awards at Fiscal Year-End**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Option Awards** | **Option Awards** | **Option Awards** | **Option Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** | **Stock Awards** |
| <br>**Name** | **Number of<br> Securities<br> Underlying<br> Unexercised<br> Options (#)<br> Exercisable** | **Number of<br> Securities<br> Underlying<br> Unexercised<br> Options (#)<br> Unexercisable** | **Option<br> Exercise<br> Price <br> ($)** | **Option<br> Expiration<br> Date** | **Number of<br> Shares or<br> Units of<br> Stock That<br> Have Not<br> Vested<br> (#)** | **Market** **<br> Value of<br> Shares or <br> Units of<br> Stock That<br> Have Not<br> Vested<br> ($)<sup>(9)</sup>** | **Equity <br> Incentive Plan<br> Awards:<br> Number of<br> Unearned<br> Shares, Units<br> or Other<br> Rights That<br> Have Not<br> Vested<br> (#)** | **Equity** **<br> Incentive Plan<br> Awards:<br> Market or<br> Payout Value<br> of Unearned<br> Shares, Units<br> or Other<br> Rights That<br> Have Not<br> Vested<br> ($)<sup>(9)</sup>** |
| **Michael D. Dougherty** | 16109 | – | 89.39 | 01/25/27 |  |  |  |  |
| **Michael D. Dougherty** | 11542 | – | 113.01 | 01/31/28 |  |  |  |  |
| **Michael D. Dougherty** | 19354 | – | 94.54 | 01/29/30 |  |  |  |  |
|  | 11902 | – | 117.37 | 01/27/31 |  |  |  |  |
|  | 18331 | – | 111.32 | 01/26/32 |  |  |  |  |
|  | 10714<sup>(1)</sup> | 5356<sup>(1)</sup> | 117.78 | 02/01/33 |  |  |  |  |
|  | 8389<sup>(2)</sup> | 16777<sup>(2)</sup> | 89.96 | 01/31/34 |  |  |  |  |
|  | – | 47059<sup>(3)</sup> | 48.78 | 01/29/35 |  |  |  |  |
|  |  |  |  |  |  |  | 4447<sup>(4)</sup> | 281273 |
|  |  |  |  |  | 2848<sup>(5)</sup> | 180136 |  |  |
|  |  |  |  |  | 4262<sup>(6)</sup> | 269572 |  |  |
|  |  |  |  |  | 18931<sup>(7)</sup> | 1197386 |  |  |

---

*(1)* *Represents a stock option granted on February 1, 2023 under the 2017 Omnibus Incentive Plan, which will generally vest with respect to one-third of the shares on each of the first, second, and third anniversaries of the date of grant.* 

*(2)* *Represents a stock option granted on January 31, 2024 under the 2017 Omnibus Incentive Plan, which will generally vest with respect to one-third of the shares on each of the first, second, and third anniversaries of the date of grant.* 

*(3)* *Represents a stock option granted on January 29, 2025 under the 2024 Omnibus Incentive Plan, which will generally vest with respect to one-third of the shares on each of the first, second, and third anniversaries of the date of grant.* 

*(4)* *Represents PRSU awards made on January 31, 2024 under the 2017 Omnibus Incentive Plan for the three-year performance period beginning January 1, 2024 and ending December 31, 2026 (the "2024 PRSU Grant"). Units subject to the 2024 PRSU Grant may be earned and vested after the end of the three-year performance period and prior to March 15, 2027. The amount shown is the target number of units that could be earned and paid out in shares. There is no assurance that the target amount will be the actual amount ultimately paid* 

*(5)* *Represents a time-based RSU award granted on February 1, 2023 under the 2017 Omnibus Incentive Plan that will generally vest with respect to 100% of the units on February 1, 2026. For Mr. Speetzen, 642 shares were withheld in December 2025, and Mr. Dougherty, 124 shares were withheld in December 2023 to cover FICA/Medicare tax for grants where the executive previously met a portion of the retirement eligibility criteria.* 

*(6)* *Represents a time-based RSU award granted on January 31, 2024 under the 2017 Omnibus Incentive Plan that will generally vest with respect to 100% of the units on February 9, 2027. For Mr. Speetzen, 874 shares were withheld in December 2025, and for Mr. Dougherty, 185 shares were withheld in December 2024 to cover FICA/Medicare tax for grants where the executive previously met a portion of the retirement eligibility criteria.* 

*(7)* *Represents a time-based RSU award granted on January 29, 2025 under the 2017 Omnibus Incentive Plan that will generally vest with respect to one-third of the units on February 10, 2026, February 9, 2027, and February 8, 2028. For Mr. Speetzen, 3,319 shares and for Mr. Dougherty, 750 shares were withheld in December 2025 to cover FICA/Medicare tax for grants where the executive previously met a portion of the retirement eligibility criteria.* 

*(8)* *These amounts are based upon our stock price of $63.25 on December 31, 2025, the last day of the year. The actual value realized by our NEOs could be different based upon the eventual stock prices at the time of settlement.* 

---

| | |
|:---|:---|
| **56**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Executive Compensation**

**Option Exercises and Stock Vested in 2025**

**Option Exercises and Stock Vested in 2025**

The following table provides information concerning the aggregate number of stock options exercised, and PRSUs and RSUs that vested for each of our NEOs during 2025, and the aggregate dollar values realized by each of our NEOs upon such event.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Option Awards** | **Option Awards** | | **Stock Awards** |
| <br>**Name** | **Number of** **<br> Shares<br> Acquired on<br> Exercise<br> (#)** | **Value** **<br> Realized on<br> Exercise<br> ($)** | <br>**&nbsp;&nbsp;&nbsp;&nbsp;** | **Value** **<br> Realized on<br> Vesting<br> ($)<sup>(2)</sup>** |
| **Michael T. Speetzen** | – | – | 12914<sup>(3)</sup> | 695161 |
| **Robert P. Mack** | – | – | 3818<sup>(3)</sup> | 205523 |
| **James P. Williams** | – | – | 2695<sup>(3)</sup> | 145072 |
| **Benjamin D. Duke** | – | – | 1303<sup>(3)</sup> | 49154 |
| **Michael D. Dougherty** | – | – | 2799<sup>(3)</sup> | 150670 |

---

*(1)* *Amounts shown in this column include time-based RSUs that vested in 2025. There were no shares issuable to our NEOs in settlement of PRSUs as of December 31, 2025 for the 2023-2025 performance period because no PRSUs were earned.* 

*(2)* *Amounts shown in this column are based on fair market value of a share of our common stock on the applicable vesting date.* 

*(3)* *This amount represents RSUs that vested January 24, 2025 valued at $53.83 per share for Mssrs. Speetzen, Mack, Williams and Dougherty. Mr. Duke had 402 RSUs vest on February 18, 2025 valued at $46.25 per share and 901 RSUs vest on May 5, 2025 valued at $33.92 per share. Mr. Speetzen elected to defer receipt of 30% of the RSU settlement shares with an equivalent number of deferred stock units then credited to the Company stock fund in his SERP account, the terms of which are discussed below under Nonqualified Deferred Compensation on page 58.* 

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **57** |

---

------

[**Table of Contents**](#toc)

**Executive Compensation**

**Policies and Practices Regarding the Timing of Grants of Certain Equity Awards**

**Policies and Practices Regarding the Timing of Grants of Certain Equity Awards**

For many years, the regular quarterly meetings of the Board and its committees have occurred during the two days immediately following the Company's release of its quarterly earnings results. The Compensation Committee approves the annual equity awards for executives during its first quarter meeting, typically in late January or early February, the day after the release of the quarterly earnings results. The Compensation Committee does not take material nonpublic information into account when determining the timing or terms of the annual equity awards, nor is the purpose of the timing of such awards intended to affect the value of executive compensation.

Consistent with this practice, in 2025, the Company released its earnings results announcing its fourth quarter and full year financial results for the year ended December 31, 2024 on January 28, 2025 and the Compensation Committee granted annual stock options on January 29, 2025, one business day following the earnings release. The Compensation Committee believes that the Company was not in possession of material nonpublic information after the release of earnings and that the public markets had a sufficient period of time to absorb the Company's earnings results.

The following table presents information regarding stock options awarded to our named executive officers in 2025, during any period beginning four business days before the filing of a periodic report on Form 10-Q or Form 10-K or the filing or furnishing of a current report on Form 8-K disclosing material non-public information, and ending one business day after the filing or furnishing of such report with the SEC.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name** | **Grant date** | **Number of**<br> **securities**<br> **underlying**<br> **the award** | **Exercise**<br> **price of the**<br> **award ($/**<br> **Sh)** | **Grant date**<br> **fair value of**<br> **the award** | **Percentage change in the closing market**<br> **price of the securities underlying the**<br> **award between the trading day ending**<br> **immediately prior to the disclosure of**<br> **material nonpublic information and the**<br> **trading day beginning immediately**<br> **following the disclosure of material**<br> **nonpublic information** |
| **(a)** | **(b)** | **(c)** | **(d)** | **(e)** | **(f)** |
| **Michael T. Speetzen** | 01/29/25 | 269192 | 48.78 | 3661011 | (14%) |
| **Robert P. Mack** | 01/29/25 | 102942 | 48.78 | 1400011 | (14%) |
| **James P. Williams** | 01/29/25 | 67648 | 48.78 | 920013 | (14%) |
| **Benjamin D. Duke** | 01/29/25 | 64706 | 48.78 | 880002 | (14%) |
| **Michael D. Dougherty** | 01/29/25 | 47059 | 48.78 | 640002 | (14%) |

---

**Nonqualified Deferred Compensation**

We sponsor a 401(k) Plan that allows employees to make plan contributions on a pre-tax basis. Employees are automatically enrolled at 5% of covered compensation and can affirmatively elect to contribute 0-50% of covered compensation into the 401(k) Plan. We match employee contributions dollar-for-dollar up to 5% of base salary and AIP deferrals. Although NEOs are eligible to participate in the 401(k) Plan, the application of the annual compensation limit under Section 401(a)(17) of the Code significantly limits NEOs' contributions under the 401(k) Plan. The SERP provides executives who participate in the 401(k) Plan with the opportunity to defer up to 100% of their base salary, up to 100% of amounts payable under the AIP, and PRSUs and RSUs, into the SERP. Typically, base salary and AIP deferral contributions are matched by the Company as if they had been made under the 401(k) Plan on a dollar-for-dollar basis up to 5% of covered compensation. The SERP is intended solely to increase contributions limited because of the application of the annual compensation limit under Section 401(a)(17) of the Code to the 401(k) Plan.

---

| | |
|:---|:---|
| **58**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Executive Compensation** 

**Nonqualified Deferred Compensation**

The following table sets forth information regarding the contributions by each NEO and the Company to the SERP, as well as information regarding earnings, aggregate withdrawals and distributions and balances under the SERP, for each NEO as of and for the fiscal year ended December 31, 2025.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name** | **Executive**<br> **Contributions** <br> **in Last FY**<br> **($)<sup>(1)</sup>** | **Company**<br> **Contributions**<br> **in Last FY**<br> **($)<sup>(2)</sup>** | **Aggregate**<br> **Earnings**<br> **in Last FY**<br> **($)<sup>(3)</sup>** | **Aggregate**<br> **Withdrawals/**<br> **Distributions**<br> **($)** | **Aggregate**<br> **Balance at**<br> **Last FYE**<br> **($)<sup>(4)</sup>** |
| **Michael T. Speetzen** | 309049 | 82957 | 509731 | – | 3727421 |
| **Robert P. Mack** | 110753 | 37876 | 223553 | (52849) | 1841483 |
| **James P. Williams** | 40497 | 22996 | 1500016 | – | 10797223 |
| **Benjamin D. Duke** | 53346 | 23901 | 36893 | – | 319291 |
| **Michael D. Dougherty** | 45490 | 27990 | 1443973 | – | 9916683 |

---

*(1)* *These amounts represent elective contributions into the SERP during 2025 of a portion of base salary earned during 2025 and a portion of incentive compensation earned in 2024 and payable during 2025 under the AIP and/or pursuant to the PRSU or RSU awards to each of the NEOs. The amount of any base salary deferred is included in the amount reported in the 2025 Salary column of the Summary Compensation Table and the amount of any annual incentive deferred is included in the amount reported in the 2025 "Non-Equity Incentive Plan Compensation" column of the Summary Compensation Table. The amount of any PRSU or RSU settlement that is deferred does not necessarily correspond to the grant date fair value of that PRSU award reported in the Summary Compensation Table in the year the award was granted. Deferrals related to amounts otherwise payable in 2025 (even if considered earned in 2024) will be shown as executive contributions for 2025.* 

*(2)* *These amounts represent Company matching contributions to the SERP during 2025. The amount in this column for each NEO is included in the "All Other Compensation" column of the Summary Compensation Table for 2025.* 

*(3)* *These amounts represent earnings or losses during 2025 credited to the respective NEOs' SERP accounts. None of these amounts are included in compensation reported in the Summary Compensation Table because none of the earnings are considered to be "above market."* 

*(4)* *Of the aggregate balances shown, the following amounts were previously reported as salary, annual incentive compensation, LTIP award compensation or all other compensation in Summary Compensation Tables covering fiscal years prior to 2025: Mr. Speetzen, $2,878,028; Mr. Mack, $1,238,518; Mr. Williams $402,777; and Mr. Dougherty $70,972.* 

PRSUs and RSUs deferred into the SERP are held by the Company for 6 months and one day, at which time shares in settlement of the PRSUs and RSUs are paid to the participant in their SERP account. The shares can be sold, with proceeds invested in the investment options available under the SERP. The SERP account of each NEO is deemed to be invested in the fund(s) designated by the NEO. For this purpose, the NEOs may choose among the same funds that are available to our employees generally under the 401(k) Plan or self-direct any portion of their investments. Deemed investment earnings and losses are applied to each NEO's SERP account based upon the performance of the applicable investment fund. At December 31, 2025, accounts of the NEOs were invested in the following funds:

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **59** |

---

------

[**Table of Contents**](#toc)

**Executive Compensation**

**Nonqualified Deferred Compensation**

---

| | |
|:---|:---|
| American Funds EuroPacific Growth Fund<sup>®</sup> Class R-6 | Vanguard Institutional Index Fund Institutional Plus Shares |
| T. Rowe Price International Discovery Fund I Class | Vanguard Institutional Target Retirement 2030 Fund Institutional Shares |
| Fidelity<sup>®</sup> Investments Money Market Treasury Only - Institutional Class | Vanguard Institutional Target Retirement 2035 Fund Institutional Shares |
| Fidelity Global Index ex. U.S. Index Fund | Vanguard Mid-Cap Index Fund Institutional Shares |
| Fidelity Total Bond Fund | Vanguard Small-Cap Index Fund Institutional Shares |
| DWS RREEF Real Assets Fund - Class R6 | Vanguard Total Bond Market Index Fund Institutional Shares |
| Polaris Stock Fund | Allspring Special Small Cap Value Fund - Class R6 |
| Neuberger Berman Small Cap Growth Fund R6 Class | BlackRock Strategic Global Bond Fund, Inc. Institutional Shares |
| MFS Mid Cap Value Fund Class R6 |  |

---

The return on these funds ranged from 4.19% to 29.18% in 2025. Under the SERP, NEOs may elect to receive distributions (i) 6 months following separation of service or one year after separation of service; (ii) upon the attainment of a certain age, designated by the NEO, between 59 ½ to 70 ½, provided that the NEO will not attain the designated age for at least 3 years after his election; or (iii) the earlier or later of (i) or (ii). NEOs may elect to receive the distribution in a lump sum or in monthly, quarterly or annual installments over a period not to exceed 10 years. If the installment method is elected, the NEO's account will continue to be credited with a prorated amount of deemed investment earnings during the period.

---

| | |
|:---|:---|
| **60**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Potential Payments Upon Termination or Change In Control**

Our NEOs are eligible to receive certain payments and benefits in the event of termination of their employment, including following a change in control pursuant to severance arrangements and equity award agreements with the Company.

**Severance Arrangements with Named Executive Officers**

We have entered into severance arrangements with our NEOs, which provide certain benefits to the NEOs upon their termination of employment without cause and under certain circumstances due to a resignation for good reason, including following a change in control. For this purpose, a "change in control" is deemed to occur if:

● There is a substantial change in the composition of the Board which causes at
 least one-half of the Board to consist of new directors that were not nominated by the Company; or

● A third party acquires ownership of 35% or more of our common stock, unless such acquisition
 is approved by the Board; or

● We engage in certain extraordinary corporate events (such as a liquidation, dissolution, reorganization,
 merger or sale of all or substantially all of our assets), unless we are the surviving entity after such transaction or at
 least one-half of our Board members continue to serve as directors of the surviving entity after such transaction, as applicable.

Under the severance arrangements, an NEO will be considered to have been terminated without cause if they are terminated other than for (i) repeated willful violations of the NEO's employment obligations or (ii) conviction of a felony. An NEO will be considered to have terminated their employment for good reason if they terminate employment due to (i) a material reduction in base salary (except for any reduction of no more than 10% that applies as part of a reduction to substantially all senior executives), (ii) a material reduction in duties, responsibilities, authority, positions or titles, (iii) the Company requiring the NEO to be based at any location that is more than a 50-mile radius from the NEO's then-current principal office or (iv) material breach by the Company of any material terms or provisions of any employment agreement between the Company and the NEO, all as specified in the applicable agreement.

**Severance Agreements with NEOs**

**Change in Control Related Payments**

We have entered into severance agreements with our NEOs which provide that if upon or within 24 months after a change in control, any of such NEOs terminates employment for good reason or if their employment is terminated by the Company without cause, then the NEO will be entitled to:

● A lump sum cash payment equal to three (for Mr. Speetzen), two-and-a-half (for
 Mr. Mack) or two (for Messrs. Williams, Duke and Dougherty) times the sum of the NEO's (x) annual base salary and (y)
 annual target cash incentive award under the AIP, in each case, as in effect on the date of termination;

● A prorated portion of the target annual cash incentive award under the AIP for the year in
 which the termination occurs;

● The value of accrued but unused vacation time measured as of the date of termination;

● Any earned but unpaid cash incentive awards under the AIP for the preceding fiscal year; and

● Treatment of outstanding and unvested equity awards as specified below.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **61** |

---

------

[**Table of Contents**](#toc)

**Potential Payments Upon Termination or Change In Control**

**Equity Award Treatment Upon Termination**

**Non-Change in Control Termination Related Payments**

Under the severance agreements, a non-change in control termination is deemed to occur if the NEO is terminated by the Company without cause or solely for Mr. Speetzen, if he terminates employment for good reason, in each case, other than within 24 months following a change in control. In the event of a non-change in control termination, the NEO will be entitled to:

● An amount equal to two (for Mr. Speetzen), one-and-a-half (for Mr. Mack) or one (for Messrs. Williams,
 Duke and Dougherty) times the sum of the NEOs' (x) annual base salary and (y) annual target cash incentive award under
 the AIP, in each case, as in effect on the date of termination, which will be payable over a period of two (for Mr. Speetzen),
 one-and-a-half (for Mr. Mack) or one (for Messrs. Williams, Duke and Dougherty) years beginning on the date of termination
 in periodic installments in accordance with the Company's normal payroll practices;

● A lump sum cash payment in an amount equal to (A) a prorated portion of the target cash incentive award under the AIP
 for the year in which the termination occurs plus (B) the value of the NEO's accrued but unused vacation time measured
 as of the date of termination;

● Any earned but unpaid cash incentive award under the AIP for the preceding fiscal year;

● If the NEO elects to receive benefits under the Consolidated Omnibus Reconciliation Act ("COBRA"), payment for
 the COBRA premiums for the NEO and/or the NEO's dependents under our group health plans for a period of two (for Mr.
 Speetzen), one-and-a-half (for Mr. Mack) or one (for Messrs. Williams, Duke and Dougherty) years;

● Reasonable executive outplacement services; and

● Treatment of outstanding and unvested equity awards as specified below.

**Retirement Related Payments**

Under the severance agreements, a qualifying retirement means a termination of the employee's employment with the Company, other than a termination by the Company for cause, in which the termination occurs on or after such employee has reached the age of 55 and has completed at least ten years of continuous employment, provided that the NEO gives the Company written notice of his or her intention to retire at least one year in advance of such retirement and the NEO continues to remain employed with the Company throughout the notice period (i.e., does not voluntarily resign or incur a termination for cause before the end of the notice period). Upon a qualifying retirement, an NEO will be entitled to:

● Subject to the discretion of the Board and approval by the Compensation Committee,
 an amount equal to a prorated portion of the cash incentive award under the AIP based on actual performance for the year in
 which the termination occurs;

● Any earned but unpaid cash incentive award under the AIP for the preceding fiscal year;

● A lump sum payment equal to the value of the NEO's accrued but unused vacation time
 measured as of the date of termination; and

● Treatment of outstanding and unvested equity awards as specified below.

As a condition to receiving payments and benefits under the severance agreement, the NEOs must execute a general waiver and release of any claims against the Company.

The amounts payable to each NEO under the severance agreements and stock option, RSU, and PRSU awards are quantified in the tables appearing under the caption "Potential Payments to Our Named Executive Officers Upon Termination".

**Equity Award Treatment Upon Termination**

**Change in Control Related Treatment**

If any NEO resigns for good reason or is terminated by the Company without cause, in each case, upon or within 24 months following a change in control, all outstanding and unvested equity awards held by such NEO as of the date of termination will accelerate and vest in full, with any outstanding and unvested PRSUs vesting based on target performance and outstanding options remain exercisable until the original option expiration date.

**Non-Change in Control Termination Related Treatment**

If an NEO is terminated by the Company without cause or, solely for Mr. Speetzen, if he resigns for good reason, in each case, other than in connection with a change in control, (i) all outstanding and unvested options and RSUs held by such NEO, as of the date of termination, will accelerate and vest on a pro-rated basis based on the number of days that have elapsed in the vesting period from the grant date through the date of termination and (ii) all outstanding and unvested PRSUs will remain outstanding and eligible to vest in the same form and at the same time that such awards were originally scheduled to vest on a pro-rated basis based on actual performance (as certified by the Compensation Committee) and the number of days that have elapsed in the vesting period from the grant date through the date of termination. Any outstanding options that become vested in connection with such termination will remain exercisable until the original option expiration date.

---

| | |
|:---|:---|
| **62**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Potential Payments Upon Termination or Change In Control**

**Non-Compete and Non-Solicitation Agreements**

**Qualifying Retirement Treatment**

Upon an NEO's termination of employment as a result of a qualifying retirement, (i) all outstanding and unvested options and RSUs held by such NEO as of the date of termination will accelerate and vest in full and (ii) all outstanding and unvested PRSUs that are held by such NEO as of the date of termination will remain outstanding and vest in the same form and at the same time that such awards would have vested as if the NEO had remained continuously employed through the full vesting period based on actual performance (as certified by the Compensation Committee). Any outstanding options will remain exercisable until the original option expiration date.

**Death or Disability Treatment**

Upon an NEO's termination of employment as a result of death or disability, (i) all outstanding and unvested options will accelerate and vest in full, (ii) RSUs will continue to vest as if the NEO continued to remain employed for the duration of the vesting period and (iii) a pro-rata portion of the PRSUs will continue to vest based on actual performance achievement (with such pro-rata portion determined by multiplying the number of units that would otherwise have vested had the NEO remained employed through the end of the performance period by a fraction where the numerator is the number of full calendar months during the performance period prior to the executive's employment termination date and the denominator is 36). Any outstanding options that become vested in connection with such termination will remain exercisable for a period ending on the earlier of (x) the one-year anniversary of the date of termination of employment and (y) the original option expiration date.

The amounts payable to each NEO under the severance agreements and equity award agreements are quantified in the table appearing under the caption "Potential Payments to Our Named Executive Officers".

**Non-Compete and Non-Solicitation Agreements**

The NEOs were required to enter into non-competition agreements as a condition to the receipt of certain equity grants, under which they agree to not engage in competitive activities or soliciting employees for a period of eighteen months following their termination of employment.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **63** |

---

------

[**Table of Contents**](#toc)

**Potential Payments Upon Termination or Change In Control**

**Potential Payments to Our Named Executive Officers Upon Termination**

**Potential Payments to Our Named Executive Officers Upon Termination**

The following tables quantify the amounts and benefits payable to each of the NEOs upon termination under various scenarios. In calculating the payments set forth in such tables, we have assumed that (i) the date of termination was December 31, 2025, and (ii) the stock price was $63.25 per share, the closing market price of our common stock on December 31, 2025, the last day of fiscal year 2025. The tables do not reflect payments and benefits that are provided on a non-discriminatory basis to salaried employees generally upon termination, including:

● Earned but unpaid base salary through the date of termination;

● Earned, unused vacation pay through the date of termination;

● Company matching contributions to the 401(k) Plan in an amount which takes into account the
 final payouts for base salary, incentive awards under the AIP, if any, and earned, unused vacation;

● Distributions of plan balances under the Polaris 401(k) Plan; and

● A life insurance benefit equal to two times base salary up to a maximum of $650,000, payable
 in the event of termination upon death.

The tables also do not reflect amounts attributable to vested, non-forfeitable equity-based awards or awards that are earned but not vested with a performance period ending December 31, 2025 (see *Outstanding Equity Awards at Fiscal Year-End* on page 54), or distributions of plan balances under the SERP (see *Nonqualified Deferred Compensation* on page 58). In addition, the tables do not reflect any applicable tax withholdings or other deductions by the Company from the amounts otherwise payable to the NEOs upon termination of employment. To the extent applicable, the present value of the payments presented in the tables below was calculated using a discount rate of 5%.

We provide a number of lifetime benefits and perquisites to our NEOs upon retirement. For purposes of quantifying the value of such benefits and perquisites in the tables below, we have used an average life expectancy age of 78 for such individuals. The costs of medical, dental, and vision coverage are based on current annual premiums multiplied by the number of years between the executive officer's age and 78 for those that receive it until then. Company parts, garments and accessories coverage is based on the average spent for the NEOs in 2025, based upon grade level, multiplied by the number of years between the executive officer's age and 78 (for those who receive it).

---

| | |
|:---|:---|
| **64**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Potential Payments Upon Termination or Change In Control**

**Potential Payments to Our Named Executive Officers**

**Potential Payments to Our Named Executive Officers**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Without Cause**<br> **Termination by**<br> **Company**<br> **($)** | **Without Cause**<br> **Termination**<br> **Change in Control**<br> **($)** | **Change in**<br> **Control no**<br> **Termination**<br> **($)** | **Death or**<br> **Disability**<br> **($)** | **Retirement**<br> **($)** |
| **Michael T. Speetzen** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash Compensation | 5767351 | 8651027 | – | – | – |
| &nbsp;&nbsp;&nbsp;&nbsp;Annual Cash Incentives<sup>(1)</sup> | 2719747 | 2719747 | – | 2719747 | 2719747 |
| &nbsp;&nbsp;&nbsp;&nbsp;PRSUs<sup>(2)</sup> | 833003 | 1249504 | – | 1249504 | 1249504 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock Options<sup>(3)</sup> | 1184425 | 3895208 | – | 3895208 | 3895208 |
| &nbsp;&nbsp;&nbsp;&nbsp;RSUs<sup>(4)</sup> | 2820009 | 6608360 | – | 6608360 | 6608360 |
| &nbsp;&nbsp;&nbsp;&nbsp;Medical and Dental Insurance | 55608 | – | – | – | 205598 |
| &nbsp;&nbsp;&nbsp;&nbsp;Polaris Parts, Garments and Accessories | – | – | – | – | 417729 |
| **Total** | **13380143** | **23123846** | **–** | **14472819** | **15096146** |
| **Robert P. Mack** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash Compensation | 2260500 | 3767500 | – | – | – |
| &nbsp;&nbsp;&nbsp;&nbsp;Annual Cash Incentives<sup>(1)</sup> | 1237077 | 1237077 | – | 1237077 | – |
| &nbsp;&nbsp;&nbsp;&nbsp;PRSUs<sup>(2)</sup> | 257807 | 386711 | – | 386711 | – |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock Options<sup>(3)</sup> | 452937 | 1489571 | – | 1489571 | – |
| &nbsp;&nbsp;&nbsp;&nbsp;RSUs<sup>(4)</sup> | 1314087 | 3358069 | – | 3358069 | – |
| &nbsp;&nbsp;&nbsp;&nbsp;Medical and Dental Insurance | 28316 | – | – | – | – |
| &nbsp;&nbsp;&nbsp;&nbsp;Polaris Parts, Garments and Accessories | – | – | – | – | – |
| **Total** | **5550724** | **10238928** | **–** | **6471428** | **–** |
| **James P. Williams** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash Compensation | 1062000 | 2124000 | – | – | – |
| &nbsp;&nbsp;&nbsp;&nbsp;Annual Cash Incentives<sup>(1)</sup> | 774907 | 774907 | – | 774907 | 774907 |
| &nbsp;&nbsp;&nbsp;&nbsp;PRSUs<sup>(2)</sup> | 151758 | 227637 | – | 227637 | 227637 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock Options<sup>(3)</sup> | 297646 | 978867 | – | 978867 | 978867 |
| &nbsp;&nbsp;&nbsp;&nbsp;RSUs<sup>(4)</sup> | 851277 | 2184908 | – | 2184908 | 2184908 |
| &nbsp;&nbsp;&nbsp;&nbsp;Medical and Dental Insurance | 27654 | – | – | – | 51202 |
| &nbsp;&nbsp;&nbsp;&nbsp;Polaris Parts, Garments and Accessories | – | – | – | – | 186906 |
| **Total** | **3165242** | **6290319** | **–** | **4166319** | **4404427** |

---

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **65** |

---

------

[**Table of Contents**](#toc)

**Potential Payments Upon Termination or Change In Control**

**Potential Payments to Our Named Executive Officers**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Without Cause**<br> **Termination by**<br> **Company**<br> **($)** | **Without Cause**<br> **Termination**<br> **Change in Control**<br> **($)** | **Change in**<br> **Control no**<br> **Termination**<br> **($)** | **Death or**<br> **Disability**<br> **($)** | **Retirement**<br> **($)** |
| **Benjamin D. Duke** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash Compensation | 1204800 | 2409600 | – | – | – |
| &nbsp;&nbsp;&nbsp;&nbsp;Annual Cash Incentives<sup>(1)</sup> | 818791 | 818791 | – | 818791 | – |
| &nbsp;&nbsp;&nbsp;&nbsp;PRSUs<sup>(2)</sup> | 140626 | 210939 | – | 210939 | – |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock Options <sup>(3)</sup> | 284702 | 936296 | – | 936296 | – |
| &nbsp;&nbsp;&nbsp;&nbsp;RSUs<sup>(4)</sup> | 784438 | 2056827 | – | 2056827 | – |
| &nbsp;&nbsp;&nbsp;&nbsp;Medical and Dental Insurance | 26863 | – | – | – | – |
| &nbsp;&nbsp;&nbsp;&nbsp;Polaris Parts, Garments and Accessories | – | – | – | – | – |
| **Total** | **3260220** | **6432453** | **–** | **4022853** | **–** |
| **Michael D. Dougherty<sup>(5)</sup>** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash Compensation | 1238000 | 2476000 | – | – | – |
| &nbsp;&nbsp;&nbsp;&nbsp;Annual Cash Incentives<sup>(1)</sup> | 1005190 | 1005190 | – | 1005190 | 1005190 |
| &nbsp;&nbsp;&nbsp;&nbsp;PRSUs<sup>(2)</sup> | 187515 | 281273 | – | 281273 | 281273 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock Options<sup>(3)</sup> | 207056 | 680944 | – | 680944 | 680944 |
| &nbsp;&nbsp;&nbsp;&nbsp;RSUs<sup>(4)</sup> | 672207 | 1647093 | – | 1647093 | 1647093 |
| &nbsp;&nbsp;&nbsp;&nbsp;Medical and Dental Insurance | 19122 | – | – | – | 74774 |
| &nbsp;&nbsp;&nbsp;&nbsp;Polaris Parts, Garments and Accessories | – | – | – | – | 194184 |
| **Total** | **3329090** | **6090500** | **–** | **3614500** | **3883458** |

---

*(1)* *This amount reflects the pro rata target cash incentive award adjusted for Company performance, if applicable, earned under the AIP by our NEOs for work performed in the fiscal year in which the termination occurs.* 

*(2)* *The amounts reflected for our NEOs represent the pro rata target payout for the 2024 PRSU awards and assumes the payments would be made by March 2027, respectively. The PRSU awards are accelerated and vest upon a Change in Control only if the award is not continued or the recipient is terminated by the Company without cause or terminates his or her employment for good reason.* 

*(3)* *Represents the in-the-money value of unvested and accelerated stock options.* 

*(4)* *Represents unvested and accelerated RSUs.* 

*(5)* *Mr. Dougherty's employment with the Company terminated on February 2, 2026. As previously disclosed, in October 2025, in connection with the separation of our Indian Motorcycle business (the "Transaction"), the Company entered into a Transaction Bonus and Separation Benefits Agreement with Mr. Dougherty, pursuant to which Mr. Dougherty would receive, in lieu of any rights he had under his severance agreement, (i) a transaction bonus equal to four times his then-current base salary ($2,476,000), (ii) his 2025 annual bonus based on the greater of target and actual performance, payable at the same time the Company pays 2025 annual bonuses to its other employees ($1,005,190) and (iii) a prorated portion of his 2026 annual bonus based on target performance and the number of days he worked from January 1, 2026, through the closing of the Transaction ($52,573), in each case, subject to Mr. Dougherty remaining continuously employed through the closing of the Transaction. In addition, because Mr. Dougherty would have satisfied the retirement eligibility requirements at the time of his separation, his equity awards would be treated in accordance with the retirement provisions of the severance agreement (described above), subject to Mr. Dougherty remaining continuously employed through the closing of the Transaction. The value of the accelerated vesting of his awards as of his termination date was $1,480,641 in the aggregate. Mr. Dougherty is also eligible to continue to use Company products pursuant to the Company's Active Officer Product Program and was deemed to have retired as of the closing of the Transaction for purposes of the Company's executive retirement benefits and plans.* 

---

| | |
|:---|:---|
| **66**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Pay Ratio Disclosure**

As a result of rules adopted by the SEC under the Dodd-Frank Wall Street Reform and Consumer Protection Act (the "Dodd-Frank Act"), beginning for fiscal years starting January 1, 2017, the SEC requires disclosure of the ratio of the median employee's annual total compensation to that of our CEO. The Company's CEO for 2025 was Mr. Speetzen.

As of October 31, 2025, when we identified the median employee, our employee population, including all full-time, part-time, seasonal and temporary workers, consisted of approximately 14,656 individuals, of which 7,601 or approximately 52% were working in the United States, 7,055 or approximately 48% were working outside the United States and 4,947 or approximately 34% were salaried. Given the logistical difficulties and significant difference in the composition of total compensation in our operations in India, China, Japan and Vietnam, we elected to exclude all of our employees in India (407 employees), China (175 employees), Japan (8 employees), and Vietnam (61 employees) from our determination of the median employee. This meant that we excluded a total of 651 employees, or 4.4% of our total employee population, from the calculation. The median employee was selected from an adjusted employee population of approximately 14,005 full-time, part-time, seasonal and temporary workers, consisting of 7,601 employees in the United States and 6,404 employees located outside the United States.

The median employee was identified using gross wages including overtime, vacation, jury duty, and sick time paid during the ten-month period from January 1, 2025 to October 31, 2025, and excluded any variable compensation such as equity awards, bonuses, commissions, and allowances for items such as cell phones and cars for employees which are not widely distributed throughout the employee population. Wages paid in foreign currencies were converted into U.S. dollars using the exchange rate as of October 31, 2025.

The 2025 annual total compensation for the median employee was calculated using the same methodology used for our NEOs as set forth on the *Summary Compensation Table* on page 51. This resulted in the median employee's annual total compensation in 2025 as shown below.

---

| | |
|:---|:---|
| Annual Total Compensation of Median Employee | $39984 |
| Annual Total Compensation of CEO (Mr. Speetzen) | $11144637 |

---

Based on this information for fiscal year 2025, we reasonably estimate that the ratio of our CEO's annual total compensation to the annual total compensation of our median employee was approximately 279:1. Our pay ratio estimate has been calculated in a manner consistent with Item 402(u) of Regulation S-K.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **67** |

---

------

[**Table of Contents**](#toc)

**Pay Versus Performance Disclosure**

As required by Section 953(a) of the Dodd-Frank Act and Item 402(v) of Regulation S-K, we are providing the following information about the relationship between executive "compensation actually paid" and certain financial performance of our Company, illustrating pay versus performance, or PVP.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Year** | **Summary** **<br> Compensation<br> Table Total for<br> PEO Speetzen<br> ($)<sup>(1)</sup>** | **Compensation** **<br> Actually Paid to<br> PEO Speetzen<br> ($)<sup>(1)(3)</sup>** | **Avg. Summary** **<br> Compensation<br> Table Total for<br> Non-PEO NEOs<br> ($)<sup>(2)</sup>** | **Average** **<br> Compensation<br> Actually Paid to<br> Non-PEO NEOs<br> ($)<sup>(2)</sup>** | **&nbsp;&nbsp;&nbsp;&nbsp; Value of Initial Fixed<br> $100 Investment<br> Based On:** | **&nbsp;&nbsp;&nbsp;&nbsp; Value of Initial Fixed<br> $100 Investment<br> Based On:** | **Net** **<br> Income<br> ($ in<br> Millions<sup>(5)</sup>** | **Adjusted** **<br> EBITDA<br> ($ in<br> Millions)<sup>(6)</sup>** |
| **Year** | **Summary** **<br> Compensation<br> Table Total for<br> PEO Speetzen<br> ($)<sup>(1)</sup>** | **Compensation** **<br> Actually Paid to<br> PEO Speetzen<br> ($)<sup>(1)(3)</sup>** | **Avg. Summary** **<br> Compensation<br> Table Total for<br> Non-PEO NEOs<br> ($)<sup>(2)</sup>** | **Average** **<br> Compensation<br> Actually Paid to<br> Non-PEO NEOs<br> ($)<sup>(2)</sup>** | **TSR<sup>(4)</sup>** | **S&P** **<br> 1500<br> Leisure<br> TSR<sup>(4)</sup>** | **Net** **<br> Income<br> ($ in<br> Millions<sup>(5)</sup>** | **Adjusted** **<br> EBITDA<br> ($ in<br> Millions)<sup>(6)</sup>** |
| 2025 | 11144637 | 14526291 | 3977148 | 5026144 | 77.64 | 95.74 | (465.5) | 538.2 |
| 2024 | 9026124 | 1115331 | 2980095 | 1221006 | 66.94 | 75.75 | 110.8 | 635.4 |
| 2023 | 8873477 | 6091505 | 3084958 | 2296051 | 106.55 | 88.50 | 502.8 | 1069.2 |
| 2022 | 8764103 | 7956973 | 3391580 | 3114271 | 110.71 | 84.71 | 447.1 | 1096.9 |
| 2021 | 9758906 | 10909327 | 4432529 | 5484661 | 117.80 | 121.26 | 493.9 | 956.3 |

---

*(1)* *2021-2025 principal executive officer ("PEO"): M. Speetzen* 

*(2)* *The non-PEO named executive officers ("NEOs") reflects the following individuals in each year: <br> 2025: R. Mack, M. Dougherty, B. Duke, and J. Williams <br> 2024: R. Mack, K. Pucel, S. Menneto, S. Eastman, M. Dougherty, and J. Williams <br> 2023: R. Mack, K. Pucel, S. Menneto, and S. Eastman <br> 2022: R. Mack, K. Pucel, S. Menneto, and S. Eastman <br> 2021: R. Mack, K. Pucel, S. Menneto, and L. Clark Dougherty* 

*(3)* *Compensation Actually Paid ("CAP") illustrated in the table above for 2025 is calculated by making the following adjustments from the Summary Compensation Table ("SCT") totals as follows:* 

---

| | |
|:---|:---|
| **Item and Value Added (Deducted)** | **2025** |
| **For PEO:** | **Speetzen** |
| *- SCT "Stock Awards" column value* | $3292784 |
| *- SCT "Option Awards" column value* | $3661011 |
| *+ Covered Year-end fair value of outstanding equity awards granted in Covered Year* | $10420907 |
| *+/- change in fair value (from prior year-end to Covered Year-end) of Covered Year-end outstanding equity awards granted prior to Covered Year* | $336146 |
| *+/- change in fair value (from prior year-end to vesting date in Covered Year) of equity awards granted in years prior to Covered Year that vested in Covered Year* | $(421604) |
| **For Non-PEO Named Executive Officers (Average):** |  |
| - SCT "Stock Awards" column value | $1295187 |
| *- SCT "Option Awards" column value* | $960007 |
| *+ Covered Year-end fair value of outstanding equity awards granted in Covered Year* | $3329446 |
| *+/- change in fair value (from prior year-end to Covered Year-end) of Covered Year-end outstanding equity awards granted prior to Covered Year* | $72470 |
| *+/- change in fair value (from prior year-end to vesting date in Covered Year) of equity awards granted in years prior to Covered Year that vested in Covered Year* | $(97726) |

---

---

| | |
|:---|:---|
| **68**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Pay Versus Performance Disclosure**

Please note that, while similar adjustment information was provided in our 2025, 2024, and 2023 proxy statements for 2021, 2022, 2023, and 2024, under applicable SEC guidance, repeating such adjustment information is not required in this proxy statement because it is not material to our stockholders' understanding of the information reported in the PVP table for 2025 or the relationship disclosures provided below.

*(4)* *For each year, our cumulative Total Shareholder Return ("TSR") was calculated for a period beginning with our closing price on NYSE on December 31, 2020 through and including the last day of such year (each one-year, two-year, three-year, four-year, and five-year period, a "Measurement Period"), assuming dividend reinvestment. Each of these yearly percentage changes was then applied to a deemed fixed investment of $100 at the beginning of the Measurement Period to produce the year-end value of such investment as of the end of 2025, 2024, 2023, 2022, and 2021, as applicable. Because years are presented in the table in reverse chronological order (from top to bottom), the table should be read from bottom to top for purposes of understanding cumulative returns over time. The peer group TSR set forth in this table utilizes the S&P Composite 1500 Leisure Products Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended December 31, 2025. Historical stock performance is not necessarily indicative of future stock performance.* 

*(5)* *Net Income is the amount reported in the Company's audited financial statements for the applicable year.* 

*(6)* *We determined Adjusted EBITDA to be the most important financial performance measure used to link Company performance to CAP to our PEO and Non-PEO NEOs in 2025. Adjusted EBITDA is a non-GAAP measure and is defined in the "2025 Performance Metrics and Target Bonus Amounts" section of the CD&A on page 42. Adjusted EBITDA may not have been the most important financial performance measure for years prior to 2025, and we may determine a different financial performance measure to be the most important financial performance measure in future years.* 

*Relationship Between PEO and Non-PEO NEO CAP and TSR*

The following chart sets forth the relationship between CAP for our PEO, the average of CAP for our Non-PEO NEOs, and the cumulative TSR over the five most recently completed fiscal years for the Company and the S&P 1500 Leisure TSR.

![](pro014545-def14ax71x1.jpg)

*Relationship Between PEO and Non-PEO NEO CAP and Net Income*

The following chart sets forth the relationship between CAP for our PEO, the average of CAP for our Non-PEO NEOs, and our net income during the five most recently completed fiscal years.

![](pro014545-def14ax71x2.jpg)

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **69** |

---

------

[**Table of Contents**](#toc)

**Pay Versus Performance Disclosure**

*Relationship Between PEO and Non-PEO NEO CAP and Adjusted EBITDA ($ Millions)*

The following chart sets forth the relationship between CAP for our PEO, the average of CAP for our Non-PEO NEOs, and our Adjusted EBITDA ($ Millions) during the five most recently completed fiscal years.

![](pro014545-def14ax72x1.jpg)

*Tabular List of Most Important Financial Performance Measures*

The following table presents the financial performance measures that the Company considers to have been the most important in linking CAP for our PEO and Non-PEO NEOs for 2025 to Company performance. The measures in this table are not ranked.

---

| |
|:---|
| **Most Important Performance Measures** |
| Relative Total Shareholder Return (TSR) |
| Adjusted EBITDA\* |
| Revenue |

---

*\** *Non-GAAP measures defined in the "2025 Performance Metrics and Target Bonus Amounts" section of the CD&A on page 42*

---

| | |
|:---|:---|
| **70**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Equity Compensation Plan Information**

Our stockholders have approved our 1995 Stock Option Plan, Employee Stock Purchase Plan, Deferred Compensation Plan for Directors, 2017 Omnibus Incentive Plan and 2024 Omnibus Incentive Plan. Awards may currently be made only under the 2024 Omnibus Incentive Plan and the Employee Stock Purchase Plan.

We do not have any equity compensation plans outstanding that have not been approved by stockholders.

The following table sets forth certain information as of December 31, 2025, with respect to compensation plans under which shares of our common stock may be issued.

---

| | | | |
|:---|:---|:---|:---|
| **Plan Category** | **Number of** **<br> securities to be<br> issued upon<br> exercise of<br> outstanding<br> options, warrants<br> and rights** | **Weighted-average** **<br> exercise price of<br> outstanding<br> options, warrants<br> and rights** | **Number of securities** **<br> remaining available<br> for future issuance<br> under equity<br> compensation plans<br> (excluding securities<br> reflected in the first<br> column)** |
| Equity compensation plans approved by security holders | 5114774<sup>(1)(2)</sup> | 85.78<sup>(3)</sup> | 5698902<sup>(4)</sup> |
| Equity compensation plans not approved by security holders |  | N/A |  |
| **Total** | **5114774** | **85.78** | **5698902** |

---

*(1)* *Includes 3,237,633 shares issuable upon exercise of outstanding stock options, 1,420,313 shares issuable upon settlement of outstanding RSUs, 117,238 shares issuable upon settlement of outstanding PRSUs at target, 207,145 shares issuable upon settlement of deferred stock units and accompanying dividend equivalent units issued under the Omnibus Plan to non-employee directors and 132,445 shares issuable upon settlement of CSEs awarded to non-employee directors under the Deferred Compensation Plan for Directors. The actual number of PRSUs that will be earned depends on our financial performance over a period of time.* 

*(2)* *The weighted average remaining contractual life of outstanding options was 5.4 years as of December 31, 2025. Unvested stock options, RSUs and PRSUs do not receive dividend equivalents.* 

*(3)* *Reflects the weighted-average exercise price of outstanding options. There is no exercise price for outstanding deferred stock units, RSUs, CSEs or PRSUs.* 

*(4)* *A total of 4,404,739 shares were available under the Polaris Inc. 2024 Omnibus Incentive Plan (the Omnibus Plan pool is decreased by three shares for every one share subject to a full-value award), which shares may be issued other than upon the exercise of an option, warrant or right, and a total of 1,294,163 shares were available under the Employee Stock Purchase Plan.* 

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **71** |

---

------

[**Table of Contents**](#toc)

**Proposal 2 — Approval, on an Advisory Basis, of the Compensation of the Company's Named Executive Officers**

As required pursuant to Section 14A of the Exchange Act, we are providing our stockholders with the opportunity to vote to approve the compensation of our Named Executive Officers (NEOs) as disclosed in this Proxy Statement. As described in the Compensation Discussion and Analysis (CD&A), our executive compensation philosophy and programs align executive compensation decisions with our desired business direction, strategy and performance. The primary objectives and priorities of the compensation program include:

● Emphasizing variable compensation that is tied to our
 financial and stock price performance to generate and reward superior individual and collective performance;

● Linking executives' incentive goals with the interests of our
 stockholders, providing equity-based forms of compensation and establishing specific stock ownership guidelines for key management
 employees;

● Supporting and rewarding executives for consistent performance over
 time and achievement of our long-term strategic goals; and

● Attracting and retaining highly qualified executives whose abilities
 are critical to our success and competitive advantages.

At the 2023 Annual Meeting, stockholders voted to continue to hold an advisory "Say-on-Pay" vote on an annual basis. As such, our stockholders have a right to cast an advisory vote on our executive compensation program at the Annual Meeting. The next Say-on-Pay vote is expected to be held at the 2027 Annual Meeting. As a result, we are presenting this proposal, which gives you, as a stockholder, the opportunity to vote on the following resolution:

"RESOLVED, that the stockholders approve the compensation of Polaris Inc. NEOs, as disclosed in the Compensation Discussion and Analysis, the compensation tables, and the related disclosure contained in this Proxy Statement."

The Board urges stockholders to endorse the compensation programs for our NEOs by voting "FOR" the resolution.

As discussed in the CD&A contained in this Proxy Statement, the Compensation Committee of the Board believes that the executive compensation provided for 2025 is reasonable and consistent with our pay for performance philosophy. Compensation for the year is established in January or February and is guided by the prior year performance as well as projections for the forthcoming year. In deciding how to vote on this proposal, the Board advises you to consider our pay for performance philosophy coupled with the factors related to the compensation of our NEOs in fiscal 2025, each of which is discussed in the CD&A.

Because your vote is advisory, it will not be binding on the Board and will not overrule any decision by the Board or require the Board to take any action. However, the Board and the Compensation Committee will carefully review the voting results. To the extent there is any significant negative vote on this proposal, we may consult directly with stockholders to better understand the concerns that influenced the vote. The Board and the Compensation Committee would consider constructive feedback obtained through this process in making future decisions about executive compensation programs.

**The Board, upon recommendation of the Compensation Committee, unanimously recommends a vote FOR the approval of the compensation of our Named Executive Officers.**

---

| | |
|:---|:---|
| **72**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**The Company's Board of Directors Recommends a vote "FOR" the approval of the amended and restated Polaris Inc. 2024 Omnibus Incentive Plan**

**Introduction**

We are asking stockholders to approve the amendment and restatement of the Polaris Inc. 2024 Omnibus Incentive Plan. On March 2, 2026, the Board approved and adopted, subject to approval by stockholders at the Annual Meeting, the amendment and restatement of the Polaris Inc. 2024 Omnibus Incentive Plan. In this proposal, we refer to the amended and restated Polaris Inc. 2024 Omnibus Incentive Plan as the ("A&R 2024 Plan") and we refer to the Polaris Inc. 2024 Omnibus Incentive Plan as the ("2024 Plan").

The Board is recommending that the Company's stockholders vote in favor of the A&R 2024 Plan. The A&R 2024 Plan will continue to afford the Compensation Committee the ability to design compensatory awards that are responsive to the Company's needs and includes authorization for a variety of awards designed to advance the interests and long-term success of the Company, including by encouraging stock ownership among officers and other employees of the Company and its subsidiaries, non-employee directors of the Company and certain non-employees who provide employee-type services.

We are asking stockholders to approve the A&R 2024 Plan, which would constitute approval of an additional 4,580,000 shares of common stock, par value $0.01 per share, of the Company ("Common Stock") for issuance thereunder and would therefore result in a new aggregate share reserve under the A&R 2024 Plan of 8,905,000 shares. The addition of shares of Common Stock and the adoption of a director compensation limit are the only material changes from the 2024 Plan, although the A&R 2024 Plan also includes certain minor, technical updates to the whistleblower protection provisions currently included in the 2024 Plan.

The actual text of the A&R 2024 Plan is attached to this proxy statement as Appendix B. The following description of the A&R 2024 Plan is only a summary of its principal terms and provisions, and is qualified by reference to the actual text as set forth in Appendix B.

**Why We Recommend That You Vote for This Proposal**

The A&R 2024 Plan authorizes the Compensation Committee to provide equity-based compensation in the form of stock options, appreciation rights ("SARs"), restricted stock, restricted stock units ("RSUs"), performance-based awards, dividend equivalents, and certain other awards denominated or payable in, or otherwise based on, shares of Common Stock (or factors that may influence the value of our shares), plus cash incentive awards, to the Company's non-employee directors, plus officers and other employees and certain consultants to the Company and its subsidiaries, in order to provide to such persons incentives and rewards for service and/or performance. Some of the key features of the A&R 2024 Plan that reflect our commitment to effective management of equity and incentive compensation are set forth below in this subsection.

We believe our future success depends in part on our ability to attract, motivate and retain high-quality employees and directors, and that the ability to provide equity-based and incentive-based awards under the A&R 2024 Plan is critical to achieving this success. We would be at a severe competitive disadvantage if we could not use share-based awards to recruit and compensate our employees and directors. The Board believes that it is both necessary and appropriate to adopt and approve the A&R 2024 Plan in order to enable the Company to continue offering meaningful equity-based incentives to key employees and directors.

The use of shares of our Common Stock as part of our compensation program is also important to our continued success because equity-based awards are an essential component of our compensation program for certain employees, as they can link compensation with long-term stockholder value creation and reward participants based on service and/or Company or individual performance. As discussed in further detail in the "Compensation Discussion and Analysis" section, equity compensation represents a significant portion of the compensation package for our CEO and other Named Executive Officers. Because our equity awards generally vest over multiple years, the value ultimately realized from these awards depends on the long-term value of shares of our Common Stock. Our equity compensation program also helps us to attract and retain talent in a highly competitive market, targeting individuals who are motivated by pay-for-performance.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **73** |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**Factors Considered in Setting Size of Requested Share Reserve**

Therefore, the Board recommends that our stockholders vote **FOR** the A&R 2024 Plan. Unless a contrary choice is specified, proxies solicited by the Board will be voted **FOR** approval of the A&R 2024 Plan.

The table below shows, as of March 9, 2026, the shares of Common Stock reserved for issuance under awards outstanding under the 2024 Plan and the Prior Plans (as defined below) (in each case, with performance-based awards reflected based on potential maximum achievement):

---

| | | |
|:---|:---|:---|
|  | **Shares Reserved for Issuance**<br> **Under Outstanding Awards<sup>(1)</sup>** | **Shares Available**<br> **for Future Awards<sup>(2)</sup>** |
| 2024 Plan | 2849180 | 2650955 |
| Prior Plans | 2780445 | N/A |

---

*(1)* *Shares reserved for issuance under outstanding awards as of March 9, 2026 consist of the following:* 

---

| | | | |
|:---|:---|:---|:---|
| **Options (#)** | **Weighted Average**<br> **Option Exercise Price** | **Weighted Average Option**<br> **Term to Expiration (Years)** | **Full Value**<br> **Awards (#)** |
| 3777656 | **$**82.25 | 6.37 | 1851969 |

---

*(2)* *Awards under the 2024 Plan reduce the 2024 Plan's share reserve by one share for each share subject to an option or SAR award, and by three shares for each share subject to a full-value award.* 

If the A&R 2024 Plan is not approved, we may be compelled to increase significantly the cash component of our employee and director compensation, which may not necessarily align employee and director compensation interests with the investment interests of our stockholders. Replacing equity awards with cash would also increase cash compensation expense and use cash that could be better utilized.

**Factors Considered in Setting Size of Requested Share Reserve**

The following includes aggregated information regarding our view of the overhang and dilution associated with the 2024 Plan (or otherwise) and the potential stockholder dilution that would result if the A&R 2024 Plan is approved. The information below is as of March 9, 2026. As of that date, there were approximately 56,615,893 shares of our Common Stock outstanding.

In determining the number of shares to request under the A&R 2024 Plan, we considered a number of factors, including the following:

● Outstanding full-value awards (restricted stock, RSUs, performance stock units, and non-employee director DSU and CSE awards): 1,851,969 shares of Common Stock (approximately 7.37% of our outstanding shares of Common Stock, on a fully-diluted basis);

● 3,777,656 stock options or SARs were outstanding (approximately 10.20% of our outstanding shares of Common Stock, on a fully-diluted basis);

● Total shares of Common Stock available for future awards under the 2024 Plan: 2,650,955 shares of Common Stock (representing approximately 4.47% of our outstanding shares of Common Stock, on a fully-diluted basis); and

● The total number of shares of Common Stock subject to outstanding awards (5,629,625 shares of Common Stock), plus the total number of shares of Common Stock available for future awards under the 2024 Plan (2,650,955 shares of Common Stock), represents a current overhang percentage of 12.76%, on a fully-diluted basis (potential dilution of our stockholders represented by the 2024 Plan and outstanding awards).

● Proposed new shares of Common Stock available for awards under the A&R 2024 Plan: 4,580,000 shares of Common Stock, which represents about 7.48% of our outstanding shares of Common Stock, on a fully-diluted basis. This percentage reflects the dilution of our stockholders that would occur if the A&R 2024 Plan is approved.

● The total shares of Common Stock subject to outstanding awards as of the Record Date (5,629,625 shares of Common Stock), plus the proposed additional shares of Common Stock available for awards under the A&R 2024 Plan (4,580,000 shares of Common Stock), plus the total number of shares of Common Stock currently available for future awards under the 2024 Plan (2,650,955 shares of Common Stock), represent a total overhang of 12,860,580 shares (18.51%, on a fully-diluted basis) under the A&R 2024 Plan.

---

| | |
|:---|:---|
| **74**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**Key Compensation Practices Reflected in the A&R 2024 Plan**

Based on the closing price on the NYSE for our shares of Common Stock on the Record Date of $52.73 per share, the aggregate market value as of the Record Date of the new 4,580,000 shares of Common Stock requested under the A&R 2024 Plan was $241,503,400.

We also considered the Company's three-year average burn rate. As detailed in the table below, our three-year average "burn rate" was 1.95% for fiscal years 2023 through 2025:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Fiscal Year** | **Options**<br> **Granted** | **Time-Based**<br> **Full Value**<br> **Awards**<br> **Granted** | **Target**<br> **Performance-**<br> **Based Awards**<br> **Granted<sup>(1)</sup>** | **Performance-**<br> **Based Awards**<br> **Earned<sup>(2)</sup>** | **Total<sup>(3)</sup>** | **Weighted**<br> **Average Basic**<br> **Common Shares**<br> **Outstanding** | **Burn**<br> **Rate** |
| 2025 | 887888 | 964748 | - | - | 1852636 | 56894884 | 3.26% |
| 2024 | 386055 | 440323 | 82864 | 5491 | 831869 | 56516279 | 1.47% |
| 2023 | 294359 | 296067 | 66551 | 43555 | 633981 | 57107739 | 1.11% |
| 3-Year Average |  |  |  |  |  |  | 1.95% |

---

*(1)* *The actual number of shares awarded is adjusted to between zero and 200% of the target award amount based upon achievement of pre-determined objectives. The amounts actually earned with respect to these awards may not yet be determinable.* 

*(2)* *Performance-based awards earned were subject to achievement of pre-determined objectives for awards granted in fiscal years 2021 through 2023. Awards were subject to a three-year performance period.* 

*(3)* *Includes options granted, time-based full value awards granted (including non-employee director DSU and CSE awards) and performance-based awards earned.* 

In determining the number of shares to request for approval under the A&R 2024 Plan, our management team also worked with Aon and the Compensation Committee to evaluate a number of factors, including our recent share usage and criteria expected to be utilized by institutional proxy advisory firms in evaluating our proposal for the A&R 2024 Plan.

If the A&R 2024 Plan is approved, we intend to use the shares authorized under the A&R 2024 Plan to continue our practice of incentivizing key individuals through equity grants. We currently anticipate that the new shares requested in connection with the approval of the A&R 2024 Plan, combined with the shares available for future awards under the 2024 Plan, will last about 3 years, based on our historic grant rates and the approximate current share price (but could last for a different period of time if actual practice does not match recent rates or our share price changes materially).

Expectations regarding future share usage under the A&R 2024 Plan are naturally based on a number of assumptions regarding factors such as future growth in the population of eligible participants, the rate of future compensation increases, the rate at which shares are returned to the A&R 2024 Plan reserve through forfeitures, cancelations and the like, the level at which performance-based awards pay out, and our future stock price performance. While the Compensation Committee believes that the assumptions utilized are reasonable, future share usage may differ from current expectations to the extent that actual events differ from the assumptions utilized. As noted below, our Compensation Committee would retain full discretion under the A&R 2024 Plan to determine the number and amount of awards to be granted under the A&R 2024 Plan, subject to the terms of the A&R 2024 Plan. Other than as set forth under "New Plan Benefits" below, future benefits that may be received by participants under the A&R 2024 Plan are not determinable at this time.

**Key Compensation Practices Reflected in the A&R 2024 Plan**

Below are certain highlights of the A&R 2024 Plan. The A&R 2024 Plan includes a number of features that we believe are consistent with the interests of our stockholders and sound corporate governance practices, including the following:

● **Administration.** The A&R 2024 Plan will generally
 be administered by the Compensation Committee.

● **Reasonable A&R 2024 Plan limits.** Subject to adjustment as described in the A&R
 2024 Plan, total awards under the A&R 2024 Plan are limited to 8,905,000 shares (consisting of 4,325,000 shares originally
 approved under the 2024 Plan and an additional 4,580,000 shares to be approved under the A&R 2024 Plan, subject to stockholder
 approval at the Annual Meeting) (1) plus, as of the effective date of the 2024 Plan, the total number of shares remaining
 available for future grant under the 2007 Plan (as defined below), and (2) plus any shares made available to the A&R
 2024 Plan from grants under the A&R 2024 Plan or the Prior Plans as described below, including under the A&R 2024
 Plan's share counting rules. These shares may be shares of original issuance or treasury shares or a combination of
 the two.

● **No repricing, replacement or repurchase of underwater options or stock appreciation rights without stockholder approval.** The A&R 2024 Plan prohibits, without stockholder approval, actions to reprice,
 replace or repurchase options or SARs when the exercise price per share of an option or SAR exceeds the fair market value
 of the underlying shares.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **75** |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**Summary of Other Material Terms of the A&R 2024 Plan**

● **No discounted option or SAR grants.** The A&R 2024 Plan prohibits
 the grant of options or SARs with an exercise price less than the fair market value of our Common Stock on the date of grant
 (except in the limited case of "substitute awards" as described below).

● **No liberal share recycling provision.** Shares delivered or withheld to pay the
 exercise price of an option award or to satisfy a tax withholding obligation in connection with other awards, plus shares
 that we repurchase using option exercise proceeds, plus shares subject to a SAR award that are not issued in connection with
 the stock settlement of that award upon its exercise, may not be used again for new grants.

● **Share counting – fungible ratio.** Shares of Common Stock that are issued under
 the A&R 2024 Plan or that are potentially issuable pursuant to outstanding awards will reduce the maximum number of shares
 remaining available for issuance under the A&R 2024 Plan by one share for each share issued or issuable pursuant to an
 option or SAR award, and by three shares for each share issued or issuable pursuant to a full-value award.

● **No liberal definition of "change in control."** No change in control
 would be triggered simply by stockholder approval of a business combination transaction, the announcement or commencement
 of a tender offer or any board assessment that a change in control is imminent.

● **Default provisions for double trigger accelerated vesting/payment following a change in control.** If an outstanding award is continued, assumed or replaced in connection with a change in control that
 involves a business combination, the A&R 2024 Plan's default terms provide that accelerated vesting or payment of
 the award will occur only if the participant's employment is terminated involuntarily without cause within one year
 of the change in control, unless the participant's award agreement provides otherwise.

● **Limits on dividends and dividend equivalents.** The A&R 2024 Plan prohibits
 the payment of dividend equivalents on stock options and SARs, and requires that any dividends and dividend equivalents payable
 or credited on unvested full-value awards must be subject to the same restrictions and risk of forfeiture as the underlying
 shares or share equivalents.

● **Minimum vesting or performance period.** For all share-settled awards (other
 than shares delivered in settlement of fully-vested cash obligations), including options and SARs, a minimum vesting period
 of one year is prescribed for awards subject only to service-based vesting conditions, and a minimum performance period of
 one year is prescribed for awards subject to performance-based vesting conditions, in each case subject to exceptions as described
 in the A&R 2024 Plan.

**Summary of Other Material Terms of the A&R 2024 Plan**

The material features of the A&R 2024 Plan are summarized below. The summary is qualified in its entirety by reference to the full text of the A&R 2024 Plan, which is attached to this Proxy Statement as Appendix B. In evaluating this proposal, stockholders should consider all of the information in this proposal.

**Plan Purpose**

The A&R 2024 Plan is intended to advance the interests of our Company and its stockholders by enabling the Company and our affiliated entities to attract and retain qualified individuals through opportunities for equity participation in our Company, and to reward those individuals who contribute to the achievement of our financial and strategic business goals through incentive compensation. Awards under the A&R 2024 Plan are intended to serve as incentives and rewards for service and/or performance.

**Administration**

The A&R 2024 Plan is generally administered by the Compensation Committee of our Board. However, at the discretion of the Board, the A&R 2024 Plan may be administered by the Board, including with respect to the administration of any responsibilities and duties held by the Compensation Committee under the A&R 2024 Plan. The Compensation Committee has the authority to determine, within the limits of the express provisions of the A&R 2024 Plan, the individuals to whom awards will be granted, the nature, amount and terms of such awards and the objectives and conditions for earning such awards. The Compensation Committee may also establish subplans and modify the terms of award agreements to the extent necessary to comply with local laws in connection with awards made to participants outside of the United States. To the extent consistent with applicable law, the Compensation Committee has discretion to delegate its authority under the A&R 2024 Plan to a subcommittee, to executive officers (with respect to awards to participants who are not directors or executive officers) or, in connection with

---

| | |
|:---|:---|
| **76**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**Summary of Other Material Terms of the A&R 2024 Plan**

nondiscretionary administrative duties, to other parties as it deems appropriate. In addition, the Compensation Committee is authorized to take any action it determines in its sole discretion to be appropriate subject only to the express limitations contained in the A&R 2024 Plan, and no authorization in any A&R 2024 Plan section or other provision of the A&R 2024 Plan is intended or may be deemed to constitute a limitation on the authority of the Compensation Committee.

Except in connection with equity restructurings and other situations in which share adjustments are specifically authorized, the A&R 2024 Plan prohibits the Compensation Committee from repricing any outstanding "underwater" option or SAR without prior approval of our stockholders. For these purposes, "repricing" includes amending the terms of an underwater option or SAR to lower the exercise price, or canceling an underwater option or SAR in exchange for replacement options or SARs having a lower exercise price, for other forms of awards, or for cash or other property.

**Available Shares**

Subject to adjustment as described in the A&R 2024 Plan, the shares of our Common Stock that are available for awards under the A&R 2024 Plan will not exceed, in the aggregate 8,905,000 Shares (consisting of 4,325,000 Shares originally approved on the effective date of the 2024 Plan and an additional 4,580,000 Shares to be approved by the Company's stockholders at the Annual Meeting) (1) <u>plus</u>, as of the effective date of the 2024 Plan, the total number of shares remaining available for future grant under the Polaris Inc. 2007 Omnibus Incentive Plan, as amended and restated (the "2007 Plan"), and (2) <u>plus</u> the number of shares subject to outstanding awards under the A&R 2024 Plan and, as applicable, the Polaris Inc. 1995 Stock Option Plan, 1999 Broad-Based Stock Option Plan, Restricted Stock Plan, 2003 Nonemployee Director Stock Option Plan, and the 2007 Plan, in each case as amended or amended and restated (the "Prior Plans") as of the date the 2024 Plan was originally adopted that subsequently expire or are forfeited or settled in cash. The pool of shares available for issuance under the A&R 2024 Plan may be used for all types of equity awards available under the A&R 2024 Plan, which include stock options, SARs, restricted stock awards, restricted stock unit awards and other stock-based awards, as described in more detail below.

**Share Counting**

Shares of Common Stock that are issued under the A&R 2024 Plan or that are potentially issuable pursuant to outstanding awards will reduce the maximum number of shares remaining available for issuance under the A&R 2024 Plan by one share for each share issued or issuable pursuant to an option or SAR award, and by three shares for each share issued or issuable pursuant to a full-value award.

Subject to certain exceptions described in the A&R 2024 Plan, any shares of Common Stock subject to an award under the A&R 2024 Plan, or to an award under any of the Prior Plans that is outstanding on the date the A&R 2024 Plan is adopted, that expires, is forfeited, or is settled or exchanged for cash (or is unearned in whole or in part) will, to the extent of such expiration, forfeiture, settlement, exchange or unearned amount, automatically become available for issuance under the A&R 2024 Plan. Each share that again becomes available for issuance will increase the A&R 2024 Plan's share reserve by the same number of shares by which the share reserve was decreased when the award was first granted. The A&R 2024 Plan further provides that the following shares of Common Stock will not be added (or added back, as applicable) to the aggregate number of shares of Common Stock available under the A&R 2024 Plan: (1) any shares tendered or withheld to pay the exercise price of a stock option, or (2) any shares tendered or withheld to satisfy a tax withholding obligation in connection with any award, (3) any shares we repurchase using option exercise proceeds and (4) any shares subject to a SAR that are not issued in connection with the stock settlement of the SAR on its exercise may not be used again for new grants. If under the A&R 2024 Plan a participant has elected to give up the right to receive compensation in exchange for shares based on fair market value, such shares will not count against the share authorization described above.

Awards granted under the A&R 2024 Plan upon the assumption of, or in substitution for, outstanding equity awards previously granted by an entity acquired by the Company or any of our affiliates (referred to as "substitute awards") will not reduce the number of shares of Common Stock authorized for issuance under the A&R 2024 Plan. Additionally, if a company acquired by the Company or any of our affiliates has shares available under a pre-existing plan approved by stockholders and not adopted in contemplation of such acquisition, the shares available for grant pursuant to the terms of that pre-existing plan may be used for awards under the A&R 2024 Plan and will not reduce the shares authorized for issuance under the A&R 2024 Plan, but only if the shares are used for awards made to individuals who were not employed by or providing services to the Company or any of our affiliates immediately prior to such acquisition.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **77** |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**Summary of Other Material Terms of the A&R 2024 Plan**

**Share or Award Adjustment Provisions**

If certain transactions or events described in the A&R 2024 Plan occur that cause the per share value of our Common Stock to change, such as stock splits, spin-offs, stock dividends or certain recapitalizations (referred to as "equity restructurings"), or if certain similar events occur, then the Compensation Committee will equitably adjust (1) the class of shares issuable and the maximum number and kind of shares subject to the A&R 2024 Plan, (2) outstanding awards as to the class, number of shares and exercise price per share, (3) award limitations prescribed by the A&R 2024 Plan, and (4) any other award terms. In the event of any such transaction or event, or in the event of a change in control of the Company, the Compensation Committee may provide in substitution for any or all outstanding awards under the A&R 2024 Plan such alternative consideration (including cash), if any, as it may in good faith determine to be equitable under the circumstances and will require in connection therewith the surrender of all awards so replaced in a manner that complies with applicable tax code requirements. In addition, for each stock option or SAR with an exercise price or base price, respectively, less than the consideration offered in connection with certain transactions or events identified in the A&R 2024 Plan, the Compensation Committee may in its discretion elect to cancel such stock option or SAR without any payment to the person holding such stock option or SAR. Other types of transactions may also affect the Common Stock, such as reorganizations, mergers or consolidations. If there is such a transaction and the Compensation Committee determines that adjustments of the type previously described in connection with equity restructurings would be appropriate to prevent any dilution or enlargement of benefits under the A&R 2024 Plan, the Compensation Committee will make such adjustments as it deems equitable.

**Eligible Participants**

The Compensation Committee may grant awards to any Company non-employee director or any employee of, or consultant or certain other persons providing services to, the Company or our affiliates. As of the Record Date, there are approximately 14,100 employees, 440 consultants and 8 non-employee directors eligible to participate in the 2024 Plan. Although consultants of the Company and its affiliates are eligible to participate in the A&R 2024 Plan, we have not granted equity awards to consultants in recent years and, due to the temporary status of such service providers, do not have a current estimate of how many such consultants may be eligible in the future to participate in the A&R 2024 Plan. We do not currently expect to make material grants of awards under the A&R 2024 Plan to consultants. The basis for participation in the A&R 2024 Plan by eligible persons is the selection of such persons by the Committee (or its authorized delegate) in its discretion.

**Director Compensation Limit**

In no event will the value of any awards granted to any non-employee director under the Plan in any one calendar year for such service, when added to any cash fees payable to such non-employee director for such service in such calendar year, have an aggregate maximum value (computed as of the date of grant in accordance with financial accounting rules) in excess of $1,000,000.

**Types of Awards**

Awards under the A&R 2024 Plan may include stock options, stock appreciation rights, restricted stock, restricted stock units, other stock-based awards and cash incentive awards.

**Stock Options**

A stock option is a right to purchase shares of Common Stock upon exercise of the stock option. The Compensation Committee may grant to participants options to purchase our Common Stock that qualify as incentive stock options for purposes of Section 422 of the Code (incentive stock options), options that do not qualify as incentive stock options (non-qualified stock options) or a combination thereof. The terms and conditions of stock option grants, including the number of shares, exercise price, vesting periods, and other conditions on exercise, will be determined by the Compensation Committee. The maximum number of Shares that may be issued or transferred pursuant to incentive stock options under the A&R 2024 Plan is 4,580,000 shares (subject to adjustment as provided in the A&R 2024 Plan).

---

| | |
|:---|:---|
| **78**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**Summary of Other Material Terms of the A&R 2024 Plan**

Each grant of stock options will be evidenced by an award agreement. Each award agreement will be subject to the A&R 2024 Plan and will contain such other terms and provisions, consistent with the A&R 2024 Plan, as the Committee may approve. The per share exercise price for stock options will be determined by the Compensation Committee in its discretion, but may not be less than 100% of the fair market value of one share of our Common Stock on the date when the stock option is granted (except in the case of substitute awards described above). Additionally, in the case of incentive stock options granted to a holder of more than 10% of the total combined voting power of all classes of our stock on the date of grant, the exercise price may not be less than 110% of the fair market value of one share of Common Stock on the date the stock option is granted.

Stock options must be exercised within a period fixed by the Compensation Committee that may not exceed ten years from the date of grant, except that in the case of incentive stock options granted to a holder of more than 10% of the total combined voting power of all classes of our stock on the date of grant, the exercise period may not exceed five years. No dividends or dividend equivalents may be paid or credited with respect to shares subject to an option award.

At the Compensation Committee's discretion, payment for shares of Common Stock on the exercise of stock options may be made in (1) cash, (2) in shares of our Common Stock held by the participant, (3) by withholding a number of shares otherwise deliverable upon exercise of the option, or (4) in any manner acceptable to the Compensation Committee (including one or more forms of broker-assisted "cashless" exercise).

**Stock Appreciation Rights**

The Compensation Committee may grant to a participant an award of SARs, which entitles the participant to receive, upon its exercise, a payment equal to (1) the excess of the fair market value of a share of Common Stock on the exercise date over the SAR exercise price, times (2) the number of shares of Common Stock with respect to which the SAR is exercised. The payment upon exercise of a SAR may be in cash, shares of Common Stock, or any combination thereof, as approved by the Compensation Committee in its sole discretion.

Each grant of SARs will be evidenced by an award agreement. Each award agreement will be subject to the A&R 2024 Plan and will contain such other terms and provisions, consistent with the A&R 2024 Plan, as the Committee may approve. The per share exercise price for a SAR will be determined by the Compensation Committee in its discretion, but may not be less than 100% of the fair market value of one share of our Common Stock on the date when the SAR is granted (except in the case of substitute awards described above). SARs must be exercised within a period fixed by the Compensation Committee that may not exceed ten years from the date of grant. No dividends or dividend equivalents may be paid or credited with respect to shares subject to a SAR award.

**Restricted Stock and Restricted Stock Units**

The Compensation Committee may award to a participant shares of Common Stock subject to specified restrictions (restricted stock). Shares of restricted stock are subject to forfeiture if specified vesting conditions, such as continued employment over a specified vesting period and/or the attainment of specified performance objectives over a specified performance period, are not satisfied. Any dividends or distributions payable with respect to shares that are subject to the unvested portion of a restricted stock award will be subject to the same restrictions and risk of forfeiture as the shares to which such dividends or distributions relate.

The Compensation Committee also may award to a participant restricted stock units, each representing the right to receive in the future, in cash and/or shares of our Common Stock as determined by the Compensation Committee, the fair market value of a share of Common Stock. Restricted stock units are subject to forfeiture if specified vesting conditions, such as continued employment over a specified vesting period and/or the attainment of specified performance objectives over a specified performance period, are not satisfied. The terms and conditions of restricted stock and restricted stock unit awards are determined by the Compensation Committee. The Compensation Committee may provide for the payment of dividend equivalents on restricted stock unit awards but any such dividend equivalents will be subject to the same restrictions and risk of forfeiture as the underlying units to which such dividend equivalents relate.

Each grant of restricted stock or restricted stock units will be evidenced by an award agreement. Each award agreement will be subject to the A&R 2024 Plan and will contain such other terms and provisions, consistent with the A&R 2024 Plan, as the Compensation Committee may approve.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **79** |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**Summary of Other Material Terms of the A&R 2024 Plan**

**Other Stock-Based Awards**

The Compensation Committee may grant equity-based or equity-related awards, referred to as "other stock-based awards," other than options, SARs, restricted stock or restricted stock units. The terms and conditions of each other stock-based award will be determined by the Compensation Committee. Payment under any other stock-based awards will be made in Common Stock or cash, as determined by the Compensation Committee. The Compensation Committee may provide for the payment of dividend equivalents on other stock-based awards but any such dividend equivalents will be subject to the same restrictions and risk of forfeiture as the underlying share equivalents to which such dividend equivalents relate.

Each grant of other stock-based awards will be evidenced by an award agreement. Each award agreement will be subject to the A&R 2024 Plan and will contain such other terms and provisions of such award, consistent with the A&R 2024 Plan, as the Committee may approve.

**Cash Incentive Awards**

The Compensation Committee may grant cash incentive awards in such amounts and subject to such terms and conditions as it shall determine. Such cash incentive awards will specify the amount payable to which it pertains, which amount may be subject to adjustment to reflect changes in compensation or other factors. The performance period with respect to each cash incentive award will be such period of time as will be determined by the Compensation Committee.

Each grant of cash incentive awards will be evidenced by an award agreement. Each award agreement will be subject to the A&R 2024 Plan and will contain such other terms and provisions of such award, consistent with the A&R 2024 Plan, as the Committee may approve.

**Minimum Vesting or Performance Requirements**

Awards that vest based solely on the satisfaction by the participant of service-based vesting conditions shall be subject to a vesting period of not less than one year from the applicable date of grant. Awards whose vesting is subject to the satisfaction of performance goals shall be subject to a performance period of not less than one year. These minimum vesting and performance periods will not apply, however, (1) to cash-settled awards, (2) to shares delivered in lieu of fully-vested cash obligations, (3) to a substitute award that does not reduce the vesting period of the award being assumed or replaced, and (4) to awards involving an aggregate number of shares not in excess of 5% of the maximum share reserve determinable under the A&R 2024 Plan (including any applicable adjustments). These requirements, however, will not preclude the Committee, in its sole discretion, from providing for continued vesting or accelerated vesting for any award under the A&R 2024 Plan upon certain events, including in connection with or following a participant's death, disability, or termination of employment or service or a change in control or corporate transaction, or exercising its administrative authority following a grant under the terms of the A&R 2024 Plan.

**Amendment and Termination**

The Compensation Committee may at any time amend, terminate or modify the A&R 2024 Plan or any award agreement issued thereunder. No such action may be taken that adversely affects in any material way any award previously granted under the A&R 2024 Plan without the written consent of the participant, except for amendments necessary to comply with applicable laws or stock exchange rules. In addition, no material amendment of the A&R 2024 Plan may be made without stockholder approval if stockholder approval is required by law, regulation, or stock exchange rules, and no "underwater" option or SAR may be repriced in any manner (except for anti-dilution adjustments) without stockholder approval (see "Administration" above). In no event may any awards be made under the A&R 2024 Plan on or after April 25, 2034.

**Change in Control of the Company**

If a change in control of our Company that involves a corporate transaction occurs, then the consequences will be as described in this paragraph unless the Compensation Committee provides otherwise in an applicable award agreement. If any outstanding award is continued, assumed or replaced by the surviving or successor entity in connection with such corporate transaction, and if within one year after the change in control a participant's employment or other service is involuntarily terminated without cause, then (1)

---

| | |
|:---|:---|
| **80**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**Summary of Other Material Terms of the A&R 2024 Plan**

each of the participant's outstanding options and SARs will become exercisable in full and remain exercisable for one year, and (2) each of the participant's other unvested awards will fully vest. To the extent vesting of any award is subject to satisfaction of specified performance measures/goals, such award shall be deemed "fully vested" as if the performance goals are deemed to have been satisfied at the target level of performance. If any outstanding award is not continued, assumed or replaced in connection with a change in control involving a corporate transaction, then (1) all outstanding options and SARs will become fully exercisable for a period of time prior to the effective time of the corporate transaction and will then terminate at the effective time of the corporate transaction, and (2) all other awards will fully vest immediately prior to the effective time of the corporate transaction (with awards subject to satisfaction of specified performance goals vesting at the target level of performance). Alternatively, the Compensation Committee may elect to terminate awards in exchange for a payment with respect to each award in an amount equal to the excess, if any, between the fair market value of the shares subject to the award immediately prior to the effective date of such corporate transaction (which may be the fair market value of the consideration to be received in the corporate transaction for the same number of shares) over the aggregate exercise price (if any) for the shares subject to such award (or, if there is no excess, such award may be terminated without payment), or a comparable cash value for a cash incentive award, as applicable.

If a change in control of our Company that does not involve a corporate transaction occurs, the Compensation Committee may, in its discretion, take such action as it deems appropriate with respect to outstanding awards, which may include providing for the cancelation of any award in exchange for payments in a manner similar to that provided above in connection with a corporate transaction, or making such adjustments to the awards then outstanding as the Committee deems appropriate to reflect such change in control, which may include the acceleration of vesting in full or in part. The Committee will not be required to treat all awards similarly in such circumstances. For purposes of the A&R 2024 Plan, the following terms have the meanings indicated:

● A "change in control" generally occurs if (1) a person or group
 acquires 35% or more of our outstanding voting power, (2) our incumbent directors cease to constitute a majority of the Board,
 or (3) a corporate transaction is consummated (unless our voting securities immediately prior to the transaction continue
 to represent over 50% of the voting power of our Company or the surviving entity immediately after the transaction).

● "Cause" means, unless defined differently by the Compensation Committee or
 in an agreement between the Company and the participant, (1) a material breach of any confidentiality, nonsolicitation, noncompetition,
 invention assignment or similar agreement with our Company or any affiliate, (2) an act of dishonesty resulting in personal
 enrichment at the expense of our Company, (3) persistent failure to perform duties, (4) any failure to materially conform
 to our business conduct or ethics code, or (5) indictment or conviction for a felony.

● A "corporate transaction" means any of the following: (1) a reorganization,
 merger, consolidation or statutory share exchange involving our Company, or (2) a sale or other disposition, in one or a series
 of transactions, of all or substantially all of the assets of the Company (or the purchase or other acquisition, in one or
 a series of transactions, of assets of another corporation or entity).

**Deferral of Payouts**

The Compensation Committee may permit or require the deferral by a participant of the receipt of shares or cash in settlement of any full-value award under the A&R 2024 Plan, and will prescribe the terms, conditions and procedures for such deferrals.

**Transferability of Awards**

Except as otherwise provided by the Committee, no stock option, appreciation right, restricted stock, restricted stock unit, cash incentive award, other stock-based Award or dividend equivalents paid with respect to awards made under the A&R 2024 Plan will be transferable by a participant except by will or the laws of descent and distribution. In no event will any such award granted under the A&R 2024 Plan be transferred for value.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **81** |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**Summary of Other Material Terms of the A&R 2024 Plan**

**Clawback**

Awards granted under the A&R 2024 Plan are subject to the terms and conditions of the Company's clawback provisions and policies in effect from time to time, including specifically to implement applicable law or stock exchange rules and regulations (the "Compensation Recovery Policy"). Award agreements will be interpreted consistently with (or deemed superseded by and/ or subject to, as applicable) the terms and conditions of the Compensation Recovery Policy. Further, by accepting any award under the A&R 2024 Plan, each participant agrees to fully cooperate with and assist the Company in connection with any of such participant's obligations to the Company pursuant to the Compensation Recovery Policy, as further described in the A&R 2024 Plan. Award agreements may otherwise provide for the cancelation or forfeiture of an award or the forfeiture and repayment to the Company of any gain or earnings related to an award (or other provisions intended to have similar effects), including such terms and conditions as may be determined by the Board or the Compensation Committee as further described in the A&R 2024 Plan.

**Withholding**

The Company has the authority and the right to deduct or withhold, or require a participant to remit to the Company, an amount sufficient to satisfy federal, state, and local taxes, domestic or foreign, or other amounts required by law or regulation to be withheld with respect to any taxable event arising as a result of the A&R 2024 Plan. Share withholding may be conducted under the A&R 2024 Plan as described further in the applicable terms of the A&R 2024 Plan.

**Amendment, Modification, Suspension and Termination**

In general, the Compensation Committee may amend, modify, suspend or terminate the A&R 2024 Plan or any award agreement from time to time and in whole or in part. However, if any amendment (1) would materially increase the benefits accruing to participants under the A&R 2024 Plan, (2) would materially increase the number of shares which may be issued under the A&R 2024 Plan, (3) would materially modify the requirements for participation in the A&R 2024 Plan, or (4) must otherwise be approved by our stockholders in order to comply with applicable law or the rules of NYSE, then such amendment will be subject to stockholder approval and will not be effective unless and until such approval has been obtained. The Compensation Committee may make certain equitable and appropriate adjustments to awards and award agreements, as further described in the A&R 2024 Plan. Except in the case of certain adjustments permitted under the A&R 2024 Plan, no such termination, amendment, suspension or modification will adversely affect in any material way and award previously granted under the A&R 2024 Plan without written participant consent.

**No Right to Continued Employment**

The A&R 2024 Plan does not confer upon any participant any right with respect to continuance of employment or service with the Company or any of its subsidiaries.

**Effective Date**

The 2024 Plan originally became effective on April 25, 2024. The A&R 2024 Plan will become effective on the date it is approved by the Company's stockholders.

---

| | |
|:---|:---|
| **82**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**U.S. Federal Income Tax Consequences**

**U.S. Federal Income Tax Consequences**

The following is a summary of the principal United States federal income tax consequences to the Company and to participants subject to U.S. taxation with respect to awards granted under the A&R 2024 Plan, based on current statutes, regulations and interpretations.

**Non-Qualified Stock Options**

If a participant is granted a non-qualified stock option under the A&R 2024 Plan, the participant will not recognize taxable income upon the grant of the option. Generally, the participant will recognize ordinary income at the time of exercise in an amount equal to the difference between the fair market value of the shares acquired at the time of exercise and the exercise price paid. The participant's basis in the Common Stock for purposes of determining gain or loss on a subsequent sale or disposition of such shares will generally be the fair market value of our Common Stock on the date the option was exercised. Any subsequent gain or loss will be taxable as a capital gain or loss. The Company will generally be entitled to a federal income tax deduction at the time and for the same amount as the participant recognizes as ordinary income, subject to Code Section 162(m) with respect to covered employees.

**Incentive Stock Options**

If a participant is granted an incentive stock option under the A&R 2024 Plan, the participant will not recognize taxable income upon grant of the option. Additionally, if applicable holding period requirements (a minimum of two years from the date of grant and one year from the date of exercise) are met, the participant will not recognize taxable income at the time of exercise. However, the excess of the fair market value of the shares acquired at the time of exercise over the aggregate exercise price is an item of tax preference income potentially subject to the alternative minimum tax. If shares acquired upon exercise of an incentive stock option are held for the holding period described above, the gain or loss (in an amount equal to the difference between the fair market value on the date of sale and the exercise price) upon disposition of the shares will be treated as a long-term capital gain or loss, and the Company will not be entitled to any deduction. Except in the event of death, if the holding period requirements are not met, the incentive stock option will be treated as one that does not meet the requirements of the Code for incentive stock options and the tax consequences described for nonqualified stock options will generally apply.

**Other Awards, Including Cash Incentive Awards**

The current federal income tax consequences of other awards authorized under the A&R 2024 Plan generally follow certain basic patterns. An award of restricted stock results in income recognition by a participant in an amount equal to the fair market value of the shares received at the time the restrictions lapse and the shares vest, unless the participant elects under Code Section 83(b) to accelerate income recognition and the taxability of the award to the date of grant. Restricted stock unit awards generally result in income recognition by a participant at the time payment of such an award is made in an amount equal to the amount paid in cash or the then-current fair market value of the shares received, as applicable. SAR awards result in income recognition by a participant at the time such an award is exercised in an amount equal to the amount paid in cash or the then-current fair market value of the shares received by the participant, as applicable. No income will generally be recognized upon the grant of cash incentive awards, but upon payment of cash incentive awards, the participant will generally be required to include as taxable ordinary income in the year of receipt an amount equal to the amount of cash received and the fair market value of any unrestricted shares of Common Stock received in payment of such award. In each of the foregoing cases, the Company will generally have a corresponding deduction at the time the participant recognizes ordinary income, subject to Code Section 162(m) with respect to covered employees.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **83** |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**New Plan Benefits**

**Tax Consequences to the Company or its Subsidiaries**

To the extent that a participant recognizes ordinary income in the circumstances described above, the Company or the subsidiary for which the participant performs services will be entitled to a corresponding deduction provided that, among other things, the income meets the test of reasonableness, is an ordinary and necessary business expense, is not an "excess parachute payment" within the meaning of Section 280G of the Code and is not disallowed by the $1 million limitation on certain executive compensation under Section 162(m) of the Code.

**New Plan Benefits**

Future awards under the A&R 2024 Plan may be made at the discretion of the Compensation Committee; therefore, it is not generally possible to quantify the benefits or amounts that may be received by the named executive officers or groups noted in the table below pursuant to the A&R 2024 Plan in the future. However, estimated awards that are anticipated to be made in 2026 to our non-employee directors based on the current non-employee director compensation program are set forth in the table below.

---

| | |
|:---|:---|
| **Name and Position** | **Dollar Value ($)** |
| George W. Bilicic | 150000 |
| Gary E. Hendrickson | 150000 |
| Gwenne A. Henricks | 150000 |
| Darryl R. Jackson | 150000 |
| Bernd F. Kessler | 150000 |
| Lawrence D. Kingsley | 150000 |
| Gwynne E. Shotwell | 150000 |
| John P. Wiehoff | 150000 |
| **Executive Officers as a Group** | N/A |
| **Non-Executive Directors as a Group** | 1200000<sup>(1)</sup> |
| **Non-Executive Officer Employees as a Group** | N/A |

---

*(1)* *The amount disclosed is an estimate for all deferred stock units to be issued to eight of our non-employee directors after the Annual Meeting based on the current non-employee director compensation program, using the current $150,000 target grant date value per non-employee director for deferred stock units under that program.* 

---

| | |
|:---|:---|
| **84**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Proposal 3 — Approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan**

**Historical Awards**

**Historical Awards**

Since its inception, the following grants have been made under the 2024 Plan to the persons and categories of persons identified below:

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **Number of Shares Subject**<br> **to Options/SARs** | **Number of Shares Subject**<br> **to RSUs/DSUs/CSEs** | **Number of**<br> **PRSUs\*** |
| **Named Executive Officers:** | | | |
| Michael T. Speetzen | 512467 | 140498 | - |
| Robert P. Mack | 174494 | 62300 | - |
| James P. Williams | 104855 | 38301 | - |
| Benjamin D. Duke | 99051 | 36301 | - |
| Michael D. Dougherty | 47059 | 19681 | - |
| **Executive Officers as a Group** | 937926 | 297081 | - |
| **Non-Executive Directors as a Group** | - | 72541 | - |
| **Each nominee for election as a director:** |  |  |  |
| George W. Bilicic | - | 10349 | - |
| Gary E. Hendrickson | - | 10425 | - |
| Gwenne A. Henricks | - | 9821 | - |
| **Each associate of the foregoing** | - | - | - |
| **Each other person who received 5% of such awards** | - | - | - |
| **Non-Executive Officer Employees as a Group** | 396445 | 779619 | - |

---

**Registration with the SEC**

We intend to file a Registration Statement on Form S-8 relating to the issuance of shares of Common Stock under the A&R 2024 Plan with the SEC pursuant to the Securities Act of 1933, as amended, as soon as practicable after approval of the A&R 2024 Plan by our stockholders.

**The Board, upon recommendation of the Compensation Committee, unanimously recommends a vote FOR the approval of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan.**

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **85** |

---

------

[**Table of Contents**](#toc)

---

| | |
|:---|:---|
| **Proposal 4 —** | **Ratification of Appointment of Independent Registered Public Accounting Firm** |

---

The Audit Committee has appointed Ernst & Young LLP ("EY") as our independent registered public accounting firm for fiscal 2026, and the Board is asking stockholders to ratify that appointment. Although current law, rules and regulations, as well as the Audit Committee Charter require our independent registered public accounting firm to be engaged, retained, and supervised by the Audit Committee, the Board considers the appointment of an independent registered public accounting firm to be an important matter of stockholder concern and considers a proposal for stockholders to ratify such appointment to be an opportunity for stockholders to provide direct feedback to the Board on a significant issue of corporate governance.

If the appointment of EY as our independent registered public accounting firm for fiscal 2026, is not ratified by our stockholders, the Audit Committee will review its future appointment of an independent registered public accounting firm in the light of that vote result.

Representatives of EY will be present at the virtual Annual Meeting, will have an opportunity to make a statement if they so desire, and will be available to respond to appropriate questions.

**The Board, upon recommendation of the Audit Committee, unanimously recommends a vote FOR the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2026.**

---

| | |
|:---|:---|
| **86**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Audit Committee Report**

The Audit Committee reports to and acts on behalf of the Board by providing oversight of (1) the integrity of our financial statements, (2) the effectiveness of the Company's internal controls over financial reporting, (3) our compliance with legal and regulatory requirements, (4) the independent registered public accounting firm's performance, qualifications and independence and (5) the responsibilities, performance, budget and staffing of our internal audit function. The Audit Committee is comprised of five directors, all of whom meet the standards of independence adopted by the SEC and the NYSE.

In performing the Audit Committee oversight responsibilities, we have reviewed and discussed our audited financial statements for the year ended December 31, 2025 with management and with representatives of EY, our independent registered public accounting firm. The Audit Committee also reviewed, and discussed with management and representatives of EY, management's assessment and report and EY's report and attestation on the effectiveness of internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act of 2002.

The Audit Committee also discussed with the independent registered public accounting firm matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board ("PCAOB") and the SEC. The Audit Committee has received from our independent registered public accounting firm the written disclosures and the letter required by applicable requirements of the PCAOB regarding the independent accountant's communication with the audit committee concerning independence, and the Audit Committee has discussed the independence of EY with representatives of such firm. The Audit Committee is satisfied that the non-audit services provided to us by the independent registered public accounting firm are compatible with maintaining their independence.

Management is responsible for our system of internal controls and the financial reporting process. EY is responsible for performing an audit of the consolidated financial statements in accordance with the standards of the PCAOB and issuing a report thereon. The Audit Committee's responsibility is to monitor and oversee these processes.

Based on the reviews and discussions referred to in this Report, the Audit Committee recommends to the Board that the audited financial statements be included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

AUDIT COMMITTEE

Darryl R. Jackson, Chair

George W. Bilicic

Gwenne A. Henricks

Gwynne E. Shotwell

John P. Wiehoff

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **87** |

---

------

[**Table of Contents**](#toc)

**Fees Paid to Independent Registered Public Accounting Firm**

**Audit and Non-Audit Fees**

The following table presents fees for professional audit services rendered by EY for the audit of the Company's annual financial statements for the fiscal years ended December 31, 2024 and December 31, 2025, and fees for other services rendered by EY.

---

| | | |
|:---|:---|:---|
|  | **Fiscal 2024** | **Fiscal 2025** |
| Audit Fees<sup>(1)</sup> | $3855500 | $3971500 |
| Audit-Related Fees<sup>(2)</sup> | $109200 | $247200 |
| Tax Fees<sup>(3)</sup> | $113200 | $208090 |
| All Other Fees | $0 | $0 |

---

*(1)* *These fees include amounts for the annual audit of our consolidated financial statements and internal control over financial reporting, statutory audits at certain foreign subsidiaries, and the reviews of the consolidated financial statements included in our Quarterly Reports on Form 10-Q. 2024 includes $507,000 in fees billed subsequent to the filing of the proxy statement for our 2025 annual meeting of stockholders.* 

*(2)* *These fees represent amounts related to the performance of the audit or review of the consolidated financial statements that are not reported under the Audit Fees category such as the audit of employee benefit plans, the issuance of certain industry reports, and procedures to support the issuance of public debt.* 

*(3)* *These fees were primarily related to tax planning and compliance services, including assistance related to certain foreign subsidiaries.* 

**Audit Committee Pre-Approval Requirements**

The Audit Committee's charter provides that it has the sole authority to review in advance and grant any pre-approvals of (i) all auditing services to be provided by the independent registered public accounting firm, (ii) all significant non-audit services to be provided by the independent registered public accounting firm as permitted by Section 10A of the Exchange Act and the PCAOB and (iii) all fees and the terms of engagement with respect to such services. All audit and non-audit services performed by EY during fiscal 2025 were pre-approved pursuant to the procedures outlined above.

---

| | |
|:---|:---|
| **88**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Security Ownership of Certain Beneficial Owners and Management**

The following table sets forth certain information with respect to the beneficial ownership of our common stock as of February 13, 2026 (except as otherwise indicated below) by each person known to us who then beneficially owned more than 5% of the outstanding shares of our common stock, each director, each nominee for director, each NEO and all current executive officers and directors as a group. As of February 13, 2026, there were 56,734,970 shares of common stock outstanding. Except as otherwise indicated, the named beneficial owner has sole voting and investment power with respect to the shares held by such beneficial owner. The table also includes information with respect to CSEs and deferred stock units credited as of February 13, 2026 to the accounts of each director as described in this Proxy Statement under the heading "Director Compensation" on page 30.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name and Address of Beneficial Owner** | **Amount and Nature of <br> Beneficial Ownership** | **Percent <br> of Class** | **Common Stock <br> Equivalents<sup>(12)</sup>** | **Deferred Stock <br> Units<sup>(13)</sup>** |
| Capital World Investors<sup>(1)</sup> | 6716582 | 11.84% | - | - |
| BlackRock, Inc.<sup>(2)</sup> | 6341438 | 11.18% | - | - |
| The Vanguard Group<sup>(3)</sup> | 5807449 | 10.24% | - | - |
| State Street Corporation<sup>(4)</sup> | 3137866 | 5.53% | - | - |
| Polaris Inc. Employee Stock Ownership Plan<sup>(5)</sup> | 2913834 | 5.14% | - | - |
| Michael T. Speetzen<sup>(6)</sup><br> Chief Executive Officer | 559362 | \* | - | - |
| Robert P. Mack<sup>(7)</sup><br> Chief Financial Officer and Executive Vice <br> President - Finance and Corporate Development | 206846 | \* | - | - |
| James P. Williams<sup>(8)</sup><br> Senior Vice President - Chief Human <br> Resources Officer | 274409 | \* | - | - |
| Benjamin D. Duke<sup>(9)</sup><br> President – Marine | 51960 | \* |  |  |
| Michael D. Dougherty<sup>(10)</sup><br> Former President - On Road and International | 256161 | \* | - | - |
| George W. Bilicic <br> Director | 4028 | \* | 13236 | 16264 |
| Gary E. Hendrickson <br> Director | 5000 | \* | 121623 | 28631 |
| Gwenne A. Henricks <br> Director | 1200 | \* | 15117 | 19945 |
| Darryl R. Jackson <br> Director | - | \* | - | 9656 |
| Bernd F. Kessler <br> Director | - | \* | 25407 | 32319 |
| Lawrence D. Kingsley <br> Director | 10075 | \* | 5278 | 19945 |
| Gwynne E. Shotwell <br> Director | - | \* | 10478 | 14707 |
| John P. Wiehoff <br> Director | - | \* | 43394 | 43159 |
| All directors and current executive officers as a group (15 persons)<sup>(11)</sup> | 1377535 | 2.4% | 234533 | 184626 |

---

*\** *Indicates ownership of less than 1%.*

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **89** |

---

------

[**Table of Contents**](#toc)

**Security Ownership of Certain Beneficial Owners and Management**

*(1)* *The address for Capital World Investors and its affiliates (collectively, "CapWorld") is 333 South Hope Street, 55th Floor, Los Angeles, CA 90071. CapWorld, an investment advisor, has sole voting and dispositive power with respect to 6,716,528 shares. This information was reported on a Schedule 13G/A filed by CapWorld with the SEC on May 13, 2025 and is as of March 31, 2025.* 

*(2)* *The address for BlackRock Inc. and its subsidiaries (collectively, "BlackRock") is 50 Hudson Yards, New York, NY 10001. BlackRock has sole voting power with respect to 6,200,509 shares, and sole dispositive power with respect to 6,341,438 shares. This information was reported on a Schedule 13G/A filed by BlackRock with the SEC on July 2, 2025 and is as of June 30, 2025.* 

*(3)* *The address for The Vanguard Group and its subsidiaries (collectively, "Vanguard") is 100 Vanguard Boulevard, Malvern, PA 19355. Vanguard has shared voting power with respect to 20,658 shares, sole dispositive power with respect to 5,736,224 shares and shared dispositive power with respect to 71,225 shares. This information was reported on a Schedule 13G/A filed by Vanguard with the SEC on February 13, 2024 and is as of December 29, 2023.* 

*(4)* *The address for State Street Corporation and its subsidiaries (collectively, "State Street") is One Congress Street, Suite 1 Boston, MA 02114. State Street has shared voting power with respect to 2,903,794 shares, and shared dispositive power with respect to 3,137,866 shares. This information was reported on a Schedule 13G filed by State Street with the SEC on August 8, 2025 and is as of June 30, 2025.* 

*(5)* *The address for the ESOP is 2100 Highway 55, Medina, MN 55340. The ESOP has shared voting and shared dispositive power with respect to 2,913,834.32 shares. This information was reported on a Schedule 13G/A filed by the ESOP with the SEC on February 13, 2024 and is as of December 31, 2023.* 

*(6)* *This figure represents: (a) 2,000 outstanding shares owned directly by Mr. Speetzen; (b) 1,655 shares held by Mr. Speetzen's family members; (c) 18,305 shares held in the name of the Trustee in connection with the SERP; and (d) options to purchase 537,402 shares, which Mr. Speetzen could exercise within 60 days of February 13, 2026.* 

*(7)* *This figure represents: (a) 26,383 outstanding shares owned directly by Mr. Mack; (b) 2,776 shares held in the name of the Trustee in connection with the SERP; and (c) options to purchase 177,687 shares, which Mr. Mack could exercise within 60 days of February 13, 2026.* 

*(8)* *This figure represents: (a) 12,633 outstanding shares owned directly by Mr. Williams; (b) 34,104 shares held in the name of the Trustee in connection with the SERP; and (c) options to purchase 227,672 shares, which Mr. Williams could exercise within 60 days of February 14, 2025.* 

*(9)* *This figure represents: (a) 214 outstanding shares owned directly by Mr. Duke; (b) 165 shares held in the ESOP; and (c) options to purchase 51,581 shares, which Mr. Duke could exercise within 60 days of February 13, 2026.* 

*(10)* *Mr. Dougherty's ownership is as of February 2, 2026, the effective date of his retirement. This figure represents: (a) 35,632 outstanding shares owned directly by Mr. Dougherty; (b) 36,007 shares held by Mr. Dougherty's family members; (c) 4,733 shares held by Mr. Dougherty in the ESOP; (d) 8,256 shares held in the name of the Trustee in connection with the SERP; and (e) options to purchase 171,533 shares, which Mr. Dougherty could exercise within 60 days of February 13, 2026.* 

*(11)* *This figure represents: (a) the outstanding and attainable shares, restricted stock units and options discussed in the preceding footnotes (6) through (10); 1,383 outstanding shares beneficially owned directly or indirectly by other executive officers; (b) 257 shares held in the ESOP by other executive officers; and (c) options to purchase 6,854 shares, which the other executive officers could exercise within 60 days of February 13, 2026.* 

*(12)* *Represents the number of CSEs credited as of February 13, 2026 to the accounts of each non-employee director and the accompanying dividend equivalent units, as maintained by us under the Polaris Inc. Deferred Compensation Plan for Directors. A director will receive one share of common stock for every CSE and dividend equivalent unit held by that director upon his or her termination of service as a member of the Board or upon a change of control of our Company or such later date as elected by the Director.* 

*(13)* *Represents the number of deferred stock units awarded to each of the non-employee directors under the 2024 Omnibus Incentive Plan and the accompanying dividend equivalent units. A director will receive one share of common stock for every deferred stock unit and dividend equivalent unit upon his or her termination of service as a director or upon a change in control of our Company.* 

---

| | |
|:---|:---|
| **90**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Security Ownership of Certain Beneficial Owners and Management** 

**Delinquent Section 16(a) Reports**

**Delinquent Section 16(a) Reports**

Section 16(a) of the Exchange Act requires our directors and executive officers to file initial reports of ownership and reports of changes of ownership of our common stock with the SEC. Executive officers and directors are required to furnish us with copies of all Section 16(a) reports that they file. To our knowledge, based solely upon a review of the reports filed by the executive officers and directors during 2025 and written representations that no other reports were required, we believe that during (or prior to) the year ended December 31, 2025, all filing requirements applicable to our directors, executive officers and 10% beneficial owners, if any, were complied with on a timely basis, other than, due to administrative error, (i) a Form 4 reporting the quarterly distribution of shares out of the Company's SERP for Mr. Mack, which was filed late on January 30, 2026, and (ii) a Form 4 reporting the deferral of shares into the SERP for Mr. Williams, which was filed late on February 13, 2026.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **91** |

---

------

[**Table of Contents**](#toc)

**Questions and Answers about the Annual Meeting and Voting**

---

| | |
|:---|:---|
| **Q:** | **Who is soliciting my proxy, and why?** |

---

---

| | |
|:---|:---|
| A: | Polaris is soliciting proxies for use at the Annual Meeting, including any postponements or adjournments. The proxy materials were first mailed to you beginning on or about March 17, 2026. The Proxy Statement summarizes the information you need to vote at the Annual Meeting. |

---

---

| | |
|:---|:---|
| **Q:** | **Why did I receive a notice in the mail regarding the Internet availability of proxy materials instead of a paper copy of the proxy materials?** |

---

---

| | |
|:---|:---|
| A: | "Notice and Access" rules adopted by the SEC permit us to furnish proxy materials, including this Proxy Statement and our Annual Report for 2025, to our stockholders by providing electronic access to such documents rather than printed copies. Most stockholders will not receive printed copies of the proxy materials unless they request them. Instead, the Notice, which was mailed to most of our stockholders, will tell you how to access and review all the proxy materials and how to submit your proxy online. If you would like to receive a paper or email copy of our proxy materials, you should follow the instructions for requesting such materials in the Notice. Any request to receive proxy materials by mail will remain in effect until you revoke it. |

---

---

| | |
|:---|:---|
| **Q:** | **Who can vote?** |

---

---

| | |
|:---|:---|
| A: | You can vote if you were a stockholder at the close of business on the record date of March 9, 2026. There were a total of 56,615,893 shares of our common stock outstanding on that date. |

---

---

| | |
|:---|:---|
| **Q:** | **What constitutes a quorum to conduct business at the Annual Meeting?** |

---

---

| | |
|:---|:---|
| A: | A majority of the outstanding shares on the record date is necessary to constitute a quorum for the transaction of business at the Annual Meeting. If you submit a valid proxy or join the virtual Annual Meeting, your shares will be counted to determine whether there is a quorum. A properly executed proxy marked "**ABSTAIN**" with respect to a proposal will be counted for purposes of determining whether there is a quorum. |

---

---

| | |
|:---|:---|
| **92**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Questions and Answers about the Annual Meeting and Voting**

---

| | |
|:---|:---|
| **Q:** | **What am I voting on, what vote is required to approve each proposal and how does the Board recommend I vote?** |

---

---

| | |
|:---|:---|
| A: | The table below summarizes the proposals that will be voted on, the vote required to approve each item, how votes are counted and how the Board recommends you vote: |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Proposal** | **Vote Required** | **Voting Options** | **Board**<br> **Recommendation** | **Broker** <br> **Discretionary**<br> **Voting Allowed<sup>(1)</sup>** | **Impact of**<br> **Abstention** |
| **Proposal 1** — Elect three Class II directors for three-year terms ending in 2029 | Majority of votes cast (votes cast "For" must exceed votes cast "Against"<sup>(2)</sup>) | FOR, AGAINST, ABSTAIN | FOR | No |  |
| **Proposal 2** — Approve, on an advisory basis, the compensation of our Named Executive Officers | We will consider our stockholders to have approved the compensation of our Named Executive Officers if there are more votes cast "For" the proposal than "Against" | FOR, AGAINST, ABSTAIN | FOR | No | AGAINST |
| **Proposal 3** - Adopt the Amended & Restated 2024 Polaris Inc. Omnibus Incentive Plan | Majority of votes present in person (i.e., online) or by proxy and entitled to vote on this item | FOR, AGAINST, ABSTAIN | FOR | No | AGAINST |
| **Proposal 4** — Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2026 | Majority of votes present in person (i.e., online) or by proxy and entitled to vote on this item | FOR, AGAINST, ABSTAIN | FOR | Yes | AGAINST |

---

*(1)* *If you are a beneficial owner and do not provide your broker with specific voting instructions, your broker will only be permitted to vote on Proposal 4 and there will be a so-called "broker non-vote" with respect to your shares on Proposals 1, 2 and 3. Your shares covered by such a "non-vote" proxy will be deemed present at the meeting for purposes of determining a quorum, but will have no effect on the vote for Proposals 1, 2, and 3. If a quorum for the Annual Meeting could not be established without including broker non-votes, then the broker non-votes required to establish the minimum quorum would have the same effect as votes against Proposal 4.* 

*(2)* *A majority voting standard is applicable only to uncontested elections. If there are more nominees than directors to be elected, then our Certificate of Incorporation provides that a plurality voting standard is applicable.* 

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **93** |

---

------

[**Table of Contents**](#toc)

**Questions and Answers about the Annual Meeting and Voting**

---

| | |
|:---|:---|
| **Q:** | **How do I cast my vote?** |

---

---

| | |
|:---|:---|
| A: | If you are a stockholder of record (that is, if your shares are owned in your name), you may vote: |

---

● Online at www.proxyvote.com by 11:59 p.m. Eastern Time on April 29, 2026 for shares held directly and by 11:59 p.m. Eastern Time on April 27, 2026 for shares held in a plan;

● By telephone (within the U.S. or Canada) toll-free at 1-800-690-6903 by 11:59 p.m. Eastern Time on April 29, 2026 for shares held directly and by 11:59 p.m. Eastern Time on April 27, 2026 for shares held in a plan;

● By mail, by completing, signing, dating and mailing the proxy card in the envelope provided if you receive paper materials; or

● By attending the virtual Annual Meeting and voting online at *www.virtualshareholdermeeting.com/PII* 2026.

Whichever method you use, the individuals identified as your proxies will vote your shares in accordance with your instructions. If you submit a proxy without giving specific voting instructions, the individuals identified as your proxies will vote those shares as recommended by the Board. By submitting your proxy, you authorize the proxies to use their judgment to determine how to vote on any other matter brought before the Annual Meeting.

If you are a "street name" stockholder (meaning that your shares are registered in the name of your bank or broker), you will receive instructions from your bank, broker or other nominee describing how to vote your shares. We encourage you to provide your voting instructions promptly so that your shares are counted.

You cannot vote by marking the Notice and returning it.

---

| | |
|:---|:---|
| **Q:** | **Can I revoke or change my vote?** |

---

---

| | |
|:---|:---|
| A: | You can revoke your proxy or change your vote at any time before it is voted at the Annual Meeting by: |

---

● Submitting a new proxy with a more recent date by (1) following the telephone voting instructions; (2) following the Internet voting instructions; or (3) completing, signing, dating and returning a new proxy card to us;

● Giving written notice of revocation to our Corporate Secretary at Polaris Inc., 2100 Highway 55, Medina, Minnesota 55340; or

● Voting online during the annual meeting.

---

| | |
|:---|:---|
| **Q:** | **Why is this Annual Meeting only virtual and how do I attend?** |

---

---

| | |
|:---|:---|
| A: | We have been hosting virtual annual meetings since 2018, and believe they offer many benefits, including expanded access and cost savings for our stockholders and us. We have designed the virtual Annual Meeting to provide substantially the same opportunities to participate as you would have at an in-person meeting. Stockholders will be able to attend and participate online and submit questions during the Annual Meeting by visiting *www.virtualshareholdermeeting.com/PII2026*. See the question below for further details on how to submit questions. To attend and participate in the Annual Meeting, you will need the 16-digit control number that is printed in the box marked by the arrow on your Notice of Internet Availability of Proxy Materials or proxy card. The Annual Meeting will begin promptly at 9:00 a.m. Central Time and access to the meeting website will be available at 8:45 a.m. Central Time. The Annual Meeting platform is fully supported across browsers (Edge, Firefox, Chrome, and Safari) and devices (desktops, laptops, tablets, and cell phones) running the most updated version of applicable software and plugins. Attendees should allow plenty of time to log in and verify that they can hear streaming audio prior to the start of the Annual Meeting. |

---

For technical assistance on the day of the Annual Meeting, please call the support line at 800-986-0822 (Toll Free) or 303-562-9302 (International Toll).

---

| | |
|:---|:---|
| **Q:** | **Can I submit questions? If so, how?** |

---

---

| | |
|:---|:---|
| A: | Stockholders who wish to submit a question to Polaris for the meeting may do so live by typing it in the dialog box provided at any point during the meeting until the floor is closed to questions. Questions pertinent to the Annual Meeting that comply with the meeting Rules of Conduct will be answered during the meeting, subject to time constraints. If we do not have time to respond to a stockholder's properly submitted question, we will respond directly to that stockholder using the contact information provided. The Rules of Conduct will be available on the meeting website. |

---

---

| | |
|:---|:---|
| **94**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Questions and Answers about the Annual Meeting and Voting**

---

| | |
|:---|:---|
| **Q:** | **Who will count the votes?** |

---

---

| | |
|:---|:---|
| A: | Broadridge Financial Solutions, our independent proxy tabulator, will count the votes. A representative of Broadridge Financial Solutions and the Company's Vice President and Corporate Controller, will act as inspectors of election for the meeting. |

---

---

| | |
|:---|:---|
| **Q:** | **Is my vote confidential?** |

---

---

| | |
|:---|:---|
| A: | All proxies and all vote tabulations that identify an individual stockholder are confidential. Your vote will not be disclosed, except: |

---

● to allow Broadridge Financial Solutions to tabulate the vote;

● to allow the Company's Vice President and Corporate Controller, and a representative of Broadridge Financial Solutions to certify the results of the vote; and

● to meet applicable legal requirements.

---

| | |
|:---|:---|
| **Q:** | **What happens if I don't vote the shares that I own?** |

---

---

| | |
|:---|:---|
| A: | *For shares registered in your name.* If you do not vote shares that are registered in your name, either by giving your proxy or voting online at the Annual Meeting, your shares will not be counted in determining the presence of a quorum or in determining the outcome of the vote on any proposals presented at the Annual Meeting. |

---

*For shares held in street name.* If you do not submit voting instructions to your broker, then your shares will not be counted except with respect to ratification of the selection of our independent registered public accounting firm. 

*For shares held in certain employee plans.* If you hold shares in the ESOP or the 401(k) Plan and you do not submit your voting instructions, those shares will be voted in the manner described in the following question.

---

| | |
|:---|:---|
| **Q:** | **How are common shares in the Polaris Employee Stock Ownership Plan and the Polaris 401(k) Retirement Savings Plan voted?** |

---

---

| | |
|:---|:---|
| A: | If you hold shares of common stock through the ESOP or the 401(k) Plan, your proxy card will instruct the applicable trustee how to vote the shares allocated to your plan account. If you do not return your proxy card (or you submit it with an unclear voting designation or with no voting designation at all), then the plan trustee will vote the shares in your account in proportion to the instructions the trustee actually receives from other plan participants. |

---

---

| | |
|:---|:---|
| **Q:** | **What does it mean if I get more than one Notice or proxy card?** |

---

---

| | |
|:---|:---|
| A: | Your shares are probably registered in more than one account. You should provide voting instructions for all Notices and proxy cards you receive. |

---

---

| | |
|:---|:---|
| **Q:** | **How many votes can I cast?** |

---

---

| | |
|:---|:---|
| A: | You are entitled to one vote per share on all matters presented at the meeting. |

---

---

| | |
|:---|:---|
| **Q:** | **How is this proxy solicitation being conducted?** |

---

---

| | |
|:---|:---|
| A: | We engaged Alliance Advisors, LLC to assist in the distribution of proxy materials and the solicitation of votes for a fee of $18,500, plus out-of-pocket expenses. We will pay for the cost of soliciting proxies, and we will reimburse brokerage houses and other custodians, nominees and fiduciaries for their reasonable out-of-pocket expenses for forwarding proxy and solicitation materials to our stockholders. In addition, some of our employees may solicit proxies. Alliance Advisors, LLC and our employees may solicit proxies in person, by telephone and by mail. Our employees will not receive special compensation for these services. |

---

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **95** |

---

------

[**Table of Contents**](#toc)

**Submission of Shareholder Proposals and Nominations**

If you want Polaris to include a proposal in our proxy statement and form of proxy for presentation at our 2026 Annual Meeting of Stockholders, the proposal must be submitted in writing and received by our Corporate Secretary at our principal executive offices by November 17, 2026. To be considered for inclusion, the proposal must comply with Rule 14a-8 of the Exchange Act. Rule 14a-8 and related guidance provide that certain shareholder proposals may be excluded from a proxy statement. We will evaluate any shareholder proposal received and may exclude such shareholder proposal if permitted in accordance with such rule and guidance.

If you intend to introduce an item of business or nominate a person as a director at the 2027 Annual Meeting, without including the proposal or nomination in the proxy statement, our Bylaws require that we receive notice of that intention no earlier than December 31, 2026 and no later than January 30, 2027; if however, the date of the 2027 Annual Meeting is more than 30 days before or 60 days after the anniversary date of the 2026 Annual Meeting, notice by a shareholder is timely only if so received no less than 90 days before the 2027 Annual Meeting or, if later, within 10 days after the first public announcement of the date of the 2027 Annual Meeting.

In either situation described above, the notice to the Company must include the information required by our Bylaws, including, if the item of business does not relate to the nomination of a person to serve as a director, a brief description of the business desired to be brought before the meeting and the reasons for conducting the business at the meeting, any material interest of the stockholder or any associated person of the stockholder in the business desired to be brought before the meeting, the name and address of the stockholder and any associated person of the stockholder as they appear on our books, and specified information regarding the stockholder's interests in our capital stock. Notice to the Company of the nomination of a person to serve as a director must include, as applicable, similar information as required above, as well as the name of any director nominee, information about the nominee required by SEC rules, the director nominee's consent to be named and to serve if elected, and the information required by Rule 14a-19 under the Exchange Act. Address all shareholder proposals or notices of intention to present proposals at the 2027 Annual Meeting to: Polaris Inc., 2100 Highway 55, Medina, Minnesota 55340; Attention: Corporate Secretary.

**Cautionary Note Regarding Forward-Looking Statements**

In addition to historical information, this proxy statement contains forward-looking statements that are inherently subject to risks and uncertainties, including but not limited to statements regarding estimates, projections or goals relating to our business plans and objectives, and statements regarding our environmental and other sustainability plans and goals, and the assumptions upon which those statements are based. Forward-looking statements are generally identified by words such as "believe," "anticipate," "expect," "estimate" or words of similar import. Actual results may differ materially from those referred to in the forward-looking statements due to a number of important factors, including, but not limited to, our ability to successfully achieve our environmental and other goals and targets within the expected timeframe, if at all, and those factors described in our most recently filed Annual Report on Form 10-K filed with the SEC and in our subsequent Quarterly Reports on Form 10-Q and other filings we may make with the SEC. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this proxy statement. We undertake no obligation to revise or update any forward-looking statement, whether because of new information, future events or otherwise, except as may be required by law.

---

| | |
|:---|:---|
| **96**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Additional Information**

**Householding**

We have adopted a procedure approved by the SEC called householding, which allows us to deliver a single set of our Annual Report on Form 10-K, which includes the Annual Report to Stockholders, Proxy Statement or Notice to stockholders who do not participate in electronic delivery and have the same last name and address. This process helps eliminate duplicate mailings and reduces our printing and mailing costs.

Your household may have received a single set of these proxy materials. If you would like another set, please call toll-free (866) 540-7095 or write to Broadridge Financial Solutions, Householding Department, 51 Mercedes Way, Edgewood, NY 11717.

**Annual Reports**

**Our Annual Report is available on our website at *www.polaris.com* in the "Investors" section. You may also request a free copy of our Annual Report and Proxy Statement by writing to the Corporate Secretary, Polaris Inc., 2100 Highway 55, Medina, MN 55340, or by calling (763) 542**-**0500.**

By Order of the Board of Directors

![](pro014545-def14ax99x1.jpg)

Matthew S. Winings

Senior Vice President, General Counsel and Corporate Secretary

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **97** |

---

------

[**Table of Contents**](#toc)

**Appendix A**

**Non-GAAP Reconciliation of Results**

*(In Millions, Except Per Share Data), (Unaudited)*

---

| | | |
|:---|:---|:---|
|  | **Twelve months ended December 31,** | **Twelve months ended December 31,** |
|  | **2025** | **2024** |
| **Sales** | $7152 | $7175.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product wind downs<sup>(3)</sup> | (9.2) | (0.7) |
| **Adjusted sales** | $7142.8 | $7174.7 |
| **Gross profit** | $1368.7 | $1466.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring<sup>(2)</sup> | 6.2 | 7.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product wind downs<sup>(3)</sup> | 10.2 | 11.1 |
| **Adjusted gross profit** | 1385.1 | 1485.5 |
| **(Loss) income before income taxes** | (532.7) | 140.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related costs<sup>(1)</sup> | 0.2 | 1.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring<sup>(2)</sup> | 20.1 | 23.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product wind downs<sup>(3)</sup> | 10.4 | 11.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible amortization<sup>(4)</sup> | 17.7 | 17.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Class action litigation expenses<sup>(6)</sup> | 8 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment charges<sup>(7)</sup> | 155.9 | 29.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal group held for sale<sup>(8)</sup> | 330.4 |  |
| **Adjusted income before income taxes** | 10 | 231.6 |
| **Net (loss) income attributable to Polaris Inc.** | (465.5) | 110.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related costs<sup>(1)</sup> | 0.1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring<sup>(2)</sup> | 15.3 | 17.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product wind downs<sup>(3)</sup> | 7.9 | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible amortization<sup>(4)</sup> | 13.5 | 13.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Class action litigation expenses<sup>(6)</sup> | 6.1 | 5.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment charges<sup>(7)</sup> | 140.8 | 27.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal group held for sale<sup>(8)</sup> | 281.3 |  |
| **Adjusted net (loss) income attributable to Polaris Inc.<sup>(9)</sup>** | (0.5) | 184.8 |
| **Diluted EPS attributable to Polaris Inc.** | $(8.18) | $1.95 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related costs<sup>(1)</sup> |  | 0.02 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring<sup>(2)</sup> | 0.27 | 0.31 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product wind downs<sup>(3)</sup> | 0.14 | 0.16 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible amortization<sup>(4)</sup> | 0.24 | 0.24 |
| &nbsp;&nbsp;&nbsp;&nbsp;Class action litigation expenses<sup>(6)</sup> | 0.10 | 0.09 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment charges<sup>(7)</sup> | 2.48 | 0.48 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal group held for sale<sup>(8)</sup> | 4.94 |  |
| **Adjusted EPS attributable to Polaris Inc.<sup>(9)</sup>** | $**(0.01)** | $**3.25** |

---

---

| | |
|:---|:---|
| **98**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Appendix A**

**Non-GAAP Reconciliation of Results**

---

| | | |
|:---|:---|:---|
|  | **Twelve months ended December 31,** | **Twelve months ended December 31,** |
|  | **2025** | **2024** |
| **Adjusted sales** | $**7142.8** | $**7174.7** |
| **Net (loss) income** | (464.8) | 111.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;(Benefit) provision for income taxes | (67.9) | 29.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 131.4 | 137.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 263.5 | 264.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Intangible amortization<sup>(5)</sup> | 23.0 | 21.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition-related costs<sup>(1)</sup> | 0.2 | 1.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring<sup>(2)</sup> | 20.1 | 23.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Product wind downs<sup>(3)</sup> | 10.4 | 10.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Class action litigation expenses<sup>(6)</sup> | 8.0 | 7.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment charges<sup>(7)</sup> | 155.9 | 29.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal group held for sale<sup>(8)</sup> | 330.4 |  |
| **Adjusted EBITDA** | $410.2 | $635.4 |
| **Adjusted EBITDA Margin** | 5.7% | 8.9% |

---

*(1)* *Represents adjustments for integration and acquisition-related expenses* 

*(2)* *Represents adjustments for corporate restructuring* 

*(3)* *Represents adjustments related to product wind downs, including the FTR product line within the Company's On Road segment and the Timbersled product line within the Company's Off Road segment* 

*(4)* *Represents amortization expense for intangible assets acquired through business combinations* 

*(5)* *Represents amortization expense for intangible assets acquired through business combinations and asset acquisitions* 

*(6)* *Represents adjustments for certain class action litigation-related expenses* 

*(7)* *Represents goodwill impairment charges associated with the Company's On Road segment, impairment charges related to other intangible assets associated with the Company's Off Road segment, and impairment charges related to strategic investments held by the Company* 

*(8)* *Represents impairment and other charges recorded to report the held for sale Indian Motorcycle business at fair value less an amount of estimated transaction costs* 

*(9)* *The Company used its estimated statutory tax rate of 23.8% for the non-GAAP adjustments in 2025 and 2024, except for non-deductible items* 

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **99** |

---

------

[**Table of Contents**](#toc)

**Appendix B** 

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

---

| | |
|:---|:---|
| **Article 1** | **Establishment, Purpose, and Duration** |

---

**1.1** *Establishment*. Polaris Inc. (hereinafter referred to as the "Company") has established this incentive compensation plan to be known as the Polaris Inc. 2024 Omnibus Incentive Plan, as may be amended or amended and restated from time to time (the "Plan").

This Plan permits the grant of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Cash Incentive Awards and Other Stock-Based Awards.

The Board of Directors originally approved this Plan on February 21, 2024, subject to the approval of the Company's stockholders, which was obtained on April 25, 2024 (the "Effective Date"). The amendment and restatement of this Plan was approved by the Board of Directors on March 2, 2026, subject to approval of the Company's stockholders.

**1.2** *Purpose of This Plan*. The purpose of this Plan is to provide a means through which the Company may provide Employees, Nonemployee Directors, and Third-Party Service Providers of the Company and its Affiliates and Subsidiaries with Awards intended to serve as incentives and rewards for service and/or performance.

**1.3** *Duration of This Plan*. Unless this Plan is sooner terminated as provided herein, grants may no longer be made under this Plan on or after the tenth anniversary of the Effective Date. After the term of this Plan so ends, no Awards may be granted, but Awards previously granted shall remain outstanding in accordance with their applicable terms and conditions and this Plan's terms and conditions. For clarification purposes, the terms and conditions of the Plan shall not apply to or otherwise impact previously granted and outstanding awards under the Prior Plans, as applicable (except for purposes of providing for Shares under such awards to be added to the aggregate number of Shares available under <u>Article 4</u> of this Plan pursuant to the Share counting rules of this Plan).

---

| | |
|:---|:---|
| **Article 2** | **Definitions** |

---

Whenever used in this Plan, the following terms shall have the meanings set forth below, and when the meaning is intended, the initial letter of the word shall be capitalized.

**2.1** "*Affiliate*" means any corporation or other entity that is a Subsidiary or Parent of the Company.

**2.2** "*Award*" means a grant under this Plan of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Cash Incentive Awards or Other Stock-Based Awards, in each case subject to the terms of this Plan.

**2.3** "*Award Agreement*" means: (a) a written agreement entered into by the Company and a Participant setting forth the terms and provisions applicable to an Award granted under this Plan; (b) a written statement issued by the Company to a Participant describing the terms and provisions of such Award, including, in each case, any amendment or modification thereof; or (c) any other agreement, certificate, resolution or other type or form of writing or other evidence approved by the Committee that sets forth the terms and conditions applicable to an Award granted under this Plan. The Committee may provide for the use of electronic, internet or other nonpaper Award Agreements, and the use of electronic, internet or other nonpaper means for the acceptance thereof and actions thereunder by a Participant. An Award Agreement may be in an electronic medium, may be limited to notation on the books and records of the Company and, unless otherwise determined by the Committee, need not be signed by a representative of the Company or a Participant.

**2.4** "*Board*" or "Board of Directors" means the Board of Directors of the Company.

**2.5** "*Cash Incentive Award*" means a cash award granted pursuant to <u>Article 9</u> of this Plan.

---

| | |
|:---|:---|
| **100**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

**2.6** "*Cause*" means, regarding a Participant, and unless otherwise determined by the Committee: (a) what such term is expressly defined to mean in a then-effective written agreement (including an Award Agreement) between such Participant and the Company or any Affiliate; or (b) in the absence of any such then-effective agreement or definition, (i) the Participant's material breach of any employment, confidentiality, nonsolicitation, noncompetition, invention assignment or other agreement with the Company or any Affiliate, (ii) an act or acts of dishonesty undertaken by the Participant resulting in gain or personal enrichment of the Participant at the expense of the Company or any Affiliate, (iii) persistent failure by the Participant to perform the duties associated with the Participant's employment or status as a Nonemployee Director or Third-Party Service Provider, as applicable, (iv) any failure by the Participant to materially conform to the Company's business conduct or ethics code, or (v) the indictment or conviction of the Participant for a felony.

**2.7** "*Change in Control*" means, unless otherwise provided by the Committee in an Award Agreement, any of the following after the Effective Date:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Individuals who are Incumbent Directors cease for any reason to constitute a majority
 of the members of the Board; or

(b) The acquisition in one or more transactions, other than from the Company, by any individual,
 entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) of beneficial ownership (within the
 meaning of Rule 13d-3 promulgated under the Exchange Act) of 35% or more of the combined voting power of the Company's
 Voting Securities then outstanding, unless such acquisition has been designated by the Incumbent Directors as an acquisition
 not constituting a Change in Control for purposes hereof; or

(c) The consummation of a Corporate Transaction unless, immediately following such Corporate Transaction,
 all or substantially all of the persons who were the beneficial owners of the Company's Voting Securities immediately
 prior to such Corporate Transaction beneficially own, directly or indirectly, more than 50% of the combined voting power of
 the then outstanding Voting Securities of the surviving or acquiring entity (or its Parent) resulting from such Corporate
 Transaction in substantially the same proportions as their ownership, immediately prior to such Corporate Transaction, of
 the Company's Voting Securities.

Notwithstanding the foregoing, to the extent that any Award constitutes a deferral of compensation subject to Code Section 409A, and if that Award provides for a change in the time or form of payment upon a Change in Control, then no Change in Control shall be deemed to have occurred upon an event described in <u>Section 2.7</u> unless the event would also constitute a change in ownership or effective control of, or a change in the ownership of a substantial portion of the assets of, the Company under Code Section 409A. For the avoidance of doubt, the preceding sentence shall apply only to the extent necessary to establish a time and form of payment that complies with Section 409A of the Code and shall not alter the definition of Change in Control for any purpose in respect of such Award if such alteration is not needed to comply with Section 409A of the Code.

**2.8** "*Code*" means the U.S. Internal Revenue Code of 1986, as amended from time to time. For purposes of this Plan, references to sections of the Code shall be deemed to include references to any applicable regulations thereunder and any successor or similar provision.

**2.9** "*Committee*" means the Compensation Committee of the Board (or its successor(s)) or a subcommittee thereof, or any other committee designated by the Board to administer this Plan. The members of the Committee shall be appointed from time to time by, and shall serve at the discretion of, the Board.

**2.10** "*Company*" means Polaris Inc., a Delaware corporation, and any successor thereto as provided in <u>Article 18</u> herein.

**2.11** "*Corporate Transaction*" means any of the following: (a) a reorganization, merger, consolidation or statutory share exchange involving the Company; or (b) a sale or other disposition, in one or a series of transactions, of all or substantially all of the assets of the Company (or the purchase or other acquisition, in one or a series of transactions, of assets of another corporation or entity).

**2.12** "*Director*" means any individual who is a member of the Board.

**2.13** "*Employee*" means any individual designated as an employee of the Company or any Affiliate on the payroll records thereof. An Employee shall not include any individual during any period he or she is classified or treated by the Company or an Affiliate as an independent contractor, a consultant, or an employee of an employment, consulting, or temporary agency or any other entity other than the Company or an Affiliate, without regard to whether such individual is subsequently determined to have been, or is subsequently retroactively reclassified as, a common-law employee of the Company or an Affiliate during such period.

**2.14** "*Exchange Act*" means the Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto, plus the rules and regulations thereunder, as amended from time to time.

**2.15** "*Fair Market Value*" or "*FMV*" means the fair market value of a Share determined as follows: (a) if the Shares are readily tradable on an established securities market (as determined under Code Section 409A), then Fair Market Value will be the closing sale price for a Share on the principal securities market on which it trades on the date for which it is being determined, or if no sale of Shares occurred on that date, on the immediately preceding date on which a sale of Shares occurred, as reported in The Wall Street Journal or such other source as the Committee deems reliable; or (b) if the Shares are not then readily tradable on an established securities market (as determined under Code Section 409A), then Fair Market Value will be determined by the Committee as the result of a reasonable application of a reasonable valuation method that satisfies the requirements of Code Section 409A.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **101** |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

**2.16** "*Full-Value Award*" means an Award other than in the form of an Option or SAR.

**2.17** "*Grant Date*" means the date on which the Committee (or any proper delegate) approves the grant of an Award under the Plan, or such later date as may be provided for by the Committee (or any proper delegate) on the date the Committee (or any proper delegate) approves the Award.

**2.18** "*Grant Price*" means the per share price established at the time of grant of an SAR that is used to determine the amount of any payment due upon exercise of the SAR.

**2.19** "*Incentive Stock Option*" or "*ISO*" means an Option that is designated as an Incentive Stock Option and that meets the requirements of Code Section 422, or any successor provision.

**2.20** "*Incumbent Director*" means an individual who (a) is, as of the Effective Date, a Director, or (b) is elected as a Director subsequent to the Effective Date and whose initial election, or nomination for initial election by the Company's stockholders, was approved by at least a majority of the then Incumbent Directors (either by specific vote or by approval of the proxy statement of the Company in which such person is named as a nominee for Director, without objection to such nomination).

**2.21** "*Insider*" shall mean an individual who is, on the relevant date, an officer (as defined in Exchange Act Rule 16a-1(f)) or Director of the Company, or a more than ten percent (10%) beneficial owner (within the meaning of Exchange Act Rule 13d-3) of any class of the Company's equity securities that is registered pursuant to Section 12 of the Exchange Act.

**2.22** "Nonemployee Director" means a Director who is not an Employee.

**2.23** "*Nonqualified Stock Option*" or "*NQSO*" means an Option that is not an Incentive Stock Option.

**2.24** "*Option*" means a right granted under the Plan to purchase a specified number of Shares at a specified price per Share, as described in <u>Article 6</u>.

**2.25** "*Option Price*" means the price at which a Share may be purchased by a Participant pursuant to an Option.

**2.26** "*Other Stock-Based Award*" means an Award of the type described in <u>Section 9.1</u>.

**2.27** "*Parent*" means a "parent corporation" as defined in Code Section 424(e).

**2.28** "*Participant*" means any eligible individual as set forth in <u>Article 5</u> to whom an Award is granted.

**2.29** "*Performance Period*" means the period of time during which the performance goals are to be achieved in order to determine the amount payable to, and/or the vested interest of, a Participant with respect to a performance-based Award.

**2.30** "*Period of Restriction*" means the period when Restricted Stock or Restricted Stock Units (or Other Stock-Based Awards, as applicable) are subject to a substantial risk of forfeiture (based on the passage of time, the achievement of performance goals, or upon the occurrence of other events as determined by the Committee, in its discretion), as provided in Article 8 or Article 9.

**2.31** "*Prior Plans*" means the Polaris Inc. 1995 Stock Option Plan, 1999 Broad-Based Stock Option Plan, Restricted Stock Plan, 2003 Nonemployee Director Stock Option Plan, and 2007 Omnibus Incentive Plan, in each case as may be (or may have been) amended or amended and restated from time to time.

**2.32** "*Restricted Stock*" means Shares issued to a Participant that are subject to such restrictions on transfer, forfeiture conditions and other restrictions or limitations as may be set forth in the Plan and the applicable Award Agreement, as described in <u>Article 8</u>.

**2.33** "*Restricted Stock Unit*" means a right granted under the Plan to receive, in cash and/or Shares as determined by the Committee, the fair market value of a Share, subject to such restrictions on transfer, forfeiture conditions and other restrictions or limitations as may be set forth in this Plan and the applicable Agreement, as described in <u>Article 8</u>.

**2.34** "*Share*" means a share of common stock of the Company, par value $.01 per share, or any security into which such common stock may be changed by reason of any transaction or event of the type referred to in <u>Section 4.6</u> of this Plan.

**2.35** "*Stock Appreciation Right*" or "SAR" means a right granted under the Plan to receive, in cash and/or Shares as determined by the Committee, an amount equal to the appreciation in value of a specified number of Shares between the Grant Date of the SAR and its exercise date, as described in <u>Article 7</u>.

**2.36** "*Subsidiary*" means a "subsidiary corporation," as defined in Code Section 424(f), of the Company.

**2.37** "*Substitute Award*" means an Award granted upon the assumption of, or in substitution or exchange for, outstanding awards granted by a company or other entity acquired by the Company or any Affiliate or with which the Company or any Affiliate combines.

**2.38** "*Third-Party Service Provider*" means any consultant, agent, advisor, independent contractor, or other service provider who is a natural person and who renders services to the Company or an Affiliate that: (a) are not in connection with the offer and sale of the Company's securities in a capital-raising transaction; and (b) do not directly or indirectly promote or maintain a market for the Company's securities.

**2.39** "*Voting Securities*" of an entity are the outstanding securities entitled to vote generally in the election of directors (or comparable equity interests of such entity).

---

| | |
|:---|:---|
| **102**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

---

| | |
|:---|:---|
| **Article 3** | **Administration** |

---

**3.1** *General*. The Committee shall be responsible for administering this Plan, subject to this <u>Article 3</u> and the other provisions of this Plan; <u>provided</u>, <u>however</u>, that, at the discretion of the Board, this Plan may be administered by the Board, including with respect to the administration of any responsibilities and duties held by the Committee hereunder. The interpretation and construction by the Committee of any provision of this Plan or of any Award Agreement (or related documents) and any determination by the Committee pursuant to any provision of this Plan or of any such agreement, notification or document will be final and conclusive. No member of the Committee will be liable for any such action or determination made in good faith. In addition, the Committee is authorized to take any action it determines in its sole discretion to be appropriate subject only to the express limitations contained in this Plan, and no authorization in any Plan section or other provision of this Plan is intended or may be deemed to constitute a limitation on the authority of the Committee.

**3.2** *Authority of the Committee*. The Committee shall have full and exclusive discretionary power to interpret the terms and the intent of this Plan and any Award Agreement or other agreement or document ancillary to or in connection with this Plan, to determine eligibility for Awards and to adopt such rules, regulations, forms, instruments, and guidelines for administering this Plan as the Committee may deem necessary or proper. Such authority shall include, but not be limited to: (a) selecting Award recipients; (b) establishing all Award terms and conditions, including the terms and conditions set forth in Award Agreements; (c) granting Awards as an alternative to or as the form of payment for grants or rights earned or due under compensation plans or arrangements of the Company; (d) construing any ambiguous provision of the Plan or any Award Agreement; and (e) subject to <u>Article 15</u>, cancelling or suspending an Award or the exercisability of an Award, accelerating the vesting or extending the exercise period of an Award, or otherwise adopting modifications and amendments to this Plan or any Award Agreement, including without limitation, any that are necessary to comply with the laws of the countries and other jurisdictions in which the Company or its Affiliates operate.

**3.3** *Delegation*. To the extent not inconsistent with applicable law or stock exchange rules, the Committee may delegate all or any portion of its authority under the Plan to one or more of its members or, with respect to Awards to Employees who are not Insiders, to one or more executive officers of the Company. The Committee may also delegate to one or more Employees, agents or advisors such nondiscretionary administrative duties or powers as it may deem advisable, and the Committee or any individuals to whom it has delegated duties or powers as aforesaid may employ one or more individuals to render advice with respect to any responsibility the Committee or such individuals may have under this Plan. Any delegation of authority by the Committee to an executive officer to approve Awards to Employees who are not Insiders shall be by resolution authorizing the executive officer to: (a) designate such Employees to be recipients of Awards; and (b) determine the number of Shares or amount of cash subject to any such Awards; <u>provided</u>, <u>however</u>, (c) the resolution providing such authorization sets forth the total number of Shares and/or amount of cash subject to Awards that such executive officer(s) may grant; and (d) the executive officer(s) shall report periodically to the Committee regarding the nature and scope of the Awards granted pursuant to the authority delegated. In the event of any delegation of authority under this <u>Section 3.3</u>, or exercise of authority by the Board, references in the Plan to the Committee shall be deemed to refer, as applicable, to the delegate of the Committee or to the Board.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **103** |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

---

| | |
|:---|:---|
| **Article 4** | **Shares Subject to This Plan; Maximum Awards** |

---

**4.1** *Number of Shares Available for Awards*. Subject to adjustment as provided in this <u>Article 4</u>, the number of Shares that may be the subject of Awards or dividend equivalents and issued under the Plan (the "Share Authorization") will not exceed in the aggregate (a) 8,905,000 Shares (consisting of 4,325,000 Shares originally approved on the Effective Date and an additional 4,580,000 Shares approved by the Company's stockholders in 2026), plus (b) the total number of Shares remaining available for future grant under the Polaris Inc. 2007 Omnibus Incentive Plan (including as amended and restated as of April 30, 2020) (the "2007 Amended and Restated Plan") as of the Effective Date, plus (c) the Shares that are added (or added back, as applicable) to such Share pool pursuant to the Share counting rules of this Plan. No further awards shall be made under the terms of any of the Prior Plans (including the 2007 Amended and Restated Plan) after this Plan becomes effective. Shares issued under the Plan shall come from authorized and unissued Shares, or treasury shares (or a combination thereof). In determining the number of Shares to be counted against this Share Authorization in connection with any Award, the following rules shall apply:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Shares that are subject to Awards of Options or Stock Appreciation Rights and counted against the Share Authorization shall be counted against the Share Authorization on a one-for-one basis.

(b) Shares that are subject to Full-Value Awards and counted against the Share Authorization shall be counted against the Share Authorization on a three-for-one basis.

(c) Where the number of Shares subject to an Award is variable on the Grant Date, the number of Shares to be counted against the Share Authorization shall be the maximum number of Shares that could be received under that particular Award, until such time as it has been determined that only a lesser number of shares could be received.

(d) Where two or more types of Awards are granted to a Participant in tandem with each other, such that the exercise of one type of Award with respect to a number of Shares cancels at least an equal number of Shares of the other, the number of Shares to be counted against the Share Authorization shall be the larger number of Shares that would be counted against the share reserve under either of the Awards.

(e) Substitute Awards shall not be counted against (or be added back to) the Share Authorization, nor shall they reduce the Shares authorized for grant to a Participant in any calendar year.

**4.2** *Effect of Forfeitures and Other Actions*. Any Shares subject to an Award, or to an award granted under the Prior Plans that was outstanding on the date this Plan initially became effective (a "Prior Plan Award"), that is forfeited, cancelled or expires or is settled or exchanged for cash or is unearned in whole or in part shall, to the extent of such forfeiture, cancellation, expiration, settlement, exchange or unearned amount, become available for Awards under this Plan, and the Share Authorization under <u>Section 4.1</u> shall be correspondingly increased as provided in <u>Section 4.3</u> below. The following Shares shall not, however, so become available for Awards or increase the Share Authorization under <u>Section 4.1</u>: (a) Shares tendered by the Participant or withheld by the Company (or otherwise used) in payment of the purchase price of a stock option issued under this Plan or any Prior Plan; (b) Shares tendered by the Participant or withheld by the Company (or otherwise used) to satisfy tax withholding with respect to an Award or Prior Plan Award; (c) Shares repurchased by the Company with proceeds received from the exercise of an option issued under this Plan or any Prior Plan; and (d) Shares subject to a stock appreciation right issued under this Plan or any Prior Plan that are not issued in connection with the stock settlement of that stock appreciation right upon its exercise. Further, if under this Plan a Participant has elected to give up the right to receive compensation in exchange for Shares based on fair market value, such Shares will not count against the Share Authorization under <u>Section 4.1</u>.

**4.3** *Counting Shares Again Available*. Each Share that becomes available for Awards as provided in <u>Section 4.2</u> shall increase the Share Authorization under <u>Section 4.1</u>, with such increase based on the same share ratio by which the Share Authorization (or the share authorization under an applicable Prior Plan) was decreased upon the grant of the applicable Award or award.

**4.4** *Effect of Plans Operated by Acquired Companies*. If a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines has shares available under a pre-existing plan approved by stockholders and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms of such pre-existing plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration payable to the holders of common stock of the entities party to such acquisition or combination) may be used for Awards under the Plan and shall not reduce the Shares authorized for grant under the Plan. Awards using such available shares shall not be made after the date awards or grants could have been made under the terms of the pre-existing plan, absent the acquisition or combination, and shall only be made to individuals who were not Employees or Nonemployee Directors prior to such acquisition or combination.

---

| | |
|:---|:---|
| **104**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

**4.5** *Award and Other Limits*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The maximum number of Shares of the Share Authorization that may be issued or transferred pursuant to ISOs under this Plan shall be 4,325,000, subject to adjustment as provided in <u>Section 4.6</u>.

(b) Notwithstanding anything to the contrary contained in this Plan, in no event will the value of any Awards granted to any Nonemployee Director in any one calendar year for such service, when added to any cash fees payable to such Nonemployee Director for such service in such calendar year, have an aggregate maximum value (computed as of the date of grant in accordance with applicable financial accounting rules) in excess of $1,000,000.

**4.6** *Adjustments for Changes in Capitalization*. In the event of any equity restructuring (within the meaning of Financial Accounting Standards Board Accounting Standards Codification Topic 718 — Stock Compensation) that causes the per share value of Shares to change, such as a stock dividend, combination of shares, stock split, spinoff, rights offering or recapitalization through an extraordinary dividend, then the Committee shall make or provide for such adjustments as it, in its sole discretion exercised in good faith, deems equitably required and appropriate (a) the aggregate number and kind of Shares or other securities issued or reserved for issuance under the Plan, (b) the number and kind of Shares or other securities subject to outstanding Awards, (c) the Option Price of outstanding Options, (d) the Grant Price of outstanding SARs, (e) any maximum limitations prescribed by the Plan with respect to certain types of Awards or the grants to individuals of certain types of Awards, or (f) in any other Award terms. In the event of any other change in corporate capitalization, or a merger, consolidation, spin-off, split-off, spin-out, split-up, reorganization, partial or complete liquidation of the Company, or other distribution of assets, issuance of rights or warrants to purchase securities, or any other corporate transaction or event having an effect similar to any of the foregoing (including events described in the first sentence of this <u>Section 4.6</u>), such equitable adjustments described in the foregoing sentence shall be made as determined to be equitably required and appropriate by the Committee to prevent dilution or enlargement of rights of Participants. Moreover, in the event of any such transactions or events (or in the event of a Change in Control), the Committee may provide in substitution for any or all outstanding Awards such alternative consideration (including cash), if any, as it, in good faith, may determine to be equitable in the circumstances and shall require in connection therewith the surrender of all Awards so replaced in a manner that complies with Section 409A of the Code. In all such cases, any such adjustment shall be conclusive and binding for all purposes of the Plan. No such adjustment shall be made pursuant to this <u>Section 4.6</u> in connection with the conversion of any convertible securities of the Company, or in a manner that would cause Incentive Stock Options to violate Section 422(b) of the Code or cause an Award to be subject to adverse tax consequences under Section 409A of the Code.

The Committee may also make appropriate adjustments in, or modify, the terms of any Awards under this Plan in connection with, or in anticipation of, any of the foregoing corporate events or transactions, including adjustments and/or modifications of performance goals, changes in the length of Performance Periods and changes in the expiration dates of Options or SARs. The determination of the Committee as to the foregoing adjustments, if any, shall be conclusive and binding on Participants under this Plan.

---

| | |
|:---|:---|
| **Article 5** | **Eligibility and Participation** |

---

**5.1** *Eligibility*. Individuals eligible to participate in this Plan include all Employees, Directors (including Nonemployee Directors) and Third-Party Service Providers.

**5.2** *Actual Participation*. Subject to the provisions of this Plan, the Committee may, from time to time, select from all eligible individuals, those individuals to whom Awards shall be granted and shall determine, in its sole discretion, the nature of, any and all terms permissible by law, and the amount of each Award.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **105** |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

---

| | |
|:---|:---|
| **Article 6** | **Stock Options** |

---

**6.1** *Grant of Options*. Subject to the terms and provisions of this Plan, Options may be granted to Participants in such number, and upon such terms, and at any time and from time to time, as shall be determined by the Committee, in its sole discretion, provided that ISOs may be granted only to eligible Employees of the Company or of any Affiliate of the Company in accordance with Section 3401(c) of the Code.

**6.2** *Award Agreement*. Each Option grant shall be evidenced by an Award Agreement that shall specify the Option Price, the maximum duration of the Option, the number of Shares with respect to which the Option is exercisable, the conditions upon which the Option shall become vested and/or exercisable, and such other provisions as the Committee shall determine which are not inconsistent with the terms of this Plan. The Award Agreement also shall specify whether the Option is intended to be an ISO or an NQSO.

**6.3** *Option Price*. The Option Price for each Option shall be determined by the Committee in its sole discretion and shall be specified in the Award Agreement; <u>provided</u>, <u>however</u>, the Option Price must be at least equal to one hundred percent (100%) of the FMV of a Share on the Grant Date, except in the case of Substitute Awards (to the extent consistent with Code Section 409A and, the case of ISOs, Code Section 424).

**6.4** *Term of Options*. Each Option granted to a Participant shall expire at such time as the Committee shall determine, as specified in the Award Agreement; <u>provided</u>, <u>however</u>, that no Option shall be exercisable later than the tenth (10th) anniversary of its Grant Date.

**6.5** *Exercise of Options*. Options granted under this <u>Article 6</u> shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which terms and restrictions need not be the same for each grant or for each Participant.

**6.6** *Payment*. Options granted under this <u>Article 6</u> shall be exercised by the delivery of a notice of exercise to the Company or an agent designated by the Company in a form specified or accepted by the Committee, or by complying with any alternative procedures which may be authorized by the Committee, setting forth the number of Shares with respect to which the Option is to be exercised, accompanied by full payment for the Shares.

A condition of the issuance of the Shares as to which an Option shall be exercised shall be the payment of the Option Price. The aggregate Option Price in connection with any Option exercise shall be payable to the Company, in full as determined by the Committee in its discretion, in the manner set forth in the Award Agreement, which shall be one or more of the following: (a) in cash or its equivalent; (b) by tendering (either by actual delivery or attestation) previously acquired Shares having an aggregate fair market value at the time of exercise equal to the aggregate Option Price; (c) by a cashless (broker-assisted) exercise; (d) by the withholding of a number of Shares otherwise issuable upon exercise of the Option having a fair market value on the date of exercise equal to the aggregate Option Price; (e) any other method approved or accepted by the Committee in its sole discretion; or (f) by a combination of (a), (b), (c), (d), and/or (e). Unless otherwise determined by the Committee, all payments under all of the methods indicated above shall be paid or valued in United States dollars.

**6.7** *Termination of Employment*. Each Participant's Award Agreement shall set forth the extent to which the Participant shall have the right to exercise the Option following termination of the Participant's employment or service on the Board or to the Company or its Affiliates, as the case may be. Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with each Participant, need not be uniform among all Options issued pursuant to this <u>Article 6</u>, and may reflect distinctions based on the reasons for termination.

**6.8** *Notification of Disqualifying Disposition*. If any Participant shall make any disposition of Shares issued pursuant to the exercise of an ISO under the circumstances described in Code Section 421(b) (relating to certain disqualifying dispositions), such Participant shall notify the Company of such disposition within ten (10) days thereof.

---

| | |
|:---|:---|
| **Article 7** | **Stock Appreciation Rights** |

---

**7.1** *Grant of SARs*. Subject to the terms and conditions of this Plan, SARs may be granted to Participants at any time and from time to time in such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee, in its sole discretion.

The Grant Price for each grant of an SAR shall be determined by the Committee and shall be specified in the Award Agreement; <u>provided</u>, <u>however</u>, the Grant Price must be at least equal to one hundred percent (100%) of the FMV of a Share on the Grant Date, except in the case of Substitute Awards (to the extent consistent with Code Section 409A).

**7.2** *Award Agreement*. Each SAR grant shall be evidenced by an Award Agreement that shall specify the Grant Price, the term of the SAR, and such other provisions as the Committee shall determine.

---

| | |
|:---|:---|
| **106**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

**7.3** *Term of SAR*. The term of an SAR granted under this Plan shall be determined by the Committee, as specified in the Award Agreement; <u>provided</u>, <u>however</u>, that no SAR shall be exercisable later than the tenth (10th) anniversary of its Grant Date.

**7.4** *Exercise of SARs*. SARs granted under this <u>Article 7</u> shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve, which terms and restrictions need not be the same for each grant or for each Participant.

**7.5** *Settlement of SAR Amount*. Upon the exercise of an SAR, a Participant shall be entitled to receive payment from the Company in an amount determined by multiplying:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The excess of the Fair Market Value of a Share on the date of exercise over the Grant Price; by

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The number of Shares with respect to which the SAR is exercised.

At the discretion of the Committee, the payment upon SAR exercise may be in cash, Shares, or any combination thereof, or in any other manner approved by the Committee in its sole discretion. The Committee's determination regarding the form of SAR payout shall be set forth in the Award Agreement pertaining to the grant of the SAR.

**7.6** *Termination of Employment*. Each Award Agreement shall set forth the extent to which the Participant shall have the right to exercise the SAR following termination of the Participant's employment or service on the Board or to the Company or its Affiliates, as the case may be. Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with Participants, need not be uniform among all SARs issued pursuant to this Plan, and may reflect distinctions based on the reasons for termination.

---

| | |
|:---|:---|
| **Article 8** | **Restricted Stock and Restricted Stock Units** |

---

**8.1** *Grant of Restricted Stock or Restricted Stock Units*. Subject to the terms and provisions of this Plan, Restricted Stock and/or Restricted Stock Units may be granted to Participants in such amounts and upon such terms as shall be determined by the Committee in its sole discretion.

**8.2** *Restricted Stock or Restricted Stock Unit Agreement.* Each Restricted Stock and/or Restricted Stock Unit grant shall be evidenced by an Award Agreement that shall specify the Period(s) of Restriction, the number of Shares of Restricted Stock or the number of Restricted Stock Units granted, and such other provisions as the Committee shall determine.

**8.3** *Other Restrictions*. The Committee shall impose such other conditions and/or restrictions on any Shares of Restricted Stock or Restricted Stock Units granted pursuant to this Plan as it may deem advisable, including a requirement that Participants pay a stipulated purchase price for each Share of Restricted Stock or each Restricted Stock Unit, service-based vesting conditions, restrictions on vesting and transferability based upon the achievement of specific performance goals, service-based restrictions on vesting following the attainment of the performance goals and/or time-based restrictions.

To the extent deemed appropriate by the Committee, the Company may retain the certificates, if any, representing Shares of Restricted Stock in the Company's possession until such time as all conditions and/or restrictions applicable to such Shares have been satisfied or lapse. The Company may place on any certificate, if any, representing Shares issued to a Participant pursuant to this <u>Section 8.3</u> any such legend(s) as the Company or the Committee may deem appropriate.

Except as otherwise provided in this <u>Article 8</u> or in the applicable Award Agreement, after all conditions and restrictions applicable to Shares of Restricted Stock or to Restricted Stock Units have been satisfied or lapse (including satisfaction of any applicable tax withholding obligations), vested Shares shall be made available to the Participant with respect to a Restricted Stock Award or the Restricted Stock Units shall be paid in cash, Shares, or a combination of cash and Shares as the Committee in its sole discretion shall determine. Any such Shares may, however, continue to be subject to certain restrictions as provided in <u>Section 10.2</u>.

**8.4** *Certificate Legend*. In addition to any legends placed on certificates pursuant to <u>Section 8.3</u>, each certificate, if any, representing Shares of Restricted Stock granted pursuant to this Plan may bear a legend such as the following or as otherwise determined by the Committee in its sole discretion:

The sale or transfer of Shares of stock represented by this certificate, whether voluntary, involuntary, or by operation of law, is subject to certain restrictions on transfer as set forth in the Polaris Inc. 2024 Omnibus Incentive Plan, as amended or amended and restated, and in the associated Award Agreement. A copy of the plan and such Award Agreement may be obtained from Polaris Inc.

**8.5** *Voting Rights*. Unless otherwise determined by the Committee and set forth in a Participant's Award Agreement, to the extent permitted or required by law, Participants holding Shares of Restricted Stock granted hereunder shall have the right to exercise full voting rights with respect to those Shares during the Period of Restriction. A Participant shall have no voting rights with respect to any Restricted Stock Units granted hereunder.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **107** |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

**8.6** *Termination of Employment*. Each Award Agreement shall set forth the extent to which the Participant shall have the right to retain Restricted Stock and/or Restricted Stock Units following termination of the Participant's employment or service on the Board or to the Company or its Affiliates, as the case may be. Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with each Participant, need not be uniform among all Shares of Restricted Stock or Restricted Stock Units issued pursuant to this Plan, and may reflect distinctions based on the reasons for termination.

**8.7** *Section 83(b) Election*. The Committee may provide in an Award Agreement that the Award of Restricted Stock is conditioned upon the Participant making or refraining from making an election with respect to the Award under Code Section 83(b). If a Participant makes an election pursuant to Code Section 83(b) concerning a Restricted Stock Award, the Participant shall be required to file promptly a copy of such election with the Company.

---

| | |
|:---|:---|
| **Article 9** | **Other Stock-Based Awards; Cash Incentive Awards** |

---

**9.1** *Other Stock-Based Awards*. The Committee may grant other types of equity-based or equity-related Awards not otherwise described by the terms of this Plan (including the grant or offer for sale of unrestricted Shares) in such amounts and subject to such terms and conditions, as the Committee shall determine. Such Other Stock-Based Awards may involve the transfer of actual Shares to Participants, or payment in cash or otherwise of amounts based on the value of Shares, and may include, without limitation, Awards designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States.

**9.2** *Value of Other Stock-Based Awards*. Each Other Stock-Based Award shall be expressed in terms of Shares or units based on Shares, as determined by the Committee. The Committee may establish performance goals in its discretion for such Other Stock-Based Awards. If the Committee exercises its discretion to establish performance goals, the number and/or value of Other Stock-Based Awards that will be paid out to the Participant will depend on the extent to which the performance goals are met, subject to the terms and conditions of the Plan. The Committee will otherwise determine the terms and conditions of such Other Stock-Based Awards in accordance with this Plan, and each Other Stock-Based Award shall be evidenced by an Award Agreement.

**9.3** *Cash Incentive Awards*. In accordance with this Plan, the Committee may grant Cash Incentive Awards in such amounts and subject to such terms and conditions as the Committee shall determine. Such Cash Incentive Awards will specify the amount payable to which it pertains, which amount may be subject to adjustment to reflect changes in compensation or other factors, and the Performance Period with respect to each Cash Incentive Award will be such period of time as will be determined by the Committee. Each Cash Incentive Award shall be evidenced by an Award Agreement.

**9.4** *Termination of Employment*. The Committee shall determine the extent to which the Participant shall be entitled to the vesting, payment or settlement of Other Stock-Based Awards or Cash Incentive Award following termination of the Participant's employment or service on the Board or to the Company or its Affiliates, as the case may be. Such provisions shall be determined in the sole discretion of the Committee, such provisions may be included in an agreement entered into with each Participant, but need not be uniform among all Awards of Other Stock-Based Awards and/or Cash Incentive Awards issued pursuant to the Plan, and may reflect distinctions based on the reasons for termination.

---

| | |
|:---|:---|
| **Article 10** | **General Terms of Awards** |

---

**10.1** *Dividends and Dividend Equivalents*. No dividends, dividend equivalents or distributions will be paid with respect to Shares subject to an Option or SAR Award. Any dividends or distributions payable with respect to Shares that are subject to the unvested portion of a Restricted Stock Award will be subject to the same restrictions and risk of forfeiture as the Shares to which such dividends or distributions relate. In its discretion, the Committee may provide in an Award Agreement for a Restricted Stock Unit Award or an Other Stock-Based Award that the Participant will be entitled to receive dividend equivalents, based on dividends actually declared and paid on outstanding Shares, on the units or other Share equivalents subject to the Restricted Stock Unit Award or Other Stock-Based Award, and such dividend equivalents will be subject to the same restrictions and risk of forfeiture as the units or other Share equivalents to which such dividend equivalents relate. The additional terms of any such dividend equivalents will be as set forth in the applicable Award Agreement, including the time and form of payment and whether such dividend equivalents will be credited with interest or deemed to be reinvested in additional units or Share equivalents. Any Shares issued or issuable during the term of this Plan as the result of the reinvestment of dividends or the deemed reinvestment of dividend equivalents in connection with an Award or a Prior Plan Award shall be counted against, and replenish upon any subsequent forfeiture, the Plan's Share Authorization as provided in <u>Article 4</u>.

---

| | |
|:---|:---|
| **108**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

**10.2** *Restrictions on Shares*. The Committee may impose such restrictions on any Shares acquired pursuant to the exercise of an Option or SAR, or upon the vesting or payout of a Restricted Stock Award, Restricted Stock Unit Award or Other Stock-Based Award, as it may deem advisable, including minimum holding period requirements, restrictions under applicable federal securities laws or under the requirements of any stock exchange upon which such Shares are then listed and/or traded, or under any blue sky or state securities laws applicable to such Shares.

**10.3** *Leave of Absence and Change in Status*. Except as otherwise provided in this Plan or an Award Agreement, employment of, or provision of services to, the Company or any Affiliate will not be deemed terminated in the case of (a) any approved leave of absence, (b) transfers among the Company and any Affiliates in any capacity of Employee, Director or Third-Party Service Provider, or (c) any change in status so long as the individual remains in the employment or service of the Company or any Affiliate. For purposes of continued employment by a Participant who has been granted an ISO, no approved leave of absence may exceed three months unless reemployment upon expiration of such leave is provided by statute or contract. If reemployment is not so provided, then on the date six months following the first day of such leave, any ISO held by the Participant shall cease to be treated as an ISO and shall be treated for tax purposes as a NQSO.

**10.4** *Performance-Based Awards*. Any Award may be granted as a performance-based Award if the Committee establishes one or more measures of corporate, business unit or individual performance which must be attained, and the Performance Period over which the specified performance is to be attained, as a condition to the vesting, exercisability, lapse of restrictions, retention and/or settlement in cash or Shares of such Award. In connection with any such Award, the Committee shall determine the extent to which performance measures have been attained and other applicable terms and conditions have been satisfied, and the degree to which vesting, exercisability, lapse of restrictions and/or settlement in cash or Shares of such Award has been earned. If the Committee determines that a change in the business, operations, corporate structure or capital structure of the Company, or the manner in which it conducts its business, or other events or circumstances render the applicable performance measures unsuitable, the Committee may in its discretion modify such performance measures or the goals or actual levels of achievement regarding the performance measures, in whole or in part, as the Committee deems appropriate and equitable.

**10.5** *Minimum Vesting Requirements*. Awards that vest based solely on the satisfaction by the Participant of service-based vesting conditions shall be subject to a vesting period of not less than one year from the applicable Grant Date, and Awards whose vesting is subject to the satisfaction of performance goals over a Performance Period shall be subject to a Performance Period of not less than one year. Notwithstanding the foregoing, the foregoing minimum vesting and performance period requirements will not apply to (a) cash-settled Awards, (b) Shares delivered in lieu of fully-vested cash obligations, (c) a Substitute Award that does not reduce the vesting or performance period of the award being assumed or replaced, and (d) Awards involving an aggregate number of Shares not in excess of 5% of the maximum Share Authorization determinable under <u>Section 4.1</u>, as may be adjusted under <u>Section 4.6</u>. Notwithstanding anything in this Plan to the contrary, nothing in this <u>Section 10.5</u> or otherwise in this Plan shall preclude the Committee, in its sole discretion, from (x) providing for continued vesting or accelerated vesting for any Award under the Plan upon certain events, including in connection with or following a Participant's death, disability, or termination of employment or service or a Change in Control or Corporate Transaction, or (y) exercising its authority under <u>Article 3</u> at any time following the grant of an Award.

**10.6** *Deferrals of Awards*. The Committee may, in its discretion, permit or require the deferral by a Participant of the issuance of Shares or payment of cash in settlement of any Full-Value Award, subject to such terms, conditions, rules and procedures as it may establish or prescribe for such purpose and with the intention of complying with the applicable requirements of Code Section 409A. The terms, conditions, rules and procedures for any such deferral shall be set forth in writing in the relevant Award Agreement or in such other agreement, plan or document as the Committee may determine, or some combination of such documents. The terms, conditions, rules and procedures for any such deferral shall address, to the extent relevant, matters such as: (a) the amount of compensation that may or must be deferred (or the method for calculating the amount); (b) the permissible time(s) and form(s) of payment of deferred amounts; (c) the terms and conditions of any deferral elections by a Participant or of any deferral required by the Company; and (d) the crediting of interest or dividend equivalents on deferred amounts.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **109** |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

---

| | |
|:---|:---|
| **Article 11** | **Change in Control** |

---

**11.1** *Corporate Transactions*. Unless otherwise provided in an Award Agreement, the following provisions shall apply to each outstanding Award in the event of a Change in Control that involves a Corporate Transaction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Continuation, Assumption or Replacement of Awards*. In the event of a Corporate Transaction, then the surviving or successor entity (or its Parent) may continue, assume or replace an Award outstanding as of the date of the Corporate Transaction (with such adjustments as may be required or permitted by <u>Article 4</u>), and such Award or replacement therefor shall remain outstanding and be governed by its respective terms, subject to <u>Section 11.1(d)</u> below. A surviving or successor entity may elect to continue, assume or replace only some Awards or portions of Awards. For purposes of this <u>Section 11.1(a)</u>, an Award shall be considered assumed or replaced if, in connection with the Corporate Transaction and in a manner consistent with Code Sections 409A and 424, either (i) the contractual obligations represented by the Award are expressly assumed by the surviving or successor entity (or its Parent) with appropriate adjustments to the number and type of securities subject to the Award and the Option Price or Grant Price, as applicable, thereof (plus any other Award terms) that preserves the intrinsic value of the Award existing at the time of the Corporate Transaction, or (ii) the Participant has received a comparable equity-based award (or cash-based award, in the case of a Cash Incentive Award) that preserves the intrinsic value of the Award existing at the time of the Corporate Transaction and contains terms and conditions that are substantially similar to (or no less favorable to the Participant than) those of the Award.

(b) *Acceleration*. If and to the extent that an outstanding Award under the Plan is not continued, assumed or replaced in connection with a Corporate Transaction, then (i) such Award, to the extent an outstanding Option or SAR Award, shall become fully vested and exercisable for such period of time prior to the effective time of the Corporate Transaction as is deemed fair and equitable by the Committee, and shall terminate at the effective time of the Corporate Transaction, (ii) such Award, to the extent an outstanding Full-Value Award, shall fully vest immediately prior to the effective time of the Corporate Transaction, and/or (iii) to the extent vesting of the Award is subject to satisfaction of specified performance measures/goals, such Award shall be deemed "fully vested" for purposes of this <u>Section 11.1(b)</u> as if the performance have been satisfied at the target level of performance. The Committee shall provide written notice of the period of accelerated exercisability of Options and SARs to all affected Participants. The accelerated exercisability of any Option or SAR pursuant to this <u>Section 11.1(b)</u> and the exercise of any Option or SAR whose exercisability is so accelerated shall be conditioned upon the consummation of the Corporate Transaction, and any such exercise shall be effective only immediately before such consummation.

(c) *Payment for Awards*. If and to the extent that outstanding Awards under the Plan are not continued, assumed or replaced in connection with a Corporate Transaction, then the Committee may provide that some or all of such outstanding Awards shall be cancelled at or immediately prior to the effective time of the Corporate Transaction in exchange for payments to the holders as provided in this <u>Section 11.1(c)</u>. The Committee will not be required to treat all Awards similarly for purposes of this <u>Section 11.1(c)</u>. The payment for any Award cancelled shall be in an amount equal to the difference, if any, between (i) the fair market value (as determined in good faith by the Committee) of the consideration that would otherwise be received in the Corporate Transaction for the number of Shares subject to the Award, and (ii) the aggregate Option Price or Grant Price, as applicable (if any) for the Shares subject to such Award (or the cash value of a Cash Incentive Award, as applicable). If the amount determined pursuant to clause (i) of the preceding sentence is less than or equal to the amount determined pursuant to clause (ii) of the preceding sentence with respect to any Options or SARs Award, such Award may be cancelled pursuant to this <u>Section 11.1(c)</u> without payment of any kind to the affected Participant. With respect to an Award whose vesting is subject to the satisfaction of specified performance goals, the number of Shares subject to such an Award for purposes of this <u>Section 11.1(c)</u> shall be the number of Shares as to which the Award would have been deemed "fully vested" for purposes of <u>Section 11.1(b)</u> (and the cash value for such an Award for purposes of this <u>Section 11.1(c)</u>, if a Cash Incentive Award, shall be the cash to be earned if the Award were "fully vested" for purposes of <u>Section 11.1(b)</u>). Payment of any amount under this <u>Section 11.1(c)</u> shall be made in such form, on such terms and subject to such conditions as the Committee determines in its discretion, which may or may not be the same as the form, terms and conditions applicable to payments to the Company's stockholders in connection with the Corporate Transaction, and may, in the Committee's discretion, include subjecting such payments to vesting conditions comparable to those of the Award cancelled, subjecting such payments to escrow or holdback terms comparable to those imposed upon the Company's stockholders under the Corporate Transaction, or calculating and paying the present value of payments that would otherwise be subject to escrow or holdback terms.

(d) *Termination After a Corporate Transaction*. If and to the extent that Awards are continued, assumed or replaced under the circumstances described in <u>Section 11.1(a)</u>, and if within one year after the Corporate Transaction a Participant experiences an involuntary termination of employment or provision of services as a Director or Third-Party Service Provider for reasons other than Cause, then (i) outstanding options and stock appreciation rights issued to the Participant that are not yet fully exercisable shall immediately become exercisable in full and shall remain exercisable for one year following the Participant's termination of employment or service, and (ii) any other full-value awards that are not yet fully vested shall immediately vest in full (with vesting in full for a performance-based award determined as provided in <u>Section 11.1(b)</u>).

---

| | |
|:---|:---|
| **110**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

**11.2** *Other Change in Control*. In the event of a Change in Control that does not involve a Corporate Transaction, the Committee may, in its discretion, take such action as it deems appropriate with respect to outstanding Awards, which may include: (a) providing for the cancellation of any Award in exchange for payments in a manner similar to that provided in <u>Section 11.1(c)</u>; or (b) making such adjustments to the Awards then outstanding as the Committee deems appropriate to reflect such Change in Control, which may include the acceleration of vesting in full or in part. The Committee will not be required to treat all Awards similarly in such circumstances, and may include such further provisions and limitations in any Award Agreement as it may deem equitable and in the best interests of the Company.

**11.3** *Dissolution or Liquidation*. Unless otherwise provided in an Award Agreement, in the event the stockholders of the Company approve the complete dissolution or liquidation of the Company, all outstanding Awards shall vest and become fully exercisable, and will terminate immediately prior to the consummation of any such proposed action. The Committee will notify each Participant as soon as practicable of such accelerated vesting and exercisability and pending termination.

---

| | |
|:---|:---|
| **Article 12** | **Transferability of Awards** |

---

**12.1** *Transferability*. Except as provided in <u>Section 12.2</u> below, during a Participant's lifetime, his or her Awards shall be exercisable only by the Participant. Awards shall not be transferable other than by will or the laws of descent and distribution, and shall not be transferable for value; no Awards shall be subject, in whole or in part, to attachment, execution, or levy of any kind; and any purported transfer in violation hereof shall be null and void.

**12.2** *Committee Action*. The Committee may, in its discretion, determine that notwithstanding <u>Section 12.1</u>, any or all Awards (other than ISOs) may be transferable by gift to any "family member" (as defined in General Instruction A(5) to Form S-8 under the Securities Act of 1933, as amended). Any Award held by a transferee shall continue to be subject to the same terms and conditions that were applicable to that Award immediately before the transfer thereof. For purposes of any provision of the Plan relating to notice to a Participant or to acceleration or termination of an Award upon the death or termination of employment of a Participant, the references to "Participant" shall mean the original grantee of an Award and not any transferee.

**12.3** *Domestic Relations Orders*. Without limiting the generality of <u>Section 12.1</u>, and notwithstanding <u>Section 12.2</u>, unless otherwise determined by the Committee (but subject to <u>Section 19.14</u> and Section 409A of the Code), no domestic relations order purporting to authorize a transfer of an Award shall be recognized as valid.

---

| | |
|:---|:---|
| **Article 13** | **Beneficiary Designation** |

---

Each Participant under this Plan may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Plan is to be paid in case of his death before he receives any or all of such benefit. Each such designation shall revoke all prior designations by the same Participant, shall be in a form prescribed by the Committee, and will be effective only when filed by the Participant in writing with the Company during the Participant's lifetime. In the absence of any such beneficiary designation, benefits remaining unpaid or rights remaining unexercised at the Participant's death shall be paid or exercised by the Participant's executor, administrator, or legal representative.

---

| | |
|:---|:---|
| **Article 14** | **Rights of Participants** |

---

**14.1** *Employment*. Nothing in this Plan or an Award Agreement shall interfere with or limit in any way the right of the Company or its Affiliates to terminate any Participant's employment or service on the Board or to the Company or its Affiliates at any time or for any reason not prohibited by law, nor confer upon any Participant any right to continue his employment or service as a Director or Third-Party Service Provider for any specified period of time. Neither an Award nor any benefits arising under this Plan shall constitute an employment contract with the Company or its Affiliates and, accordingly, subject to <u>Articles 3</u> and <u>15</u>, this Plan and the benefits hereunder may be terminated at any time in the sole and exclusive discretion of the Committee without giving rise to any liability on the part of the Company or its Affiliates.

**14.2** *Participation*. No individual shall have the right to be selected to receive an Award under this Plan, or, having been so selected, to be selected to receive a future Award.

**14.3** *Rights as a Stockholder*. Except as otherwise provided herein, a Participant shall have none of the rights of a stockholder with respect to Shares covered by any Award until the Participant becomes the record holder of such Shares.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **111** |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

---

| | |
|:---|:---|
| **Article 15** | **Amendment, Modification, Suspension, and Termination** |

---

**15.1** *Amendment, Modification, Suspension, and Termination*. Subject to <u>Section 15.3</u>, the Committee may, at any time and from time to time, alter, amend, modify, suspend, or terminate this Plan and any Award or Award Agreement in whole or in part; <u>provided</u>, <u>however</u>, that, without the prior approval of the Company's stockholders and except as provided in <u>Section 4.6</u>, no Option or SAR may be (a) amended to decrease the Option Price or Grant Price, as applicable, thereof, (b) cancelled in exchange for the grant of any new Option or SAR with a lower exercise price, (c) cancelled in exchange for cash, other property or the grant of any new Full-Value Award at a time when the Option Price of the Option or the Grant Price of the SAR is greater than the current Fair Market Value of a Share, or (d) otherwise subject to any action that would be treated under accounting rules as a "repricing" of such Option or SAR. In addition, no material amendment of this Plan shall be made without stockholder approval if stockholder approval is required by law, regulation, or stock exchange rule.

**15.2** *Adjustment of Awards Upon the Occurrence of Certain Unusual or Nonrecurring Events*. The Committee shall make equitable and appropriate adjustments in the terms and conditions of, and the criteria included in, Awards in recognition of unusual or nonrecurring events (including, without limitation, the events described in <u>Section 4.6</u> or <u>Section 10.4</u> hereof) affecting the Company or the financial statements of the Company or of changes in applicable laws, regulations, or accounting principles, whenever the Committee determines that such adjustments are appropriate in order to prevent unintended dilution or enlargement of the benefits or potential benefits intended to be made available under this Plan. The determination of the Committee as to the foregoing adjustments, if any, shall be conclusive and binding on Participants under this Plan.

**15.3** *Awards Previously Granted*. Notwithstanding any other provision of this Plan to the contrary (other than <u>Section 15.4</u>), no termination, amendment, suspension, or modification of this Plan or an Award Agreement shall adversely affect in any material way any Award previously granted under this Plan without the written consent of the Participant holding such Award.

**15.4** *Amendment to Conform to Law*. Notwithstanding any other provision of this Plan to the contrary, the Committee may amend the Plan or an Award Agreement, to take effect retroactively or otherwise, as deemed necessary or advisable for the purpose of conforming the Plan or an Award Agreement to any present or future law or stock exchange rule relating to plans of this or similar nature (including, but not limited to, Code Section 409A), and to any administrative regulations and rulings promulgated thereunder.

---

| | |
|:---|:---|
| **Article 16** | **Substitute Awards** |

---

The Committee may grant Awards under the Plan in substitution for, or in connection with the assumption of, existing awards granted or issued by another entity and assumed or otherwise agreed to be provided for by the Company pursuant to or by reason of a transaction involving a merger, consolidation, acquisition of property or stock, separation, reorganization or liquidation to which the Company or an Affiliate is a party, as permitted by applicable law and stock exchange rules and regulations. Subject to applicable law, the terms and conditions of the Substitute Awards may vary from the terms and conditions set forth in the Plan to the extent that the Committee at the time of the grant may deem appropriate to conform, in whole or in part, to the provisions of the awards in substitution for which they are granted.

---

| | |
|:---|:---|
| **Article 17** | **Withholding** |

---

**17.1** *Tax Withholding*. The Company shall have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy federal, state, and local taxes, domestic or foreign, or other amounts required by law or regulation to be withheld with respect to any taxable event arising as a result of this Plan.

**17.2** *Share Withholding*. With respect to tax withholding required upon the grant, vesting, exercise or settlement of an Award granted hereunder (or other applicable event), Participants may elect, subject to the approval of the Committee, as set forth in the applicable Award Agreement, to satisfy the withholding requirement, in whole or in part (up to the Participant's maximum required tax withholding rate), by having the Company withhold Shares, or by the Participant delivering to the Company already owned Shares, in either case having a fair market value on the date the tax is to be determined equal to the amount required to be withheld. All such elections shall be irrevocable, made in writing, and signed by the Participant, and shall be subject to any restrictions or limitations that the Committee, in its sole discretion, deems appropriate.

---

| | |
|:---|:---|
| **112**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

---

| | |
|:---|:---|
| **Article 18** | **Successors** |

---

All obligations of the Company under this Plan with respect to Awards granted hereunder shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.

---

| | |
|:---|:---|
| **Article 19** | **General Provisions** |

---

**19.1** *Forfeiture Events*.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Committee may specify in an Award Agreement that the Participant's rights, payments, and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture, or recoupment upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions of an Award. Such events may include, but shall not be limited to: termination of employment for Cause; termination of the Participant's provision of services to the Company or any Affiliate; violation of material Company or Affiliate policies; breach of confidentiality, nonsolicitation, noncompetition, invention assignment, or other restrictive covenants that may apply to the Participant; or other conduct by the Participant that is detrimental to the business or reputation of the Company or its Affiliates.

(b) Awards granted under this Plan are subject to the terms and conditions of the Company's clawback provisions, policy or policies (if any) as may be in effect from time to time, including specifically to implement Section 10D of the Exchange Act, and any applicable rules or regulations promulgated thereunder (including applicable rules and regulations of any national securities exchange on which the Shares at any point may be traded) (the "Compensation Recovery Policy"), and applicable sections of any Award Agreement to which this Plan is applicable or any related documents shall be interpreted consistently with (or deemed superseded by and/or subject to, as applicable) the terms and conditions of the Compensation Recovery Policy. Further, by accepting any award under the Plan, each Participant agrees (or has agreed) to fully cooperate with and assist the Company in connection with any of such Participant's obligations to the Company pursuant to the Compensation Recovery Policy, and agrees (or has agreed) that the Company may enforce its rights under the Compensation Recovery Policy through any and all reasonable means permitted under applicable law as it deems necessary or desirable under the Compensation Recovery Policy, in each case from and after the effective dates thereof. Such cooperation and assistance shall include, but is not limited to, executing, completing and submitting any documentation necessary to facilitate the recovery or recoupment by the Company from such Participant of any such amounts, including from such Participants' accounts or from any other compensation, to the extent permissible under Section 409A of the Code. Otherwise, any Award Agreement (or any part thereof) may provide for the cancellation or forfeiture of an award or the forfeiture and repayment to the Company of any gain or earnings related to an award (or other provisions intended to have similar effects), including upon such terms and conditions as may be determined by the Board or the Committee in accordance with the Compensation Recovery Policy or any applicable laws, rules, regulations or requirements that impose mandatory clawback or recoupment requirements under the circumstances set forth in such laws, rules, regulations or requirements in effect from time to time (including as may operate to create additional rights for the Company with respect to such awards and the recovery of amounts or benefits relating thereto).

**19.2** *Uncertificated Shares*. To the extent that this Plan provides for issuance of certificates to reflect the transfer of Shares, the transfer of such Shares may be effected on a noncertificated basis, to the extent not prohibited by applicable law or the rules of any stock exchange upon which such Shares are then listed and/or traded.

**19.3** *Legend*. The certificates, or book-entry confirmation or notification in the case of uncertificated Shares, for Shares may include any legend which the Committee deems appropriate to reflect any restrictions on transfer of such Shares, including the legends described in <u>Sections 8.3</u> and <u>8.4</u>.

**19.4** *Gender and Number*. Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine, the plural shall include the singular, and the singular shall include the plural.

**19.5** *Severability*. In the event any provision of this Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of this Plan, and this Plan shall be construed and enforced as if the illegal or invalid provision had not been included.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **113** |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

**19.6** *Requirements of Law*. The granting of Awards and the issuance of Shares under this Plan shall be subject to all applicable laws, rules, and regulations, including compliance with the provisions of applicable state and federal securities laws, and to such approvals by any governmental agencies or stock exchange as may be required. Notwithstanding anything in this Plan or an Award Agreement to the contrary, (a) nothing in this Plan or an Award Agreement or otherwise limits a Participant's rights to any monetary award offered by a government-administered whistleblower award program for providing information directly to a government agency (including the Securities and Exchange Commission pursuant to Section 21F of the Exchange Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act or The Sarbanes-Oxley Act of 2002) and (b) nothing in this Plan or in an Award Agreement prevents a Participant from providing, without prior notice to the Company, information to governmental authorities regarding possible legal violations or otherwise testifying or participating in any investigation or proceeding by any governmental authorities regarding possible legal violations, and for purpose of clarity a Participant is not prohibited from providing information voluntarily to the Securities and Exchange Commission pursuant to Section 21F of the Exchange Act.

**19.7** *Delivery of Title*. The Company shall have no obligation to issue or deliver evidence of title for Shares issued under this Plan prior to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Obtaining any approvals from governmental agencies that the Company determines are necessary or advisable; and

(b) Completion of any registration or other qualification of the Shares under any applicable national or foreign law or ruling of any governmental body that the Company determines to be necessary or advisable.

**19.8** *Inability to Obtain Authority*. The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company's counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.

**19.9** *Investment Representations*. The Committee may require any individual receiving Shares pursuant to an Award under this Plan to represent and warrant in writing that the individual is acquiring the Shares for investment and without any present intention to sell or distribute such Shares.

**19.10** *Employees Based Outside of the United States*. Notwithstanding any provision of this Plan to the contrary, in order to comply with the laws in other countries in which the Company or its Affiliates operate or have Employees, Directors, or Third-Party Service Providers, the Committee, in its sole discretion, shall have the power and authority to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Determine which Affiliates shall be covered by this Plan;

(b) Determine which Employees, Directors, or Third-Party Service Providers outside the United States are eligible to participate in this Plan;

(c) Modify the terms and conditions of any Award granted to Employees, Directors, or Third-Party Service Providers outside the United States to comply with applicable foreign laws;

(d) Establish subplans (to be considered part of this Plan) and modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable. Any subplans and modifications to Plan terms and procedures established under this <u>Section 19.10</u> by the Committee shall be attached to this Plan document as appendices; and

(e) Take any action, before or after an Award is made, that it deems advisable to obtain approval or comply with any necessary local government regulatory exemptions or approvals.

Notwithstanding the above, the Committee may not take any actions hereunder, and no Awards shall be granted, that would violate applicable law.

**19.11** *Unfunded Plan*. Participants shall have no right, title, or interest whatsoever in or to any investments that the Company or its Affiliates may make to aid it in meeting its obligations under this Plan. Nothing contained in this Plan, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind, or a fiduciary relationship between the Company and any Participant, beneficiary, legal representative, or any other individual. To the extent that any individual acquires a right to receive payments from the Company or its Affiliates under this Plan, such right shall be no greater than the right of an unsecured general creditor of the Company or Affiliate, as the case may be. All payments to be made hereunder shall be paid from the general funds of the Company or Affiliate, as the case may be, and no special or separate fund shall be established and no segregation of assets shall be made to assure payment of such amounts except as expressly set forth in this Plan.

**19.12** *No Fractional Shares*. No fractional Shares shall be issued or delivered pursuant to this Plan or any Award. The Committee shall determine whether cash, Awards, or other property shall be issued or paid in lieu of fractional Shares or whether such fractional Shares or any rights thereto shall be forfeited or otherwise eliminated.

**19.13** *Retirement and Welfare Plans*. Neither Awards made under this Plan nor Shares or cash paid pursuant to such Awards, may be included as "compensation" for purposes of computing the benefits payable to any Participant under the Company's or any Affiliate's retirement plans (both qualified and nonqualified) or welfare benefit plans unless such other plan expressly provides that such compensation shall be taken into account in computing a Participant's benefit.

---

| | |
|:---|:---|
| **114**&nbsp;&nbsp;&nbsp;&nbsp; | ![](footer.jpg) - 2026 Proxy Statement |

---

------

[**Table of Contents**](#toc)

**Appendix B**

**Polaris Inc. 2024 Omnibus Incentive Plan (As Amended and Restated Effective April 30, 2026)**

**19.14** *Code Section 409A*. It is intended that (a) all Awards of Options, SARs and Restricted Stock under the Plan will not provide for the deferral of compensation within the meaning of Code Section 409A and thereby be exempt from Code Section 409A, and (b) all other Awards under the Plan will either not provide for the deferral of compensation within the meaning of Code Section 409A, or will comply with the requirements of Code Section 409A, and Awards shall be structured and the Plan administered and interpreted in accordance with this intent. Any reference in this Plan to Section 409A of the Code will also include any regulations or any other formal guidance promulgated with respect to such section by the U.S. Department of the Treasury or the Internal Revenue Service. The Plan and any Award Agreement may be unilaterally amended by the Company in any manner deemed necessary or advisable by the Committee or Board in order to maintain such exemption from or compliance with Code Section 409A, and any such amendment shall conclusively be presumed to be necessary to conform to applicable law. Notwithstanding anything to the contrary in the Plan or any Award Agreement, with respect to any Award that constitutes a deferral of compensation subject to Code Section 409A:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) If any amount is payable under such Award upon a termination of employment with, or other service to, the Company and its Affiliates, such termination will be deemed to have occurred only at such time as the Participant has experienced a "separation from service" as such term is defined for purposes of Code Section 409A;

(b) Except as permitted under Section 409A of the Code, such Award may not be reduced by, or offset against, any amount owed by a Participant to the Company or any of its Subsidiaries, and such Award may not be subject to any anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment or garnishment; and

(c) If any amount shall be payable with respect to any such Award as a result of a Participant's "separation from service" at such time as the Participant is a "specified employee" within the meaning of Code Section 409A, then no payment shall be made, except as permitted under Code Section 409A, prior to the first business day after the earlier of (i) the date that is six months after the Participant's separation from service or (ii) the Participant's death. Unless the Committee has adopted a specified employee identification policy as contemplated by Code Section 409A, specified employees will be identified in accordance with the default provisions specified under Code Section 409A.

None of the Company, the Board, the Committee nor any other person involved with the administration of this Plan shall (f) in any way be responsible for ensuring the exemption of any Award from, or compliance by any Award with, the requirements of Code Section 409A, (g) have any obligation to design or administer the Plan or Awards granted thereunder in a manner that minimizes a Participant's tax liabilities, including the avoidance of any additional tax liabilities under Code Section 409A, or (h) have any liability to any Participant for any such tax liabilities.

**19.15** *Nonexclusivity of this Plan*. The adoption of this Plan shall not be construed as creating any limitations on the power of the Board or Committee to adopt such other compensation arrangements as it may deem desirable for any Participant.

**19.16** *No Constraint on Corporate Action*. Nothing in this Plan shall be construed to: (a) limit, impair, or otherwise affect the Company's or an Affiliate's right or power to make adjustments, reclassifications, reorganizations, or changes of its capital or business structure, or to merge or consolidate, or dissolve, liquidate, sell, or transfer all or any part of its business or assets; or (b) limit the right or power of the Company or an Affiliate to take any action which such entity deems to be necessary or appropriate.

**19.17** *Governing Law*. The Plan and each Award Agreement shall be governed by the laws of the State of Delaware, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Plan to the substantive law of another jurisdiction. Unless otherwise provided in the Award Agreement, recipients of an Award under this Plan are deemed to submit to the exclusive jurisdiction and venue of the federal or state courts of Delaware, to resolve any and all issues that may arise out of or relate to this Plan or any related Award Agreement.

---

| | |
|:---|:---|
| 2026 Proxy Statement ![](footer.jpg) | &nbsp;&nbsp;&nbsp;&nbsp; **115** |

---

------

[**Table of Contents**](#toc)

![](pro014545-def14ax120x1.jpg)

------

[**Table of Contents**](#toc)

*ATTN: JC WEIGELT* 

*POLARIS INC.*

*2100 HIGHWAY 55*

*MEDINA, MN 55340*

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;![](pro014545_def14ax98x1.jpg) | **SCAN TO**<br> **VIEW MATERIALS & VOTE** | &nbsp;&nbsp;&nbsp;![](pro014545_def14ax98x2.jpg) |

---

**VOTE BY INTERNET**

*Before The Meeting* - Go to **<u>www.proxyvote.com</u> or scan the QR Barcode above**

Use the Internet to transmit your voting instructions and for electronic delivery of information. Vote by 11:59 P.M. Eastern Time on April 29, 2026 for shares held directly and by 11:59 P.M. Eastern Time on April 27, 2026 for shares held in a Plan. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.

*During The Meeting* - Go to **<u>www.virtualshareholdermeeting.com/PII2026</u>**

You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions.

**VOTE BY PHONE - 1-800-690-6903**

Use any touch-tone telephone to transmit your voting instructions. Vote by 11:59 P.M. Eastern Time on April 29, 2026 for shares held directly and by 11:59 P.M. Eastern Time on April 27, 2026 for shares held in a Plan. Have your proxy card in hand when you call and then follow the instructions.

**VOTE BY MAIL**

Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.

TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:

  <u>V85916-P42481</u> <u>KEEP THIS PORTION FOR YOUR RECORDS</u> <br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; DETACH AND RETURN THIS PORTION ONLY

**THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.**

**POLARIS INC.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **The Board of Directors recommends you vote FOR the nominees listed in Proposal 1:** | **The Board of Directors recommends you vote FOR the nominees listed in Proposal 1:** |  |  |  |
| 1. | The election of three Class II directors for three-year terms ending 2029 |  |  |  |
|  | **Nominees** | **For** | **Against** | **Abstain** |
|  | 1a. George W. Bilicic | □ | &nbsp;&nbsp;□ | □ |
|  | 1b. Gary E. Hendrickson | □ | &nbsp;&nbsp;□ | □ |
|  | 1c. Gwenne A. Henricks | □ | &nbsp;&nbsp;□ | □ |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **The Board of Directors recommends you vote FOR Proposals 2, 3 and 4:** | **The Board of Directors recommends you vote FOR Proposals 2, 3 and 4:** | **For** | **Against** | **Abstain** |
| 2. | Advisory vote to approve the compensation of the Company's Named Executive Officers | □ | &nbsp;&nbsp;□ | □ |
| 3. | Adoption of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive Plan | □ | &nbsp;&nbsp;□ | □ |
| 4. | Ratification of the appointment of Ernst & Young LLP as our independent registered accounting firm for fiscal 2026 | □ | &nbsp;&nbsp;□ | □ |

---

Please sign exactly as your name(s) appear(s) on the proxy. Joint owners should each sign. When signing as attorney, executor, trustee, administrator or guardian, please give full title as such. If signing for a corporation, provide the name of the corporation and your full title. <br>

        <br> Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date

------

[**Table of Contents**](#toc)

**Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:**

The Notice and Proxy Statement and Annual Report with Form 10-K are available at www.proxyvote.com.

V85917-P42481

**POLARIS INC.**

 **Annual Meeting of Stockholders**

 **April 30, 2026 9:00 AM, CT**

 **This proxy is solicited by the Board of Directors**

The stockholder(s) hereby appoint(s) Sarah M. Maveus and Robert P. Mack, or either of them, as proxies, each with the power to appoint his or her substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this proxy, all of the shares of Common Stock of POLARIS INC. that the stockholder(s) held of record at the close of business on March 9, 2026 and is/are entitled to vote at the Annual Meeting of Stockholders to be held at 9:00 AM, CT on April 30, 2026, at www.virtualshareholdermeeting.com/PII2026, and any adjournment or postponement thereof.

**This proxy, when properly executed, will be voted in the manner directed on the reverse side. If no such direction is given, this proxy will be voted in accordance with the Board of Directors' recommendations. It will be voted in the discretion of the proxies upon such other matters as may properly come before the Annual Meeting or any adjournment thereof.**

**Continued and to be signed on reverse side**

------

### Attached PDF Documents

**Attachment 1:** `pii_courtesy-pdf.pdf`

_No text found in this document._